
<html lang="en"     class="pb-page"  data-request-id="62935e70-ce43-45d9-a8a7-77d4a17426e6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.0c00807;requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2020.63.issue-14;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="2-Arylbenzo[d]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular Dystrophy" /></meta><meta name="dc.Creator" content="Arran  Babbs" /></meta><meta name="dc.Creator" content="Adam  Berg" /></meta><meta name="dc.Creator" content="Maria  Chatzopoulou" /></meta><meta name="dc.Creator" content="Kay E.  Davies" /></meta><meta name="dc.Creator" content="Stephen G.  Davies" /></meta><meta name="dc.Creator" content="Benjamin  Edwards" /></meta><meta name="dc.Creator" content="David J.  Elsey" /></meta><meta name="dc.Creator" content="Enrico  Emer" /></meta><meta name="dc.Creator" content="Simon  Guiraud" /></meta><meta name="dc.Creator" content="Shawn  Harriman" /></meta><meta name="dc.Creator" content="Cristina  Lecci" /></meta><meta name="dc.Creator" content="Lee  Moir" /></meta><meta name="dc.Creator" content="David  Peters" /></meta><meta name="dc.Creator" content="Neil  Robinson" /></meta><meta name="dc.Creator" content="Jessica A.  Rowley" /></meta><meta name="dc.Creator" content="Angela J.  Russell" /></meta><meta name="dc.Creator" content="Sarah E.  Squire" /></meta><meta name="dc.Creator" content="Jonathon M.  Tinsley" /></meta><meta name="dc.Creator" content="Francis X.  Wilson" /></meta><meta name="dc.Creator" content="Graham M.  Wynne" /></meta><meta name="dc.Description" content="Utrophin modulation is a promising therapeutic strategy for Duchenne muscular dystrophy (DMD), which should be applicable to all patient populations. Following on from ezutromid, the first-generati..." /></meta><meta name="Description" content="Utrophin modulation is a promising therapeutic strategy for Duchenne muscular dystrophy (DMD), which should be applicable to all patient populations. Following on from ezutromid, the first-generati..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 18, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00807" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00807" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00807" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00807" /></link>
        
    
    

<title>2-Arylbenzo[d]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular Dystrophy | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00807" /></meta><meta property="og:title" content="2-Arylbenzo[d]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular Dystrophy" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0012.jpeg" /></meta><meta property="og:description" content="Utrophin modulation is a promising therapeutic strategy for Duchenne muscular dystrophy (DMD), which should be applicable to all patient populations. Following on from ezutromid, the first-generation utrophin modulator, we describe the development of a second generation of utrophin modulators, based on the bioisosteric replacement of the sulfone group with a phosphinate ester and substitution of the metabolically labile naphthalene with a haloaryl substituent. The improved physicochemical and absorption, distribution, metabolism, and excretion (ADME) properties, further reflected in the enhanced pharmacokinetic profile of the most advanced compounds, 30 and 27, led to significantly better in vivo exposure compared to ezutromid and alleviation of the dystrophic phenotype in mdx mice. While 30 was found to have dose-limiting hepatotoxicity, 27 and its enantiomers exhibited limited off-target effects, resulting in a safe profile and highlighting their potential utility as next-generation utrophin modulators suitable for progression toward a future DMD therapy." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00807"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00807">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00807&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00807&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00807&amp;href=/doi/10.1021/acs.jmedchem.0c00807" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 7880-7891</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00711" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00929" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">2-Arylbenzo[<i>d</i>]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular Dystrophy</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Arran Babbs</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Arran Babbs</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MDUK Oxford Neuromuscular Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Arran++Babbs">Arran Babbs</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Adam Berg</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adam Berg</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MDUK Oxford Neuromuscular Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adam++Berg">Adam Berg</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maria Chatzopoulou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maria Chatzopoulou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Chatzopoulou">Maria Chatzopoulou</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1886-7705" title="Orcid link">http://orcid.org/0000-0003-1886-7705</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kay E. Davies</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kay E. Davies</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MDUK Oxford Neuromuscular Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#84efe5fdaae0e5f2ede1f7c4e0f4e5e3aaebfcaae5e7aaf1ef"><span class="__cf_email__" data-cfemail="a7ccc6de89c3c6d1cec2d4e7c3d7c6c089c8df89c6c489d2cc">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kay+E.++Davies">Kay E. Davies</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stephen G. Davies</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephen G. Davies</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+G.++Davies">Stephen G. Davies</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3181-8748" title="Orcid link">http://orcid.org/0000-0003-3181-8748</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Benjamin Edwards</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Benjamin Edwards</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MDUK Oxford Neuromuscular Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin++Edwards">Benjamin Edwards</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David J. Elsey</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David J. Elsey</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Summit Therapeutics plc, 136a Eastern Avenue, Milton Park, Abingdon, Oxfordshire OX14 4SB, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Elsey">David J. Elsey</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Enrico Emer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Enrico Emer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Enrico++Emer">Enrico Emer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Simon Guiraud</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Simon Guiraud</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MDUK Oxford Neuromuscular Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Simon++Guiraud">Simon Guiraud</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shawn Harriman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shawn Harriman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Summit Therapeutics plc, 136a Eastern Avenue, Milton Park, Abingdon, Oxfordshire OX14 4SB, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shawn++Harriman">Shawn Harriman</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cristina Lecci</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cristina Lecci</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Evotec (UK) Ltd, 114 Innovation Dr, Milton Park, Milton, Abingdon OX14 4RZ, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cristina++Lecci">Cristina Lecci</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lee Moir</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lee Moir</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MDUK Oxford Neuromuscular Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lee++Moir">Lee Moir</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David Peters</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Peters</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Summit Therapeutics plc, 136a Eastern Avenue, Milton Park, Abingdon, Oxfordshire OX14 4SB, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Peters">David Peters</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Neil Robinson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Neil Robinson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">S.H.B. Enterprises Ltd, 55 Station Road, Beaconsfield HP19 1QL, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Neil++Robinson">Neil Robinson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jessica A. Rowley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jessica A. Rowley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jessica+A.++Rowley">Jessica A. Rowley</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Angela J. Russell</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Angela J. Russell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K.</div><div class="loa-info-affiliations-info">Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3PQ, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#c0a1aea7a5aca1eeb2b5b3b3a5acac80a3a8a5adeeafb8eea1a3eeb5ab"><span class="__cf_email__" data-cfemail="f2939c95979e93dc80878181979e9eb2919a979fdc9d8adc9391dc8799">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Angela+J.++Russell">Angela J. Russell</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3610-9369" title="Orcid link">http://orcid.org/0000-0003-3610-9369</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sarah E. Squire</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sarah E. Squire</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MDUK Oxford Neuromuscular Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sarah+E.++Squire">Sarah E. Squire</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jonathon M. Tinsley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jonathon M. Tinsley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Summit Therapeutics plc, 136a Eastern Avenue, Milton Park, Abingdon, Oxfordshire OX14 4SB, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jonathon+M.++Tinsley">Jonathon M. Tinsley</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Francis X. Wilson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Francis X. Wilson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Summit Therapeutics plc, 136a Eastern Avenue, Milton Park, Abingdon, Oxfordshire OX14 4SB, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Francis+X.++Wilson">Francis X. Wilson</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Graham M. Wynne</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Graham M. Wynne</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Graham+M.++Wynne">Graham M. Wynne</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00807&amp;href=/doi/10.1021%2Facs.jmedchem.0c00807" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 7880–7891</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 18, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 May 2020</li><li><span class="item_label"><b>Published</b> online</span>18 June 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 July 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00807" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00807</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7880%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DArran%2BBabbs%252C%2BAdam%2BBerg%252C%2BMaria%2BChatzopoulou%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D14%26contentID%3Dacs.jmedchem.0c00807%26title%3D2-Arylbenzo%255Bd%255Doxazole%2BPhosphinate%2BEsters%2Bas%2BSecond-Generation%2BModulators%2Bof%2BUtrophin%2Bfor%2Bthe%2BTreatment%2Bof%2BDuchenne%2BMuscular%2BDystrophy%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7891%26publicationDate%3DJuly%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00807"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1256</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00807" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;2-Arylbenzo[d]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular Dystrophy&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Arran&quot;,&quot;last_name&quot;:&quot;Babbs&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;Berg&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Chatzopoulou&quot;},{&quot;first_name&quot;:&quot;Kay&quot;,&quot;last_name&quot;:&quot;E. Davies&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;G. Davies&quot;},{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;Edwards&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Elsey&quot;},{&quot;first_name&quot;:&quot;Enrico&quot;,&quot;last_name&quot;:&quot;Emer&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;Guiraud&quot;},{&quot;first_name&quot;:&quot;Shawn&quot;,&quot;last_name&quot;:&quot;Harriman&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;Lecci&quot;},{&quot;first_name&quot;:&quot;Lee&quot;,&quot;last_name&quot;:&quot;Moir&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Peters&quot;},{&quot;first_name&quot;:&quot;Neil&quot;,&quot;last_name&quot;:&quot;Robinson&quot;},{&quot;first_name&quot;:&quot;Jessica&quot;,&quot;last_name&quot;:&quot;A. Rowley&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;J. Russell&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;E. Squire&quot;},{&quot;first_name&quot;:&quot;Jonathon&quot;,&quot;last_name&quot;:&quot;M. Tinsley&quot;},{&quot;first_name&quot;:&quot;Francis&quot;,&quot;last_name&quot;:&quot;X. Wilson&quot;},{&quot;first_name&quot;:&quot;Graham&quot;,&quot;last_name&quot;:&quot;M. Wynne&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;7880-7891&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00807&quot;},&quot;abstract&quot;:&quot;Utrophin modulation is a promising therapeutic strategy for Duchenne muscular dystrophy (DMD), which should be applicable to all patient populations. Following on from ezutromid, the first-generation utrophin modulator, we describe the development of a second generation of utrophin modulators, based on the bioisosteric replacement of the sulfone group with a phosphinate ester and substitution of the metabolically labile naphthalene with a haloaryl substituent. The improved physicochemical and absorption, distribution, metabolism, and excretion (ADME) properties, further reflected in the enhanced pharmacokinetic profile of the most advanced compounds, 30 and 27, led to significantly better in vivo exposure compared to ezutromid and alleviation of the dystrophic phenotype in mdx mice. While 30 was found to have dose-limiting hepatotoxicity, 27 and its enantiomers exhibited limited off-target effects, resulting in a safe profile and highlighting their potential utility as next-generation utrophin modulators suit&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00807&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00807" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00807&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00807" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00807&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00807" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00807&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00807&amp;href=/doi/10.1021/acs.jmedchem.0c00807" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00807" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00807" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00807%26sid%3Dliteratum%253Aachs%26pmid%3D32551645%26genre%3Darticle%26aulast%3DBabbs%26date%3D2020%26atitle%3D2-Arylbenzo%255Bd%255Doxazole%2BPhosphinate%2BEsters%2Bas%2BSecond-Generation%2BModulators%2Bof%2BUtrophin%2Bfor%2Bthe%2BTreatment%2Bof%2BDuchenne%2BMuscular%2BDystrophy%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D14%26spage%3D7880%26epage%3D7891%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a>,</li><li><a href="/action/doSearch?ConceptID=290716" title="Sulfones">Sulfones</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/jmcmar.2020.63.issue-14/20200723/jmcmar.2020.63.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00807&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Utrophin modulation is a promising therapeutic strategy for Duchenne muscular dystrophy (DMD), which should be applicable to all patient populations. Following on from ezutromid, the first-generation utrophin modulator, we describe the development of a second generation of utrophin modulators, based on the bioisosteric replacement of the sulfone group with a phosphinate ester and substitution of the metabolically labile naphthalene with a haloaryl substituent. The improved physicochemical and absorption, distribution, metabolism, and excretion (ADME) properties, further reflected in the enhanced pharmacokinetic profile of the most advanced compounds, <b>30</b> and <b>27</b>, led to significantly better <i>in vivo</i> exposure compared to ezutromid and alleviation of the dystrophic phenotype in <i>mdx</i> mice. While <b>30</b> was found to have dose-limiting hepatotoxicity, <b>27</b> and its enantiomers exhibited limited off-target effects, resulting in a safe profile and highlighting their potential utility as next-generation utrophin modulators suitable for progression toward a future DMD therapy.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83300" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83300" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Duchenne muscular dystrophy (DMD) is an X-linked recessive progressive muscle-wasting disorder that affects 1 in 5000 male births.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> DMD is caused by mutations in the dystrophin gene, leading to the functional loss of the cytoplasmic protein, dystrophin. Dystrophin (427 kDa) is a vital component of the dystrophin associated protein complex (DAPC), providing structural stability, strength, and flexibility to the skeletal muscle by connecting the internal cytoskeleton to the extracellular matrix. The absence of dystrophin results in muscle necrosis and regeneration, leading to replacement of muscle fibers with adipose and fibrotic tissues. Symptoms include progressive muscle weakness, motor development delay, and abnormal gait from early childhood, and patients usually lose ambulation by 8–12 years of age. Premature death typically results at age 20–30 because of respiratory and cardiac failure.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a></div><div class="NLM_p">For the majority of the patient population, current treatments involve alleviating downstream effects (inflammation and fibrosis) with the use of clinical management and corticosteroids.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> Although symptomatic and supportive treatments have increased the life expectancy of DMD patients raising median survival from 26 to 41 years,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> no effective disease-modifying treatment currently exists. Therapies addressing patient subpopulations through mutation-specific approaches such as stop-codon read through (ataluren) and exon skipping (eteplirsen and golodirsen, for exons 51 and 53, respectively) have received conditional approval, and gene therapy treatments are being developed.<a onclick="showRef(event, 'ref2 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref5">(2,5)</a> Consequently, there is an urgent need for a therapy that is applicable to the whole patient population.</div><div class="NLM_p">For many years, we and others have been investigating an alternative strategy to treat DMD: to upregulate the expression of utrophin, a structural and functional paralog of dystrophin, to compensate for the lack of dystrophin in patients.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The partial alleviation of DMD pathology has been achieved through the expression of a truncated utrophin minigene in transgenic <i>mdx</i> mice, providing evidence for utrophin modulation as a viable treatment strategy.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The expression of a full-length utrophin gene in the <i>mdx</i> model also prevented functional signs of DMD pathology in a dose-dependent manner.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a><named-content content-type="anchor" rid="fig1" type="simple"></named-content></div><div class="NLM_p">Ezutromid <b>1</b> (formerly SMT C1100) was a first-in-class small molecule utrophin modulator developed by Summit Therapeutics which was well tolerated in Phase 1a and 1b clinical trials following oral administration.<a onclick="showRef(event, 'ref2 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref2 ref9 ref10">(2,9,10)</a> In a multi-center, open-label Phase 2 clinical trial (PhaseOut DMD), ezutromid demonstrated a statistically significant and meaningful decrease in muscle regeneration and muscle inflammation after 24 weeks of treatment. However, these effects were not observed after 48 weeks, and the development of ezutromid was discontinued.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Although found to be safe and well tolerated in patients, the exposure of ezutromid was found to be lower than anticipated in a Phase 1 healthy volunteer trial and a Phase 1b trial of 12 DMD patients, and drug levels reduced significantly following repeated dosing.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> Ezutromid also has sub-optimal physicochemical properties and is extensively metabolized in humans to the corresponding 1,2-dihydrodiol metabolites DHD 1 and DHD 3, both of which show reduced or no activity.<a onclick="showRef(event, 'ref1 ref10 ref12'); return false;" href="javascript:void(0);" class="ref ref1 ref10 ref12">(1,10,12)</a> Taken together, these findings can rationalize the initial positive benefit followed by the lack of sustained efficacy in the Phase 2 clinical trial.</div><div class="NLM_p">As a result of these findings, a medicinal chemistry program was conducted to develop second-generation utrophin modulators, with improved physicochemical properties and metabolic stability compared to ezutromid, whilst maintaining a good safety profile. Optimization was focused around replacing the sulfone moiety (Region A, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), in order to improve the compound’s aqueous solubility, and the naphthalene moiety (Region B, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which was found to be the metabolic hotspot.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a><named-content content-type="anchor" rid="sch1" type="simple"></named-content><named-content content-type="anchor" rid="sch2" type="simple"></named-content></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Clinical candidate ezutromid (<b>1</b>, SMT C1100). Regions A and B denote sites of modifications to improve solubility (A) and metabolic stability (B) whilst maintaining a good efficacy and safety profile.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00807&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51670" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51670" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The general preparation of amide benzo[<i>d</i>]oxazoles, discussed extensively in previous publications,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> was applied here to generate naphthyl amide derivatives <b>2</b>, <b>3</b>, and cyclic sulfonamide <b>4</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Sulfonamide <b>5</b> was derived from the respective 2-aminophenol via a modification of Method B (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Amide and Sulphonamide Derivatives <b>2</b>−<b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00807&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) naphthoic acid, PPA, 180 °C, 3 h, 63%; (ii) acyl chloride, pyridine, rt, 24 h, 67–83% (<b>2–3</b>); (iii) 1.3-chloropropanesulfonyl chloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, reflux, 1 h 2. NaH, DMF, rt to 90 °C, 16 h, 22% over two steps; (iv) 1. ArCHO, MeOH, 50 °C, 45 min, 2. DDQ, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Route to Phosphinate Esters<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00807&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Method A: Step 1. ArCOCl, dioxane, 210 °C, 3 h, MW, or Method B: ArCHO, MeOH, 50 °C, 45 min, Step 2. DDQ, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h, 38% (7–83% and 19–82% for Methods A and B, respectively), or Method C: Step 1. ArCHO, EtOH, 80 °C, 90 min, Step 2. PhI(OAc)<sub>2</sub>, MeOH, 60 °C, 30 min, (44–57%) or Method D: Step 1. ArCOCl, xylenes, 155 °C, 1 h, Step 2. MsOH, 155 °C, 2–3 h, (12–81%); (ii) Method F: HP(O)OR<sub>1</sub>R<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Et<sub>3</sub>N, toluene, 110 °C, 3 h, (5–81%) or Method G: HP(O)OMeEt, Pd<sub>2</sub>(dba)<sub>3</sub>, Cs<sub>2</sub>CO<sub>3</sub>, THF, 140 °C, 30 min, MW, (6–58%); (iii) Method E: EtPH(O)OH, Pd(OAc)<sub>2</sub>, Xantphos, DIPEA, DME/toluene, 90 °C, 2 h, (46–98%); (iv) Method H: (1) SOCl<sub>2</sub>, DMF, 70 °C, 1 h, (2) DIPEA, MeOH, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 30 min, (36–85%).</p></p></figure><div class="NLM_p">A range of methods were used to access the phosphinate esters of the benzo[<i>d</i>]oxazoles based on a common general route (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>), and these methods are described in detail in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_001.pdf" class="ext-link">Supporting Information</a>. In brief, intermediate 2-arylhalobenzo[<i>d</i>]oxazoles (<b>6–8a</b>, <b>15–26a</b>, <b>28–29a</b>, <b>31–45a</b>, <b>51a</b>, <b>55a</b>) were derived either from the condensation of 2-aminophenols with the respective carboxylic acid chloride followed by dehydration (Methods A and D) or from the respective aldehyde with a consecutive oxidation step (Methods B and C). The final products were obtained from the halo-derivatives via a Pd-catalyzed functionalization with phosphinate esters or phosphinic acids (Methods E–G, <b>6–26</b>, <b>28–29</b>, <b>31–55</b>). Phosphinic acids were converted to the corresponding esters through the formation of the phosphinic acid chloride and reaction with the appropriate alcohol (Method H, <b>26b</b>, <b>55b</b>). Where scale-up synthesis was required for <i>in vivo</i> studies, the procedures were further optimized.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p last">Detailed synthetic procedures for analogues <b>27</b> and <b>30</b> are reported elsewhere.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> The synthesis of <b>26</b> was described previously;<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> however, a significant improvement in yield was observed when the compound was synthesized via the phosphinic acid route.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Replacement of the Sulfone Moiety (Region A)</h3><div class="NLM_p">Sulfones are known to form strong intermolecular interactions in the solid state, often leading to low solubility.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> For this reason, replacements of the sulfone group of ezutromid (<b>1</b>) with other hydrogen bond donor groups such as amides (<b>2</b>, <b>3</b>), sulphonamides (<b>4</b>, <b>5</b>), and phosphinates (<b>6</b>, <b>7</b>) were investigated in order to establish the impact of altering Region A on activity and solubility (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The ability of the compounds to increase utrophin levels was investigated using the previously reported cell line H2K-<i>mdx</i> utrnA-luc (H2K), a murine myoblast cell line that contains a stably integrated 8.4 kb fragment of the human utrophin promoter linked to a firefly luciferase gene.<a onclick="showRef(event, 'ref1 ref12'); return false;" href="javascript:void(0);" class="ref ref1 ref12">(1,12)</a> The replacement of the sulfone moiety was well tolerated in all cases and even led to an apparent increase in activity in the cases of amides (<b>2</b>, <b>3</b>) and phosphinates (<b>6</b>, <b>7</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Amides (<b>2</b>, <b>3</b>) and sulfonamide <b>4</b> had similar solubility to ezutromid, while phosphinate <b>7</b> was found to be significantly more soluble (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR on Region A: Replacement of the Sulfone Moiety and Preliminary SAR Investigation of Phosphinate Esters</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0007.gif" alt="" id="GRAPHIC-d7e803-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0008.gif" alt="" id="gr7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Firefly luciferase reporter gene assay reported as EC<sub>50</sub> ± SD of 3 biological replicates (3 technical replicates per experiment).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Turbidimetric solubility.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">ND: not determined.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">IA: inactive.</p></div></div><div></div></div><div class="NLM_p last">Phosphinates are an under-represented class of molecules as drugs, with most phosphorous-containing drugs containing the phosphate or phosphonate structure (nucleoside prodrugs and bisphosphonates).<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> The angiotensin converting enzyme (ACE) inhibitor fosinopril includes a phosphinate motif as a prodrug, the active species being the phosphinic acid (fosinoprilat).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Opportunity to study the underexplored chemical space in combination with the improved solubility observed from the preliminary studies led to the selection of the phosphinate as a sulfone replacement which was carried forward into more detailed structure-activity relationship (SAR) studies (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, analogues <b>6–14</b>). It was found that the phosphinate ester substituent was well tolerated in positions 5 and 6 of the benzoxazole ring (<b>6</b> and <b>7</b>, respectively), while moving it to position 4 (<b>8</b>) led to loss of activity. Whilst bulky <i>P</i>-alkyl substituents including <i>i</i>-Pr and <i>t</i>-Bu were tolerated (<b>11–13</b>), the corresponding <i>P</i>-phenyl derivative (<b>14</b>) showed no activity. Ethyl phosphinate esters (<b>9</b>, <b>10</b>) showed similar potency to their respective methyl ester counterparts (<b>6</b>, <b>7</b>). Subsequent optimization studies were performed using the methyl ethylphosphinate scaffold.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Replacement of the Naphthalene Substituent to Reduce Hydrophobicity (Region B)</h3><div class="NLM_p">As the naphthalene ring of ezutromid had been identified early on as the main site of metabolism,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> the variation of this region was investigated next (Region B, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) in order to improve metabolic stability in the new series. The replacement of naphthalene with heterobiaryls such as quinolines and isoquinolines was an approach to mitigate the cytochrome P450 oxidative metabolism<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). In a parallel approach, halogen substituents were used to block the metabolic hotspots in the phenyl ring (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR on Region B: Replacement of the Naphthalene Ring with Heterobiaryls or Haloaryls/Styryl</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0009.gif" alt="" id="GRAPHIC-d7e913-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0010.gif" alt="" id="gr8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Firefly luciferase reporter gene assay reported as EC<sub>50</sub> ± SD of 3 biological replicates (3 technical replicates per experiment).</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a>.</p></div></div><div></div></div><div class="NLM_p">A range of quinolines and isoquinolines were explored in the 2-position of the benzo[<i>d</i>]oxazole ring and the physicochemical properties, metabolic stability, and readout of phenotypic activity were investigated <i>in vitro</i> using the H2K-<i>mdx</i> reporter assay and were compared to that of ezutromid (<b>1</b>) and <b>6</b> or <b>7</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The SAR appeared to be tolerant of this variation. Similarly, the haloaryl and styryl derivatives also appeared to be active, with the exception of <i>o</i>-trifluoromethylphenyl derivative <b>43</b>.</div><div class="NLM_p">Next, we further characterized representative analogues and evaluated some basic physicochemical, plasma protein binding, and metabolic stability properties. The replacement of the 2-naphthyl moiety (<b>1</b>, <b>7</b>) with quinolinyl, styryl, and halo-phenyl derivatives (structure–property relationships (SPR), <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) improved the solubility (in most cases, to greater than 100 μM) compared to 2-naphthyl phosphinate (<b>7</b>, 30–100 μM) and especially compared to ezutromid (<b>1</b>, 3–10 μM).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SPR on Region B: Replacement of the Naphthalene Ring with Heterobiaryls or Haloaryls/Styryl</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">microsomal stability</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">PPB<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> (% bound)</th><th class="rowsep1 colsep0" colspan="2" align="center">mouse</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">human</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center">Sol<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (μM)</th><th class="colsep0 rowsep0" align="center">mouse</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center">Cl<sub>int</sub> (μL/min/mg)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char=".">Cl<sub>int</sub> (μL/min/mg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (min)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">3–10</td><td class="colsep0 rowsep0" align="left">>99</td><td class="colsep0 rowsep0" align="char" char=".">99</td><td class="colsep0 rowsep0" align="left">21.0</td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="char" char=".">14.4</td><td class="colsep0 rowsep0" align="char" char=".">96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">30–100</td><td class="colsep0 rowsep0" align="left">99</td><td class="colsep0 rowsep0" align="char" char=".">99</td><td class="colsep0 rowsep0" align="left">8.45</td><td class="colsep0 rowsep0" align="left">164</td><td class="colsep0 rowsep0" align="char" char=".">15.8</td><td class="colsep0 rowsep0" align="char" char=".">87.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="left">8.46</td><td class="colsep0 rowsep0" align="left">164</td><td class="colsep0 rowsep0" align="char" char=".">3.14</td><td class="colsep0 rowsep0" align="char" char=".">441</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left">>4400</td><td class="colsep0 rowsep0" align="char" char=".">9.81</td><td class="colsep0 rowsep0" align="char" char=".">141</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">30–100</td><td class="colsep0 rowsep0" align="left">81</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">9.51</td><td class="colsep0 rowsep0" align="char" char=".">146</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="left">11.9</td><td class="colsep0 rowsep0" align="left">116</td><td class="colsep0 rowsep0" align="char" char=".">14.6</td><td class="colsep0 rowsep0" align="char" char=".">95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">30–100</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="left">12.2</td><td class="colsep0 rowsep0" align="left">114</td><td class="colsep0 rowsep0" align="char" char=".">6.47</td><td class="colsep0 rowsep0" align="char" char=".">214</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="left">16.1</td><td class="colsep0 rowsep0" align="left">86</td><td class="colsep0 rowsep0" align="char" char=".">3.62</td><td class="colsep0 rowsep0" align="char" char=".">383</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">81</td><td class="colsep0 rowsep0" align="char" char=".">94</td><td class="colsep0 rowsep0" align="left">292</td><td class="colsep0 rowsep0" align="left">4.75</td><td class="colsep0 rowsep0" align="char" char=".">6.34</td><td class="colsep0 rowsep0" align="char" char=".">219</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">30–100</td><td class="colsep0 rowsep0" align="left">92</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="left">5.12</td><td class="colsep0 rowsep0" align="left">271</td><td class="colsep0 rowsep0" align="char" char=".">8.33</td><td class="colsep0 rowsep0" align="char" char=".">166</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="left">14.4</td><td class="colsep0 rowsep0" align="left">96</td><td class="colsep0 rowsep0" align="char" char=".">1.59</td><td class="colsep0 rowsep0" align="char" char=".">869</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">89</td><td class="colsep0 rowsep0" align="char" char=".">91</td><td class="colsep0 rowsep0" align="left">18.2</td><td class="colsep0 rowsep0" align="left">76</td><td class="colsep0 rowsep0" align="char" char=".">5.85</td><td class="colsep0 rowsep0" align="char" char=".">236</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">30–100</td><td class="colsep0 rowsep0" align="left">98</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="left">27.2</td><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="char" char=".">2120</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left">>4400</td><td class="colsep0 rowsep0" align="char" char=".">0.543</td><td class="colsep0 rowsep0" align="char" char=".">2550</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="left">24.1</td><td class="colsep0 rowsep0" align="left">58</td><td class="colsep0 rowsep0" align="char" char=".">4.43</td><td class="colsep0 rowsep0" align="char" char=".">313</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Turbidimetric solubility.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">PPB, plasma protein binding.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">ND, not determined.</p></div></div></div><div class="NLM_p">The binding of analogues <b>7</b>, <b>15</b>, <b>20</b>, <b>21</b>, <b>28</b>, <b>30</b>, <b>32</b>, <b>40</b>, and <b>41</b> to human and mouse plasma proteins varied, ranging between 80 and 99% bound fraction in humans and 72–99% bound fraction in mice (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The fraction of the compound bound to plasma proteins did not appear to be linked to phosphinate regiochemistry (5- or 6-) nor to the substituent in position 2. The most highly bound compound appeared to be the naphthalene analogue <b>7</b>, and the least were quinolines <b>20</b> and <b>21</b> and fluorophenyl derivatives <b>27</b> and <b>32</b>.</div><div class="NLM_p">The modifications greatly improved metabolic stability in most cases, apart from <b>28</b> which was cleared very quickly in mouse microsomes (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). No patterns were apparent in terms of the phosphinate or aryl/heterobiaryl/styryl substituent nor for the phosphinate regiochemistry. The most metabolically stable compound in both mouse and human liver microsomes was the styryl analogue <b>40</b>, while quinoline <b>20</b> had the lowest intrinsic clearance in mouse liver microsomes and the 2,3-dichloro analogue <b>35</b> in human liver microsomes.</div><div class="NLM_p">The metabolic profile of a selection of analogues, which had an encouraging combination of activity and absorption, distribution, metabolism, and excretion (ADME) properties, was further evaluated in different species in order to select compounds that would have a favorable profile in an <i>in vivo</i> model but might also translate to an appropriate pharmacokinetics (PK) profile in humans (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). On the basis of this evaluation, compounds <b>27</b>, <b>30</b>, and <b>41</b> were selected and evaluated for their ability to increase utrophin protein in <i>mdx</i> mouse myoblast (LU<i>mdx</i>) cells.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Metabolic Profile of the Selection of Haloaryls and <b>27</b> Close Analogues in Different Species</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" char="." /></col><col align="left" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" char="." /></col><col align="left" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="8" align="center">microsomal stability</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">Cl<sub>int</sub> (μL/min/mg)</th><th class="rowsep1 colsep0" colspan="4" align="center"><i>T</i><sub>1/2</sub> (min)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center">d</th><th class="colsep0 rowsep0" align="center">r</th><th class="colsep0 rowsep0" align="center" char=".">m</th><th class="colsep0 rowsep0" align="center" char=".">h</th><th class="colsep0 rowsep0" align="center">d</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">m</th><th class="colsep0 rowsep0" align="center" char=".">H</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left" char=".">16</td><td class="colsep0 rowsep0" align="left" char=".">4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left" char=".">86</td><td class="colsep0 rowsep0" align="left" char=".">383</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left">184</td><td class="colsep0 rowsep0" align="left" char=".">292</td><td class="colsep0 rowsep0" align="left" char=".">6.34</td><td class="colsep0 rowsep0" align="left">S<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">7.52</td><td class="colsep0 rowsep0" align="left" char=".">4.75</td><td class="colsep0 rowsep0" align="left" char=".">219</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">7.82</td><td class="colsep0 rowsep0" align="left">7.02</td><td class="colsep0 rowsep0" align="left" char=".">5.12</td><td class="colsep0 rowsep0" align="left" char=".">8.33</td><td class="colsep0 rowsep0" align="left">177</td><td class="colsep0 rowsep0" align="left">197</td><td class="colsep0 rowsep0" align="left" char=".">271</td><td class="colsep0 rowsep0" align="left" char=".">166</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">1.10</td><td class="colsep0 rowsep0" align="left">3.31</td><td class="colsep0 rowsep0" align="left" char=".">14.4</td><td class="colsep0 rowsep0" align="left" char=".">1.59</td><td class="colsep0 rowsep0" align="left">1270</td><td class="colsep0 rowsep0" align="left">419</td><td class="colsep0 rowsep0" align="left" char=".">96.1</td><td class="colsep0 rowsep0" align="left" char=".">869</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left">8.74</td><td class="colsep0 rowsep0" align="left" char=".">24.1</td><td class="colsep0 rowsep0" align="left" char=".">4.43</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">159</td><td class="colsep0 rowsep0" align="left" char=".">57.6</td><td class="colsep0 rowsep0" align="left" char=".">313</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">S: stable (100% after 45 min); d: dog; r: rat; m: mouse; h: human microsomes.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Phosphinate Selection: Utrophin Protein Upregulation in Dystrophic Mouse Muscle Cells</h3><div class="NLM_p">Acknowledging the limitations of reporter gene assays,<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> we sought further confirmation of utrophin modulation activity. The quantification of utrophin protein levels by western blot in LU<i>mdx</i> cells treated with the selected analogues <b>27</b>, <b>30</b>, and <b>41</b> was used as an orthogonal method to support the progression of these molecules to <i>in vivo</i> evaluation. We observed an increase in the utrophin protein in all three cases. Phosphinates <b>27</b> and <b>30</b> increased utrophin up to 2.5-fold in a concentration-dependent manner, while <b>41</b> increased utrophin 2-fold at 1 μM, but at 10 μM, utrophin came down to basal levels (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). <b>27</b> and <b>30</b> were therefore selected for progression into murine <i>in vivo</i> PK and efficacy studies.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Treatment with <b>27</b>, <b>30</b>, and <b>41</b> increases utrophin protein in dystrophin-deficient mouse muscle cells. Relative utrophin expression was determined by western blot, standardized for α-actinin loading and is shown as the mean of fold increase relative to DMSO ± SD (two biological replicates, 3 technical replicates each) *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00807&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Characterization and <i>In Vitro</i> Evaluation of Phosphinates <b>27</b>, <b>30</b>, and Their Enantiomers</h3><div class="NLM_p">As phosphinates have a <i>P</i>-stereogenic center, some insights into the profile of the two enantiomers were required in order to assess whether to progress the racemic mixture or a single enantiomer. The separation of the enantiomers was performed using preparative chiral HPLC,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> the specific optical rotations of <b>27</b> enantiomers were measured, and the enantiomers were assigned as (−) and (+), respectively (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). The absolute configuration of the enantiomers was later inferred through an enantioselective synthesis of <b>(+)-30</b> and <b>(−)-30</b>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The enantiomers of <b>30</b> were found to have similar levels of activity to the racemate (H2K EC<sub>50</sub>s were 1.28, 1.39 and 1.20 μM for <b>30</b>, <b>(+)-30</b> and <b>(−)-30</b>, respectively).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In contrast, <b>(+)-27</b> appeared to be slightly more active in the H2K-<i>mdx</i> reporter gene assay than enantiomer <b>(−)-27</b> and the corresponding racemic mixture, with a eudismic ratio of 5 (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Determination of Optical Rotation Value and Assignment, and SAR for <b>27</b> Enantiomers</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center"><i>a</i><sub class="stack">D</sub><sup class="stack">25</sup><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">H2K EC<sub>50</sub> ± SD<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">0.187 ± 0.030</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">0.244 ± 0.020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(−)-27</b></td><td class="colsep0 rowsep0" align="left">–40.7</td><td class="colsep0 rowsep0" align="char" char="±">0.711 ± 0.155</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(+)-27</b></td><td class="colsep0 rowsep0" align="left">+40.7</td><td class="colsep0 rowsep0" align="char" char="±">0.124 ± 0.015</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Optical rotation [<i>c</i> = 1.0, THF].</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Firefly luciferase reporter gene assay reported as EC<sub>50</sub> ± SD of 3 biological replicates (3 technical replicates per experiment).</p></div></div></div><div class="NLM_p">The metabolic stability of the pairs of enantiomers of <b>27</b> and <b>30</b> were next evaluated in murine and human hepatocytes (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). No significant differences were noted between the enantiomers of each compound in either case. No detectable racemization was observed over the course of 1 h incubation. Consistent with the metabolic stability determined in microsomes, all analogues were found to be more stable than ezutromid in human hepatocytes. The enantiomers of <b>27</b> were cleared rapidly in mouse hepatocytes, while the enantiomers of <b>30</b> were significantly more stable (Cl<sub>int</sub> > 75 for <b>27</b> enantiomers vs 16 and 15 for <b>(+)-30</b> and <b>(−)-30</b>). In human hepatocytes, all analogues had low clearance (Cl<sub>int</sub> < 4.9 μL/min/10<sup>6</sup> cells). All analogues were found to have a higher bound fraction with human plasma proteins than mouse plasma proteins.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. ADME Evaluation of <b>27</b> and <b>30</b> Enantiomers in the Mouse and Human</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" char="." /></col><col align="left" char="." /></col><col align="left" /></col><col align="left" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">hepatocyte stability<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">PPB (% bound)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">Cl<sub>int</sub> (μL/min/10<sup>6</sup> cells)</th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><i>T</i><sub>1/2</sub> (min)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center">m</th><th class="colsep0 rowsep0" align="center" char=".">h</th><th class="colsep0 rowsep0" align="center" char=".">m</th><th class="colsep0 rowsep0" align="center">h</th><th class="colsep0 rowsep0" align="center" char=".">m</th><th class="colsep0 rowsep0" align="center">H</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">>99</td><td class="colsep0 rowsep0" align="left" char=".">99</td><td class="colsep0 rowsep0" align="left" char=".">54</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left" char=".">26</td><td class="colsep0 rowsep0" align="left">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(−)-27</b></td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left" char=".">85</td><td class="colsep0 rowsep0" align="left" char=".">141</td><td class="colsep0 rowsep0" align="left"><3</td><td class="colsep0 rowsep0" align="left" char=".">9.8</td><td class="colsep0 rowsep0" align="left">>460</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(+)-27</b></td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left" char=".">85</td><td class="colsep0 rowsep0" align="left" char=".">75</td><td class="colsep0 rowsep0" align="left"><3</td><td class="colsep0 rowsep0" align="left" char=".">19</td><td class="colsep0 rowsep0" align="left">>460</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(+)-30</b></td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="left" char=".">94</td><td class="colsep0 rowsep0" align="left" char=".">16</td><td class="colsep0 rowsep0" align="left"><3</td><td class="colsep0 rowsep0" align="left" char=".">89</td><td class="colsep0 rowsep0" align="left">>460</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(−)-30</b></td><td class="colsep0 rowsep0" align="left">87</td><td class="colsep0 rowsep0" align="left" char=".">91</td><td class="colsep0 rowsep0" align="left" char=".">15</td><td class="colsep0 rowsep0" align="left">4.9</td><td class="colsep0 rowsep0" align="left" char=".">94</td><td class="colsep0 rowsep0" align="left">283</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last"><1% interconversion to the opposite enantiomeric form was observed in mouse hepatocytes after 60 min incubation; m: mouse; h: human hepatocytes.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> PK and Safety Profile for Racemic and Enantiopure Phosphinates <b>27</b> and <b>30</b></h3><div class="NLM_p">The PK of the enantiomeric pairs and racemic mixtures of <b>27</b> and <b>30</b> were investigated in the <i>mdx</i> mouse (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). In general, oral exposure was found to be low to moderate for <b>27</b> and enantiomers at 5 mg/kg, but higher for <b>30</b>. The half-life was found to be short in all cases, but <b>27</b> and its enantiomers were cleared more rapidly than <b>30</b>. Interestingly, the less-lipophilic <b>27</b> had a higher volume of distribution, potentially attributed to its lower PPB and, hence, greater unbound fraction; however, in all cases, a favorable distribution to tissues was predicted. The oral bioavailability of <b>30</b> and enantiomers was also found to be superior to that of <b>27</b>. In general, oral bioavailability was good (>50%), apart from <b>(−)-27</b>, where it was 39 and 45% at day 1 and day 7, respectively. Overall, this suggested that phosphinate <b>30</b> had a preferable pharmacokinetic profile to <b>27</b>. The reason for the observed decrease in AUC for (+)-<b>30</b> and increase in AUC for (−)-<b>30</b> after 7 days dosing was not clear. Despite this apparent difference, as discussed later, (+)-<b>30</b>, (−)-<b>30</b>, and the racemic mixture showed no significant differences in activity and efficacy <i>in vivo</i> in the <i>mdx</i> mouse.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Pharmacokinetic Properties of <b>27</b>, <b>30</b>, and Enantiomers Dosed i.v. (1 mg/kg) or p.o. (5 mg/kg) in <i>mdx</i> Mice<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd/route</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (ng/mL/h)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>d</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center">app. <i>F</i> %</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b>/i.v.</td><td class="colsep0 rowsep0" align="char" char=".">562</td><td class="colsep0 rowsep0" align="char" char=".">431</td><td class="colsep0 rowsep0" align="char" char=".">0.64</td><td class="colsep0 rowsep0" align="char" char=".">38.6</td><td class="colsep0 rowsep0" align="char" char=".">1.46</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(−)-27</b>/i.v.</td><td class="colsep0 rowsep0" align="char" char=".">477</td><td class="colsep0 rowsep0" align="char" char=".">226</td><td class="colsep0 rowsep0" align="char" char=".">0.27</td><td class="colsep0 rowsep0" align="char" char=".">73.5</td><td class="colsep0 rowsep0" align="char" char=".">1.58</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(+)-27</b>/i.v.</td><td class="colsep0 rowsep0" align="char" char=".">615</td><td class="colsep0 rowsep0" align="char" char=".">510</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td><td class="colsep0 rowsep0" align="char" char=".">32.7</td><td class="colsep0 rowsep0" align="char" char=".">1.41</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b>/p.o. D1</td><td class="colsep0 rowsep0" align="char" char=".">734</td><td class="colsep0 rowsep0" align="char" char=".">1663</td><td class="colsep0 rowsep0" align="char" char=".">2.25</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">77.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b>/p.o. D7</td><td class="colsep0 rowsep0" align="char" char=".">566</td><td class="colsep0 rowsep0" align="char" char=".">1157</td><td class="colsep0 rowsep0" align="char" char=".">1.58</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">53.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(−)-27</b>/p.o. D1</td><td class="colsep0 rowsep0" align="char" char=".">352</td><td class="colsep0 rowsep0" align="char" char=".">444</td><td class="colsep0 rowsep0" align="char" char=".">1.89</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">39.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(−)-27</b>/p.o. D7</td><td class="colsep0 rowsep0" align="char" char=".">299</td><td class="colsep0 rowsep0" align="char" char=".">513</td><td class="colsep0 rowsep0" align="char" char=".">1.21</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">45.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(+)-27</b>/p.o. D1</td><td class="colsep0 rowsep0" align="char" char=".">542</td><td class="colsep0 rowsep0" align="char" char=".">1569</td><td class="colsep0 rowsep0" align="char" char=".">1.74</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">61.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(+)-27</b>/p.o. D7</td><td class="colsep0 rowsep0" align="char" char=".">736</td><td class="colsep0 rowsep0" align="char" char=".">1622</td><td class="colsep0 rowsep0" align="char" char=".">3.09</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">63.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b>/i.v.</td><td class="colsep0 rowsep0" align="char" char=".">1365</td><td class="colsep0 rowsep0" align="char" char=".">1611</td><td class="colsep0 rowsep0" align="char" char=".">0.61</td><td class="colsep0 rowsep0" align="char" char=".">10.3</td><td class="colsep0 rowsep0" align="char" char=".">0.61</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(+)-30</b>/i.v.</td><td class="colsep0 rowsep0" align="char" char=".">1520</td><td class="colsep0 rowsep0" align="char" char=".">1079</td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="char" char=".">15.3</td><td class="colsep0 rowsep0" align="char" char=".">0.56</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(−)-30</b>/i.v.</td><td class="colsep0 rowsep0" align="char" char=".">1788</td><td class="colsep0 rowsep0" align="char" char=".">2196</td><td class="colsep0 rowsep0" align="char" char=".">0.77</td><td class="colsep0 rowsep0" align="char" char=".">7.57</td><td class="colsep0 rowsep0" align="char" char=".">0.56</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b>/p.o. D1</td><td class="colsep0 rowsep0" align="char" char=".">2341</td><td class="colsep0 rowsep0" align="char" char=".">6974</td><td class="colsep0 rowsep0" align="char" char=".">2.08</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">86.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b>/p.o. D7</td><td class="colsep0 rowsep0" align="char" char=".">3482</td><td class="colsep0 rowsep0" align="char" char=".">6910</td><td class="colsep0 rowsep0" align="char" char=".">1.24</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">85.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(+)-30</b>/p.o. D1</td><td class="colsep0 rowsep0" align="char" char=".">3488</td><td class="colsep0 rowsep0" align="char" char=".">11,613</td><td class="colsep0 rowsep0" align="char" char=".">3.71</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(+)-30</b>/p.o. D7</td><td class="colsep0 rowsep0" align="char" char=".">2796</td><td class="colsep0 rowsep0" align="char" char=".">5171</td><td class="colsep0 rowsep0" align="char" char=".">1.03</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">95.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(−)-30</b>/p.o. D1</td><td class="colsep0 rowsep0" align="char" char=".">1939</td><td class="colsep0 rowsep0" align="char" char=".">3741</td><td class="colsep0 rowsep0" align="char" char=".">1.55</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">34.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(−)-30</b>/p.o. D7</td><td class="colsep0 rowsep0" align="char" char=".">4063</td><td class="colsep0 rowsep0" align="char" char=".">10,064</td><td class="colsep0 rowsep0" align="char" char=".">0.79</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">91.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last"><i>n</i> = 3 mice per datapoint; Abbreviations: AUC: area under the curve, CL: clearance, cpd: compound, D1: 1 day, D7: 7 days, i.v.: intravenous, p.o.: per os.</p></div></div></div><div class="NLM_p last">The mutagenic potential of the leading phosphinates was evaluated in an Ames assay using genetically modified <i>Salmonella typhimurium</i> LT2 strains TA1535, TA1537, TA98, and TA100, and <i>Escherichia coli</i> WP2 strain uvrA/pKM101 pKM101 as indicator organisms. In most cases, no consistent increase in numbers of revertant (histidine or tryptophan-independent) colonies was seen with any of the five indicator strains either in the presence or absence of S9 microsomes. Thus, it was concluded that none of racemic <b>27</b>, <b>30</b>, <b>(−)-27</b>, <b>(+)-30</b>, and <b>(−)-30</b> appeared mutagenic under the conditions used in this study. Curiously, <b>(+)-27</b> showed a clear concentration-related increase in numbers of revertant colonies (histidine-dependent) for indicator strain TA98 at and above a dose of 160 μg (0.501 μmol) per plate in the presence of S9 microsomes. The increase reached 3.5 times the solvent control value at 500 μg (1.57 μmol) per plate. For this reason, <b>30</b> was initially selected for progression to a murine <i>in vivo</i> efficacy trial.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Phosphinate <b>30</b> is Identified as an Advanced Molecule but Proves to be Hepatotoxic in Rats</h3><div class="NLM_p">The <i>in vitro</i> and <i>in vivo</i> profile of <b>30</b> (also termed SMT022357) has been described in detail previously.<a onclick="showRef(event, 'ref1 ref14'); return false;" href="javascript:void(0);" class="ref ref1 ref14">(1,14)</a> In brief, <b>30</b> was found to increase the utrophin protein <i>in vitro</i> and <i>in vivo</i>, ameliorating the pathology in skeletal, respiratory, and cardiac muscle in the <i>mdx</i> mouse.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> No significant difference was observed in the activity and efficacy of the two enantiomers, and activity was shown to be comparable to that of the racemic mixture.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, <b>30</b> was found to be hepatotoxic during a maximum tolerated dose (MTD) study in rats (data not shown). Although the 100 mg/kg dose level was tolerated for both enantiomers, adverse findings were apparent based on the evidence of liver toxicity that included liver enlargement and correlative histopathology findings. As a result, the therapeutic window for this compound was deemed too small to progress further.</div><div class="NLM_p">A more detailed analysis provided evidence of hepatobiliary toxicity as γ glutamyltransferase (GGT) and total bilirubin (TBILI) were significantly elevated at both dose regimens of <b>30</b> (300 and 100 mg/kg, <a href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_001.pdf" class="ext-link">Table S1</a>). This was in good agreement with the cholestatic injury observed during the MTD study. Enantiomer <b>(−)-30</b> appeared to be less toxic; however, this was attributed to the difference in toxicokinetics between the two enantiomers (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_001.pdf" class="ext-link">Table S2</a>), as <b>(+)-30</b> showed greater exposure than <b>(−)-30</b>. It was noted that the two enantiomers had similar PK profiles in the <i>mdx</i> mouse,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> although this was not the case in rats.</div><div class="NLM_p">In order to gain insight into the mechanism of hepatotoxicity and to determine whether it could be mitigated, representative analogues were tested in HepRG spheroids, a 3D hepatocyte model where several cell health parameters can be measured simultaneously (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_001.pdf" class="ext-link">Table S3</a>). Although the limited number of analogues tested did not allow clear structure-toxicity relationships to be observed, <b>30</b> and its enantiomers were amongst the most toxic analogues tested, inducing the same type of cell damage as shown by an increase in oxidative stress and a decrease in glutathione (GSH), DNA structure, and cellular ATP. Another trifluorosubstituted analogue <b>29</b> induced similar types of damage as <b>30</b>. Analogue <b>27</b> and its enantiomers were found to have only minimal hepatotoxicity. From the results obtained, it was apparent that some analogues were significantly less toxic than others, and there was no pattern in inducing the same type of cell damage.</div><div class="NLM_p">The nature and location of the damage caused in the rat liver during the MTD study suggested P450 bio-activation to a hepatotoxic metabolite. As a result, metabolite identification (MetID) studies were undertaken in samples from this study. It was found that <b>30</b> was metabolized mainly to a glucuronide adduct of an oxidation product (<b>M1</b>) and to the corresponding phosphinic acid (<b>M3</b>). Further metabolites identified were GSH-conjugates (<b>M7–8</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, <a href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_001.pdf" class="ext-link">Table S4</a>).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Major <b>30</b> metabolites identified by MetID in samples from the MTD rat study (representative fragment ions are given).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00807&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The metabolic profile of <b>30</b> was further studied <i>in vitro</i> in 4 different species to evaluate if this profile was unique to rats and if there were significant differences in the metabolites produced in primates. The metabolites of the two enantiomers in human hepatocytes were also determined. In all cases, the main metabolic routes were oxidation and conjugation with glucuronic acid (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_001.pdf" class="ext-link">Table S5</a>). Glucuronides were detected in larger quantities in rat and dog hepatocytes. No significant differences were observed between the two enantiomers (data not shown). Interestingly, the corresponding phosphinic acid <b>M3</b> was not detected in the <i>in vitro</i> incubations.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Further Modifications on Phosphinates <b>27</b> and <b>30</b></h3><div class="NLM_p">As phosphinates <b>27</b> and <b>30</b> had otherwise proved to have promising properties, some closely related structural analogues were synthesized and their physicochemical and ADME properties evaluated. Varying the phosphinate ester and <i>P</i>-alkyl substituents did not appear to significantly affect activity in analogues of <b>27</b>; however, the combination of a <i>P</i>-phenyl substituent and changing the regiochemistry of the phosphinate ester in position 6 of the benzoxazole ring (scaffold G) led to an inactive analogue (<b>50</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). Interestingly, changing the regiochemistry of phosphinate ester to position 4 appeared to retain activity (<b>51</b>, scaffold H), in contrast to the previous SAR observed with the naphthalene substituent (<b>8</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. SAR on Analogues of Phosphinate <b>27</b> (Region A) and Bulkier Phosphinic Esters of <b>30</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0011.gif" alt="" id="GRAPHIC-d7e2711-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center">scaffold</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">H2K EC<sub>50</sub> ± SD<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">0.244 ± 0.020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">iPr</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">0.303 ± 0.084</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">0.826 ± 0.136</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">1.25 ± 0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">1.23 ± 0.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">iPr</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">1.51 ± 0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">1.19 ± 0.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">1.28 ± 0.25<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">cyclobutyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">IA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">G</td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">IA</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">Firefly luciferase reporter gene assay reported as EC<sub>50</sub> ± SD of 3 biological replicates (3 technical replicates per experiment).</p></div><div class="footnote" id="t8fn2"><sup><sup>b</sup></sup><p class="last">Ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a>.</p></div></div></div><div class="NLM_p">The physicochemical and ADME evaluation showed that good aqueous solubility was maintained in most cases, with the exception of <i>P</i>-<i>i</i>Pr <b>46</b> and <i>P</i>-Ph <b>47</b> (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>). Metabolic stability, determined in liver microsomes, varied significantly between the mouse and human (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>). <b>27</b> was found to be the most stable analogue in mouse, followed by <b>41</b>. However, in human microsomes, the most stable analogue was <b>49</b>, followed by <b>47</b>. None of the newly synthesized compounds were rapidly cleared by human microsomes, predicting a good metabolic profile.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. SPR on Analogues of Phosphinate <b>27</b> (Region A)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">microsomal stability</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">PPB<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a> (% bound)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">mouse</th><th class="rowsep1 colsep0" colspan="2" align="center">human</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center">Sol<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">mouse</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">Cl<sub>int</sub> (μL/min/mg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center">Cl<sub>int</sub> (μL/min/mg)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> (min)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">383</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">24.1</td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="left">4.43</td><td class="colsep0 rowsep0" align="left">313</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">30–100</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">39.1</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="left">4.22</td><td class="colsep0 rowsep0" align="left">329</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">10–30</td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char=".">30.6</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="left">2.17</td><td class="colsep0 rowsep0" align="left">637</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char=".">39.1</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="left">2.41</td><td class="colsep0 rowsep0" align="left">575</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char=".">83</td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="char" char=".">52.3</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="left"><3</td><td class="colsep0 rowsep0" align="left">>1024</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">Turbidimetric solubility.</p></div><div class="footnote" id="t9fn2"><sup><sup>b</sup></sup><p class="last">PPB, plasma protein binding.</p></div></div></div><div class="NLM_p">Although it was not established that the phosphinic acid metabolite <b>M3</b> was responsible for the observed toxicity, a small number of analogues of <b>30</b> with more sterically hindered phosphinate esters (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>) were synthesized aiming at minimizing hydrolysis and increasing metabolic stability. This was accomplished in all cases apart from the cyBu analogue <b>54</b> (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>); however, all new analogues were found to be inactive in the reporter gene assay (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). The possibility of an active metabolite in <b>52</b> was also investigated, however, the phosphinic acid was found to be inactive. On the basis of this hepatotoxicity data and SAR study, <b>27</b> and its enantiomers were selected for progression into more detailed safety profiling and efficacy evaluation.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. SPR on Analogues of Phosphinate <b>30</b> (Region A)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">PPB<a class="ref internalNav" href="#t10fn2" aria-label="b">b</a> (% bound)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">Caco-2<a class="ref internalNav" href="#t10fn3" aria-label="c">c</a><i>P</i><sub>app</sub> (10<sup>–6</sup> cm/s)</th><th class="rowsep1 colsep0" colspan="2" align="center">mouse hepatocyte stability</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center" char=".">Sol<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">mouse</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">A–B</th><th class="colsep0 rowsep0" align="center" char=".">B–A</th><th class="colsep0 rowsep0" align="center">Cl<sub>int</sub> (μL/min/10<sup>6</sup> cells)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (min)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">468</td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">16.4</td><td class="colsep0 rowsep0" align="left">11.9</td><td class="colsep0 rowsep0" align="char" char=".">58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="char" char=".">337</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">99</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"><2.89</td><td class="colsep0 rowsep0" align="char" char=".">240</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">10.6</td><td class="colsep0 rowsep0" align="char" char=".">5.75</td><td class="colsep0 rowsep0" align="left">8.65</td><td class="colsep0 rowsep0" align="char" char=".">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">6.38</td><td class="colsep0 rowsep0" align="char" char=".">3.98</td><td class="colsep0 rowsep0" align="left">32.8</td><td class="colsep0 rowsep0" align="char" char=".">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="char" char=".">652</td><td class="colsep0 rowsep0" align="char" char=".">99</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">8.92</td><td class="colsep0 rowsep0" align="char" char=".">78</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup><sup>a</sup></sup><p class="last">Aqueous kinetic solubility.</p></div><div class="footnote" id="t10fn2"><sup><sup>b</sup></sup><p class="last">PPB, plasma protein binding.</p></div><div class="footnote" id="t10fn3"><sup><sup>c</sup></sup><p class="last">Caco-2 permeability assay.</p></div></div></div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> De-risking Genotoxicity of <b>(+)-27</b></h3><div class="NLM_p last">While <b>27</b> and <b>(−)-27</b> proved to be clean in the Ames assay, <b>(+)-27</b> (also termed SMT022332) was shown to have weak mutagenic potential after metabolic activation with rat microsomes. In order to progress this potential candidate further it was necessary to understand whether this effect was specific to rats. Similar studies incubating <b>(+)-27</b> with human, hamster, and mouse S9 microsome fractions were all negative for mutagenicity in the TA98 strain (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_001.pdf" class="ext-link">Table S6</a>). In light of these new data, <b>(+)-27</b>’s initial positive Ames result appeared be specific to rat metabolism.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Safety Pharmacology of Phosphinate <b>27</b> and Its Enantiomers</h3><div class="NLM_p">Phosphinate <b>27</b> and its enantiomers were not found to inhibit the most common P450 isoforms involved in drug metabolism and, as such, they have a safe profile in terms of predicted drug–drug interactions based on P450 inhibition (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_001.pdf" class="ext-link">Table S7</a>). Furthermore, <b>27</b> and its enantiomers also did not interact with a broad selection of ion channels (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_001.pdf" class="ext-link">Chart S1A–C</a>). When the two enantiomers were screened against a selection of 76 GPCRs, they were found to have an encouraging profile (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_001.pdf" class="ext-link">Table S8</a>): the only notable activity observed was antagonism of the 5-HT2B receptor (EC<sub>50</sub> 50 μM and 9.3 μM for <b>(−)-27</b> and <b>(+)-27</b>, respectively). Similarly, the two enantiomers did not show any agonist or antagonist activity against a panel of nuclear hormone receptors (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_001.pdf" class="ext-link">Table S9</a>).</div><div class="NLM_p last">On the basis of these data, <b>27</b> and its enantiomers were progressed to <i>in vivo</i> efficacy studies. Phosphinate <b>27</b> and its enantiomers had already been shown to have an acceptable PK profile in the <i>mdx</i> mouse (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>), but a more detailed evaluation of the two enantiomers and evidence to demonstrate upregulation of utrophin <i>in vivo</i> were sought.</div></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Phosphinate <b>27</b> and Enantiomers <i>In Vivo</i> Efficacy Study in <i>mdx</i> Mice</h3><div class="NLM_p">Follow-up pharmacokinetic studies (data not shown) established that q.d. dosing at 30 mg/kg p.o. of <b>27</b> or its enantiomers would have adequate exposure to upregulate utrophin levels. Indeed, a statistically significant 2.2-fold upregulation of utrophin protein (<i>p</i> = 0.01) was observed in the extensor digitorum longus (EDL) muscle of 7 week-old <i>mdx</i> mice, dosed p.o. q.d. with 30 mg/kg <b>27</b> from 2 weeks of age for 5 weeks (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). In the same study, using the same dosing regimen, <b>(+)-27</b> induced a 1.9-fold increase in utrophin protein (<i>p</i> = 0.03), while <b>(−)-27</b> increased utrophin 2.1-fold in the EDL muscle (<i>p</i> = 0.06) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Considerable variability was observed amongst animals in the <b>(−)-27</b> treatment group, which could account for the lack of statistical significance.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>In vivo</i> efficacy study of <b>27</b> and enantiomers dosed once per day at 30 mg/kg p.o. in 2 week-old <i>mdx</i> mice for 5 weeks. (A) Racemic <b>27</b> and its enantiomers increase the utrophin protein expression in EDL muscles. 2.1-fold increase for <b>(−)-27</b> (non-significant) and 1.9-fold increase with <b>(+)-27</b> was observed. Values are mean ± SEM of <i>n</i> = 6 per group; *<i>p</i> < 0.05 (B) EDL force drop (%). The resistance of muscle to stress-induced damage appears improved in mice treated with <b>27</b> (29% improvement) and <b>(+)-27</b> (35% improvement). Values are mean ± SEM of <i>n</i> = 9 or higher per group; **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00807&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As a next step, we sought to determine if this increase in the utrophin protein translated into a functional improvement in the muscle. In the absence of dystrophin, muscles become unable to sustain the mechanical stress caused by eccentric contractions, thereby showing an excessive force drop.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> The reduction of force drop can thus be used in the <i>mdx</i> mouse model as a means to quantify the potential of new therapeutics for DMD. <i>Ex vivo</i> analysis of the EDL muscle showed 31.8% (<i>p</i> = 0.001) and 29.4% (<i>p</i> = 0.004) force drop, following dosing of <b>27</b> and <b>(+)-27</b>, respectively (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). Interestingly, <b>(−)-27</b> did not provide any significant improvement compared to the control <i>mdx</i> mice (44.4% and 44.9% for <b>(−)-27</b> and control, respectively) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B), whilst <b>27</b> and <b>(+)-27</b> were found to protect against the muscle damage and improve the muscle function by increasing the muscle’s resistance to the stretch-induced damage (29 and 35% improvement for <b>27</b> and <b>(+)-27</b>, respectively). Overall, the <i>in vivo</i> efficacy data of <b>27</b> and <b>(+)-27</b> were found to be similar to that of the previous advanced molecule <b>30</b>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76040" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76040" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Upregulation of utrophin is a promising therapeutic approach for DMD, which would be applicable to all patient populations. Following clinical evaluation of the first-generation compound, ezutromid, it became apparent that there were liabilities within ezutromid’s structure that could be improved, such as its metabolic profile and poor solubility. For this reason, a second generation of utrophin modulators was developed, based on bio-isosteric replacement of the sulfone group with a phosphinate ester and replacement of the naphthalene with a haloaryl substituent. The new analogues had significantly improved physicochemical and ADME properties, which was reflected further in the pharmacokinetic profile of the most advanced lead compounds. Indeed, both phosphinate analogues <b>30</b> and <b>27</b> showed significantly improved <i>in vivo</i> murine exposure compared to ezutromid. More importantly, analogue <b>30</b> showed utrophin protein upregulation in <i>mdx</i> mice, alongside alleviation of the dystrophic phenotype. However, further progression of this lead compound was halted when dose-limiting hepatotoxicity was found. After establishing that hepatotoxicity is not a general attribute of the series, another compound, <b>27</b>, was chosen for further progression. Although both enantiomers of <b>30</b> showed similar profiles <i>in vivo</i>, only enantiomer <b>(+)-27</b> was shown to upregulate the utrophin protein and improve physiology in <i>mdx</i> mice. Analogue <b>27</b> and enantiomers exhibited a safe profile and limited off-target effects, highlighting their potential utility as next-generation utrophin modulators for progression toward future DMD therapy.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38873" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38873" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Chemistry Methods</h3><div class="NLM_p">All reactions involving moisture-sensitive reagents were carried out under a nitrogen or argon atmosphere using standard vacuum line techniques and glassware that was flame-dried and cooled under nitrogen before use. Water was purified using an Elix UV-10 system. All other reagents were used as supplied (analytical or HPLC grade) without prior purification. The final compounds were purified to ≥95% and characterized by a combination of <sup>1</sup>H NMR, <sup>13</sup>C NMR, high-resolution mass spectrometry, and high-performance liquid chromatography. NMR spectra were recorded on Bruker AVANCE III spectrometers (at 400 or 500 MHz) using the deuterated solvent stated and at rt. The field was locked by external referencing to the relevant deuteron resonance. Accurate mass measurements were run on either a Bruker MicroTOF internally calibrated with polyalanine or a Micromass GCT instrument fitted with a Scientific Glass Instruments BPX5 column (15 m × 0.25 mm) using amyl acetate as a lock mass. For preparative HPLC, the instrument used was a Waters Acquity H-Class consisting of an Acquity UPLC PDA Detector, an Acquity Quaternary Solvent Manager, and an Acquity QDa mass detector. Two general methods were used: (1) a basic method, where the column was an XBridge C18 10 μm particle size (30 × 100 mm); 5–95% gradient of MeCN (0.2% NH<sub>4</sub>OH) in H<sub>2</sub>O over 14 min, and the flow rate was 40 mL/min; (2) an acidic method, where the column was an Sunfire C18 10 μm particle size (30 × 100 mm); 5–95% gradient of MeCN (0.1% HCOOH) in H<sub>2</sub>O over 14 min, and the flow rate was 40 mL/min. Thin-layer chromatography was performed on aluminum plates coated with 60 F254 silica. Flash column chromatography was performed either on Kieselgel 60 silica on a glass column or on a Biotage SP4 automated flash column chromatography platform. Melting points were recorded on an EZ-Melt Automated Melting Point Apparatus (EZ Melt) and are uncorrected. Optical rotations were recorded on a PerkinElmer 241 polarimeter with a water-jacketed 1 cm cell. Specific rotations are reported in 10<sup>–1</sup> deg cm<sup>2</sup> g<sup>–1</sup> and concentrations in g/100 mL.</div><div class="NLM_p last">The intermediates that appear with no analytical data were quickly identified with LC–MS before progressing to the next step.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Protocols for biological/Pharmacological Evaluation</h3><div class="NLM_p last">The H2K reporter gene assay, firefly luciferase biochemical inhibition assay, and the in vivo studies in <i>mdx</i> mice have been previously reported in detail.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Utrophin Western Blot Assay</h3><div class="NLM_p last">Six well plates were seeded with LU<i>mdx</i> cells (1 × 10<sup>4</sup>) per well. After 24 h (10% CO<sub>2</sub>, 33 °C), the cells were dosed with query compounds in three concentrations (0.1, 1, and 10 μM) from 10 mM solution stocks in DMSO (0.3% final DMSO concentration) and control OX01914 at 40 μM in triplicate. After 72 h, the cells were harvested (TrypLE Express, Gibco), washed (PBS), and lysed (RIPA buffer and protease inhibitors, Sigma #P8340). The protein content was quantified using a bicinchoninic acid protein assay (Thermo Scientific Pierce). For the western blot, 30 μg of lysate was separated by NuPAGE 3–8% Tris-acetate protein gel electrophoresis and transferred to a PVDF membrane (GE Healthcare). Utrophin protein was detected using the Mancho-3 antibody (1:50, kind gift from G.E. Morris, Oswestry, UK) and an AlexaFluor 800CW anti-mouse antibody (1:10,000, Invitrogen). Blots were imaged with a Licor Odyssey system and relative protein quantitation was performed using Image Studio Lite. α-actinin was detected as a loading control using Goat anti α-actinin N-19 (1:200, Santa Cruz Biotechology 7453) and an AlexaFluorTM 680RD anti-goat antibody (1:10,000, Invitrogen). The results presented are from two separate experiments (biological duplicate).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00807" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00807?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00807</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional tables, figures, schemes, graphs, experimental procedures, and copies of NMR spectra (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C spectra of all the compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular Formula Strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_001.pdf">jm0c00807_si_001.pdf (620.11 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_002.pdf">jm0c00807_si_002.pdf (13.54 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_003.csv">jm0c00807_si_003.csv (6.41 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00807" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40802" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40802" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kay E. Davies</span> - <span class="hlFld-Affiliation affiliation">MDUK
Oxford Neuromuscular Centre, Department of Physiology, Anatomy and
Genetics, University of Oxford, Oxford OX1 3PT, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ff949e86d19b9e89969a8cbf9b8f9e98d19087d19e9cd18a94"><span class="__cf_email__" data-cfemail="1c777d6532787d6a75796f5c786c7d7b327364327d7f326977">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela J. Russell</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3PQ, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3610-9369" title="Orcid link">http://orcid.org/0000-0003-3610-9369</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ddbcb3bab8b1bcf3afa8aeaeb8b1b19dbeb5b8b0f3b2a5f3bcbef3a8b6"><span class="__cf_email__" data-cfemail="b6d7d8d1d3dad798c4c3c5c5d3dadaf6d5ded3db98d9ce98d7d598c3dd">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arran Babbs</span> - <span class="hlFld-Affiliation affiliation">MDUK
Oxford Neuromuscular Centre, Department of Physiology, Anatomy and
Genetics, University of Oxford, Oxford OX1 3PT, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam Berg</span> - <span class="hlFld-Affiliation affiliation">MDUK
Oxford Neuromuscular Centre, Department of Physiology, Anatomy and
Genetics, University of Oxford, Oxford OX1 3PT, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Chatzopoulou</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1886-7705" title="Orcid link">http://orcid.org/0000-0003-1886-7705</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen G. Davies</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3181-8748" title="Orcid link">http://orcid.org/0000-0003-3181-8748</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin Edwards</span> - <span class="hlFld-Affiliation affiliation">MDUK
Oxford Neuromuscular Centre, Department of Physiology, Anatomy and
Genetics, University of Oxford, Oxford OX1 3PT, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Elsey</span> - <span class="hlFld-Affiliation affiliation">Summit
Therapeutics plc, 136a Eastern Avenue, Milton Park, Abingdon, Oxfordshire OX14 4SB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Enrico Emer</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon Guiraud</span> - <span class="hlFld-Affiliation affiliation">MDUK
Oxford Neuromuscular Centre, Department of Physiology, Anatomy and
Genetics, University of Oxford, Oxford OX1 3PT, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shawn Harriman</span> - <span class="hlFld-Affiliation affiliation">Summit
Therapeutics plc, 136a Eastern Avenue, Milton Park, Abingdon, Oxfordshire OX14 4SB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina Lecci</span> - <span class="hlFld-Affiliation affiliation">Evotec
(UK) Ltd, 114 Innovation
Dr, Milton Park, Milton, Abingdon OX14 4RZ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lee Moir</span> - <span class="hlFld-Affiliation affiliation">MDUK
Oxford Neuromuscular Centre, Department of Physiology, Anatomy and
Genetics, University of Oxford, Oxford OX1 3PT, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Peters</span> - <span class="hlFld-Affiliation affiliation">Summit
Therapeutics plc, 136a Eastern Avenue, Milton Park, Abingdon, Oxfordshire OX14 4SB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neil Robinson</span> - <span class="hlFld-Affiliation affiliation">S.H.B.
Enterprises Ltd, 55 Station
Road, Beaconsfield HP19
1QL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jessica A. Rowley</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah E. Squire</span> - <span class="hlFld-Affiliation affiliation">MDUK
Oxford Neuromuscular Centre, Department of Physiology, Anatomy and
Genetics, University of Oxford, Oxford OX1 3PT, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathon M. Tinsley</span> - <span class="hlFld-Affiliation affiliation">Summit
Therapeutics plc, 136a Eastern Avenue, Milton Park, Abingdon, Oxfordshire OX14 4SB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francis X. Wilson</span> - <span class="hlFld-Affiliation affiliation">Summit
Therapeutics plc, 136a Eastern Avenue, Milton Park, Abingdon, Oxfordshire OX14 4SB, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Graham M. Wynne</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K.</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>M.C., J.A.R., and A.J.R. collated the data and wrote the manuscript. M.C., E.E., and J.A.R. designed and performed the chemistry experiments; S.G.D., C.L., A.J.R., F.X.W., and G.M.W. supervised the chemistry. A.B., A.B., B.E., L.M., S.G., and S.E.S. designed and performed the biological in vitro and in vivo experiments; K.E.D. and J.M.T. supervised the biology. ADME studies were designed and supervised by D.J.E., S.H., and N.R. Toxicological studies were supervised by D.P. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>The authors wish to thank Summit Therapeutics plc (M.C., E.E., A.F., J.A.R.), and the Medical Research Council (1501AV003/CA2, K.E.D.) for financial support.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): D.J.E., S.H., N.R., J.M.T., F.X.W. are or were Summit Therapeutics plc employees or consultants at the time that the work was conducted. K.E.D., S.G.D., and A.J.R. are minor shareholders of Summit Therapeutics plc.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65467" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65467" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors kindly acknowledge ChemOvation Ltd (UK) for the synthesis of some of the analogues reported in Table 2, Covance Laboratories Ltd (UK) for conducting the MTD study for <b>30</b>, and the toxicity and toxicokinetic study for <b>30</b> and its enantiomers, Cyprotex Discovery Ltd (UK) for the physicochemical and ADME evaluation in Tables 3, 4, 6 (PPB), and 9, as well as the 3D HepatoTox Study and P450 inhibition, DiscoverX for the nhrMAX Biosensor Panel, Eurofins for the IonChannelProfiler, and GPCRProfiler, Evotec (UK) for physicochemical and ADME evaluation in Table 10, Gentronix for the Ames assay, RMI Laboratories for the metabolic profile of <b>30</b> in rat, dog, monkey, and human hepatocytes, Saretius for the pharmacokinetic study of <b>27</b>/<b>30</b> and enantiomers in <i>mdx</i> mice, and XenoGesis Ltd (UK) for the hepatocyte stability study in Table 6. The <i>mdx</i> study was designed to meet the known requirements of European Directive 2001/83/EC and all subsequent amendments together with any relevant International Conference on Harmonisation (ICH) guidelines. All animal procedures were performed in accordance with UK Home Office regulations which conform with the European Community Directive published in 1986 (86/609/EEC). The work was performed under the certificate of designation number XEC303F12 and project license number 30/3104 following approval by the University of Oxford Departments of Physiology, Anatomy & Genetics and Experimental Psychology Joint Departmental Ethics Review Committee. We further acknowledge G.E. Morris (Oswestry, UK) for the MANCHO3 antibody.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ACE</td><td class="NLM_def"><p class="first last">angiotensin converting enzyme</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">DAPC</td><td class="NLM_def"><p class="first last">dystrophin-associated protein complex</p></td></tr><tr><td class="NLM_term">DMD</td><td class="NLM_def"><p class="first last">Duchenne muscular dystrophy</p></td></tr><tr><td class="NLM_term">EDL</td><td class="NLM_def"><p class="first last">extensor digitorum longus</p></td></tr><tr><td class="NLM_term">GGT</td><td class="NLM_def"><p class="first last">γ glutamyltransferase</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">MetID</td><td class="NLM_def"><p class="first last">metabolite identification</p></td></tr><tr><td class="NLM_term">MTD</td><td class="NLM_def"><p class="first last">maximum tolerated dose</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">structure–property relationship</p></td></tr><tr><td class="NLM_term">TBILI</td><td class="NLM_def"><p class="first last">total bilirubin</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27166" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27166" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 24 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guiraud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squire, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babbs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">Second-generation compound for the modulation of utrophin in the therapy of DMD</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4212</span>– <span class="NLM_lpage">4224</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddv154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1093%2Fhmg%2Fddv154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=25935002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2rt7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=4212-4224&author=S.+Guiraudauthor=S.+E.+Squireauthor=B.+Edwardsauthor=H.+Chenauthor=D.+T.+Burnsauthor=N.+Shahauthor=A.+Babbsauthor=S.+G.+Daviesauthor=G.+M.+Wynneauthor=A.+J.+Russellauthor=D.+Elseyauthor=F.+X.+Wilsonauthor=J.+M.+Tinsleyauthor=K.+E.+Davies&title=Second-generation+compound+for+the+modulation+of+utrophin+in+the+therapy+of+DMD&doi=10.1093%2Fhmg%2Fddv154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Second-generation compound for the modulation of utrophin in the therapy of DMD</span></div><div class="casAuthors">Guiraud, Simon; Squire, Sarah E.; Edwards, Benjamin; Chen, Huijia; Burns, David T.; Shah, Nandini; Babbs, Arran; Davies, Stephen G.; Wynne, Graham M.; Russell, Angela J.; Elsey, David; Wilson, Francis X.; Tinsley, Jon M.; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4212-4224</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Duchenne muscular dystrophy (DMD) is a lethal, X-linked muscle-wasting disease caused by lack of the cytoskeletal protein dystrophin.  There is currently no cure for DMD although various promising approaches are progressing through human clin. trials.  By pharmacol. modulating the expression of the dystrophin-related protein utrophin, we have previously demonstrated in dystrophin-deficient mdx studies, daily SMT C1100 treatment significantly reduced muscle degeneration leading to improved muscle function.  This manuscript describes the significant disease modifying benefits assocd. with daily dosing of SMT022357, a second-generation compd. in this drug series with improved physicochem. properties and a more robust metab. profile.  These studies in the mdx mouse demonstrate that oral administration of SMT022357 leads to increased utrophin expression in skeletal, respiratory and cardiac muscles.  Significantly, utrophin expression is localized along the length of the muscle fiber, not just at the synapse, and is fiber-type independent, suggesting that drug treatment is modulating utrophin transcription in extra-synaptic myonuclei.  This results in improved sarcolemmal stability and prevents dystrophic pathol. through a significant redn. of regeneration, necrosis and fibrosis.  All these improvements combine to protect the mdx muscle from contraction induced damage and enhance physiol. function.  This detailed evaluation of the SMT C1100 drug series strongly endorses the therapeutic potential of utrophin modulation as a disease modifying therapeutic strategy for all DMD patients irresp. of their dystrophin mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAcUx0IEEY0rVg90H21EOLACvtfcHk0liMldFBXF0WXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2rt7jJ&md5=7a422c65b1b4fbeecb3e440630d5a173</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddv154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddv154%26sid%3Dliteratum%253Aachs%26aulast%3DGuiraud%26aufirst%3DS.%26aulast%3DSquire%26aufirst%3DS.%2BE.%26aulast%3DEdwards%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DBurns%26aufirst%3DD.%2BT.%26aulast%3DShah%26aufirst%3DN.%26aulast%3DBabbs%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DS.%2BG.%26aulast%3DWynne%26aufirst%3DG.%2BM.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DElsey%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DF.%2BX.%26aulast%3DTinsley%26aufirst%3DJ.%2BM.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DSecond-generation%2520compound%2520for%2520the%2520modulation%2520of%2520utrophin%2520in%2520the%2520therapy%2520of%2520DMD%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2015%26volume%3D24%26spage%3D4212%26epage%3D4224%26doi%3D10.1093%2Fhmg%2Fddv154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guiraud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">Pharmacological advances for treatment in Duchenne muscular dystrophy</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2017.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1016%2Fj.coph.2017.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=28486179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVGqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2017&pages=36-48&author=S.+Guiraudauthor=K.+E.+Davies&title=Pharmacological+advances+for+treatment+in+Duchenne+muscular+dystrophy&doi=10.1016%2Fj.coph.2017.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological advances for treatment in Duchenne muscular dystrophy</span></div><div class="casAuthors">Guiraud, Simon; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36-48</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Duchenne muscular dystrophy (DMD) is a lethal, X-linked muscle-wasting disease caused by lack of dystrophin, essential for muscle fiber integrity.  Despite extensive pre-clin. studies, development of an effective treatment has proved challenging.  More recently, significant progress has been made with the first drug approval using a genetic approach and the application of pharmacol. agents which slow the progression of the disease.  Drug development for DMD has mainly used two strategies: (1) the restoration of dystrophin expression or the expression of the compensatory utrophin protein as an efficient surrogate, and (2) the mitigation of secondary downstream pathol. mechanisms.  This review details current most promising pharmacol. approaches and clin. trials aiming to tackle the pathogenesis of this multifaceted disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4bL76CfzS1rVg90H21EOLACvtfcHk0lh6GKweTh51wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVGqurw%253D&md5=ed36a5afd8e07f41f8c3ae14195f304e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2017.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2017.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DGuiraud%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DPharmacological%2520advances%2520for%2520treatment%2520in%2520Duchenne%2520muscular%2520dystrophy%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2017%26volume%3D34%26spage%3D36%26epage%3D48%26doi%3D10.1016%2Fj.coph.2017.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guiraud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roblin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kay, D. E.</span></span> <span> </span><span class="NLM_article-title">The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy</span>. <i>Expert Opin. Orphan Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1080/21678707.2018.1438261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1080%2F21678707.2018.1438261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFSmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=179-192&author=S.+Guiraudauthor=D.+Roblinauthor=D.+E.+Kay&title=The+potential+of+utrophin+modulators+for+the+treatment+of+Duchenne+muscular+dystrophy&doi=10.1080%2F21678707.2018.1438261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy</span></div><div class="casAuthors">Guiraud, Simon; Roblin, David; Kay, Davies. E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Orphan Drugs</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">179-192</span>CODEN:
                <span class="NLM_cas:coden">EOODAJ</span>;
        ISSN:<span class="NLM_cas:issn">2167-8707</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Duchenne muscular dystrophy (DMD) is a lethal, X-linked muscle-wasting disease caused by the lack of dystrophin.  A few years after the identification of the dystrophin gene, a ubiquitously expressed transcript with high homol. to dystrophin was identified leading to the postulate that utrophin might be an effective surrogate to compensate for the lack of dystrophin in dystrophic muscles.: We review the utrophin gene, its regulation, the organization of the corresponding protein and its dynamic expression pattern in comparison with dystrophin.  In view of the evidence that utrophin acts as an efficient substitute to dystrophin to prevent the pathol., we describe the therapeutic approaches to modulate utrophin expression.  We review the current status in the development of ezutromid, the first small utrophin modulator drug currently tested in DMD patients.: A utrophin based strategy is a highly promising approach applicable to all DMD patients irresp. of their genetic defect.  Whereas accurate utrophin and regeneration quantification tools are urgently needed, the foundation of utrophin based therapies, defined 20 years ago, recently delivered first promising results in DMD patients with ezutromid.  The field is at an exciting stage on the road of a universal treatment for all DMD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcS_zSFMYHPrVg90H21EOLACvtfcHk0lh6GKweTh51wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFSmtL0%253D&md5=7c785199bc688ebe4b0f143da09fa70d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1080%2F21678707.2018.1438261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21678707.2018.1438261%26sid%3Dliteratum%253Aachs%26aulast%3DGuiraud%26aufirst%3DS.%26aulast%3DRoblin%26aufirst%3DD.%26aulast%3DKay%26aufirst%3DD.%2BE.%26atitle%3DThe%2520potential%2520of%2520utrophin%2520modulators%2520for%2520the%2520treatment%2520of%2520Duchenne%2520muscular%2520dystrophy%26jtitle%3DExpert%2520Opin.%2520Orphan%2520Drugs%26date%3D2018%26volume%3D6%26spage%3D179%26epage%3D192%26doi%3D10.1080%2F21678707.2018.1438261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leadley, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleijnen, J.</span></span> <span> </span><span class="NLM_article-title">The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review</span>. <i>Orphanet J. Rare Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">79</span>, <span class="refDoi"> DOI: 10.1186/s13023-017-0631-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1186%2Fs13023-017-0631-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=28446219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A280%3ADC%252BC1crhsVyktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=79&author=S.+Ryderauthor=R.+M.+Leadleyauthor=N.+Armstrongauthor=M.+Westwoodauthor=S.+de+Kockauthor=T.+Buttauthor=M.+Jainauthor=J.+Kleijnen&title=The+burden%2C+epidemiology%2C+costs+and+treatment+for+Duchenne+muscular+dystrophy%3A+an+evidence+review&doi=10.1186%2Fs13023-017-0631-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review</span></div><div class="casAuthors">Ryder S; Leadley R M; Armstrong N; Westwood M; de Kock S; Butt T; Jain M; Kleijnen J</div><div class="citationInfo"><span class="NLM_cas:title">Orphanet journal of rare diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Duchenne Muscular Dystrophy (DMD) is a rapidly progressive, lethal neuromuscular disorder, present from birth, which occurs almost exclusively in males.  We have reviewed contemporary evidence of burden, epidemiology, illness costs and treatment patterns of DMD.  This systematic review adhered to published methods with information also sought from the web and contacting registries.  Searches were carried out from 2005 to June 2015.  The population of interest was individuals with clearly defined DMD or their carers.  RESULTS:  Nine thousand eight hundred fifty titles were retrieved from searches.  Fifty-eight studies were reviewed with three assessed as high, 33 as medium and 22 as low quality.  We found two studies reporting birth and four reporting point prevalence, three reporting mortality, 41 reporting severity and/or progression, 18 reporting treatment patterns, 12 reporting quality of life, two reporting utility measures, three reporting costs of illness and three treatment guidelines.  Birth prevalence ranged from 15.9 to 19.5 per 100,000 live births.  Point prevalence per 100,000 males was for France, USA, UK and Canada, 10.9, 1.9, 2.2 and 6.1 respectively.  A study of adult DMD patients at a centre in France found median survival for those born between 1970 and 1994 was 40.95 years compared to 25.77 years for those born between 1955 and 1969.  Loss of ambulation occurred at a median age of 12 and ventilation starts at about 20 years.  There was international variation in use of corticosteroids, scoliosis surgery, ventilation and physiotherapy.  The economic cost of DMD climbs dramatically with disease progression - rising as much as 5.7 fold from the early ambulatory phase to the non-ambulatory phase in Germany.  CONCLUSIONS:  This is the first systematic review of treatment, progression, severity and quality of life in DMD.  It also provides the most recent description of the burden, epidemiology, illness costs and treatment patterns in DMD.  There are evidence gaps, particularly in prevalence and mortality.  People with DMD seem to be living longer, possibly due to corticosteroid use, cardiac medical management and ventilation.  Future research should incorporate registry data to improve comparability across time and between countries and to investigate the quality of life impact as the condition progresses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRKgZz0hzs5qBfKb6ELK8t0fW6udTcc2eYeqvahty80WLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crhsVyktw%253D%253D&md5=52e354eec8932fd87e0a489786449551</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1186%2Fs13023-017-0631-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13023-017-0631-3%26sid%3Dliteratum%253Aachs%26aulast%3DRyder%26aufirst%3DS.%26aulast%3DLeadley%26aufirst%3DR.%2BM.%26aulast%3DArmstrong%26aufirst%3DN.%26aulast%3DWestwood%26aufirst%3DM.%26aulast%3Dde%2BKock%26aufirst%3DS.%26aulast%3DButt%26aufirst%3DT.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DKleijnen%26aufirst%3DJ.%26atitle%3DThe%2520burden%252C%2520epidemiology%252C%2520costs%2520and%2520treatment%2520for%2520Duchenne%2520muscular%2520dystrophy%253A%2520an%2520evidence%2520review%26jtitle%3DOrphanet%2520J.%2520Rare%2520Dis.%26date%3D2017%26volume%3D12%26spage%3D79%26doi%3D10.1186%2Fs13023-017-0631-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, A.</span></span> <span> </span><span class="NLM_article-title">Mutation-Based Therapeutic Strategies for Duchenne Muscular Dystrophy: From Genetic Diagnosis to Therapy</span>. <i>J. Pers. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">16</span>, <span class="refDoi"> DOI: 10.3390/jpm9010016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.3390%2Fjpm9010016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=16&author=A.+Nakamura&title=Mutation-Based+Therapeutic+Strategies+for+Duchenne+Muscular+Dystrophy%3A+From+Genetic+Diagnosis+to+Therapy&doi=10.3390%2Fjpm9010016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3390%2Fjpm9010016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjpm9010016%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DA.%26atitle%3DMutation-Based%2520Therapeutic%2520Strategies%2520for%2520Duchenne%2520Muscular%2520Dystrophy%253A%2520From%2520Genetic%2520Diagnosis%2520to%2520Therapy%26jtitle%3DJ.%2520Pers.%2520Med.%26date%3D2019%26volume%3D9%26spage%3D16%26doi%3D10.3390%2Fjpm9010016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Love, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurr, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byth, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsden, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">An autosomal transcript in skeletal muscle with homology to dystrophin</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1038/339055a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1038%2F339055a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=2541343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADyaL1MXktVWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1989&pages=55-58&author=D.+R.+Loveauthor=D.+F.+Hillauthor=G.+Dicksonauthor=N.+K.+Spurrauthor=B.+C.+Bythauthor=R.+F.+Marsdenauthor=F.+S.+Walshauthor=Y.+H.+Edwardsauthor=K.+E.+Davies&title=An+autosomal+transcript+in+skeletal+muscle+with+homology+to+dystrophin&doi=10.1038%2F339055a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An autosomal transcript in skeletal muscle with homology to dystrophin</span></div><div class="casAuthors">Love, Donald R.; Hill, Diane F.; Dickson, George; Spurr, Nigel K.; Byth, Barbara C.; Marsden, Rosalind F.; Walsh, Frank S.; Edwards, Yvonne H.; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6219</span>),
    <span class="NLM_cas:pages">55-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The Duchenne muscular dystrophy (DMD) gene has been localized to chromosome Xp21 and codes for a 14-kilobase (kb) transcript and a protein called dystrophin, of relative mol. mass 427,000.  Dystrophin is assocd. with the cytoplasmic face of muscle fiber membranes, and its C-terminal domain is thought to mediate membrane attachment.  Although N-terminal and central domain structures share common features with other cytoskeletal components, no significant sequence similarity between the C-terminal region of dystrophin and other previously characterized proteins has been described.  Fragments from the C-terminal domain of the DMD cDNA detect a closely related sequence which exhibits nucleic acid and predicted amino acid identities with dystrophin of approx. 65 and 80%, resp.  The dystrophin-related sequence identifies a 13-kb transcript in human fetal muscle and maps to chromosome 6.  Thus, dystrophin may be a member of a family of functionally related large structural proteins in muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruW-WbVv6WP7Vg90H21EOLACvtfcHk0lhpwzwK1FCBCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktVWqtbk%253D&md5=39b72b03aa694a6c5cecb70110bc244a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F339055a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F339055a0%26sid%3Dliteratum%253Aachs%26aulast%3DLove%26aufirst%3DD.%2BR.%26aulast%3DHill%26aufirst%3DD.%2BF.%26aulast%3DDickson%26aufirst%3DG.%26aulast%3DSpurr%26aufirst%3DN.%2BK.%26aulast%3DByth%26aufirst%3DB.%2BC.%26aulast%3DMarsden%26aufirst%3DR.%2BF.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DEdwards%26aufirst%3DY.%2BH.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DAn%2520autosomal%2520transcript%2520in%2520skeletal%2520muscle%2520with%2520homology%2520to%2520dystrophin%26jtitle%3DNature%26date%3D1989%26volume%3D339%26spage%3D55%26epage%3D58%26doi%3D10.1038%2F339055a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deconinck, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backer, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phelps, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, J.-M.</span></span> <span> </span><span class="NLM_article-title">Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1216</span>– <span class="NLM_lpage">1221</span>, <span class="refDoi"> DOI: 10.1038/nm1197-1216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1038%2Fnm1197-1216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=9359695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADyaK2sXntFansb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=1216-1221&author=N.+Deconinckauthor=J.+Tinsleyauthor=F.+D.+Backerauthor=R.+Fisherauthor=D.+Kahnauthor=S.+Phelpsauthor=K.+Daviesauthor=J.-M.+Gillis&title=Expression+of+truncated+utrophin+leads+to+major+functional+improvements+in+dystrophin-deficient+muscles+of+mice&doi=10.1038%2Fnm1197-1216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice</span></div><div class="casAuthors">Deconinck, Nicolas; Tinsley, Jonathon; De Backer, Fabienne; Fisher, Rosie; Kahn, David; Phelps, Steve; Davies, Kay; Gillis, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1216-1221</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Dystrophin-deficient mice (mdx) expressing a truncated (trc) utrophin transgene show amelioration of the dystrophic phenotype.  Here, we report a multifunctional study demonstrating that trc-utrophin expression leads to major improvements of the mech. performance of muscle (i.e., force development, mech. resistance to forced lengthenings, and maximal spontaneous activity) and of the maintenance of the intracellular calcium homeostasis.  These are two essential functions of muscle fibers, known to be impaired in mdx mouse muscles and Duchenne muscular dystrophy (DMD) patients.  Our results bring strong support to the hypothesis that muscle wasting in dystrophin-deficient DMD patients could be prevented by upregulation of utrophin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4gcI8wE3cErVg90H21EOLACvtfcHk0liKmhAOBlzBjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXntFansb8%253D&md5=e1680364e0b9b2d703caf8fc2e5a5113</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnm1197-1216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1197-1216%26sid%3Dliteratum%253Aachs%26aulast%3DDeconinck%26aufirst%3DN.%26aulast%3DTinsley%26aufirst%3DJ.%26aulast%3DBacker%26aufirst%3DF.%2BD.%26aulast%3DFisher%26aufirst%3DR.%26aulast%3DKahn%26aufirst%3DD.%26aulast%3DPhelps%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DK.%26aulast%3DGillis%26aufirst%3DJ.-M.%26atitle%3DExpression%2520of%2520truncated%2520utrophin%2520leads%2520to%2520major%2520functional%2520improvements%2520in%2520dystrophin-deficient%2520muscles%2520of%2520mice%26jtitle%3DNat.%2520Med.%26date%3D1997%26volume%3D3%26spage%3D1216%26epage%3D1221%26doi%3D10.1038%2Fnm1197-1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deconinck, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phelps, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K.</span></span> <span> </span><span class="NLM_article-title">Expression of full-length utrophin prevents muscular dystrophy in <i>mdx</i> mice</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1441</span>– <span class="NLM_lpage">1444</span>, <span class="refDoi"> DOI: 10.1038/4033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1038%2F4033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=9846586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADyaK1cXnvVOhur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=1441-1444&author=J.+Tinsleyauthor=N.+Deconinckauthor=R.+Fisherauthor=D.+Kahnauthor=S.+Phelpsauthor=J.-M.+Gillisauthor=K.+Davies&title=Expression+of+full-length+utrophin+prevents+muscular+dystrophy+in+mdx+mice&doi=10.1038%2F4033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of full-length utrophin prevents muscular dystrophy in mdx mice</span></div><div class="casAuthors">Tinsley, Jonathon; Deconinck, Nicolas; Fisher, Rosie; Kahn, David; Phelps, Steve; Gillis, Jean-Marie; Davies, Kay</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1441-1444</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the muscle fiber leading to the gradual depletion of skeletal muscle.  The mol. structure of dystrophin is very similar to that of the related protein utrophin2.  Utrophin is found in all tissues and is confined to the neuromuscular and myotendinous junctions in mature muscle.  Sarcolemmal localization of a truncated utrophin transgene in the dystrophin-deficient mdx mouse significantly improves the dystrophic muscle phenotype.  Therefore, up-regulation of utrophin by drug therapy is a plausible therapeutic approach in the treatment of DMD.  Here, the authors demonstrate that expression of full-length utrophin in mdx mice prevents the development of muscular dystrophy.  The authors assessed muscle morphol., fiber regeneration and mech. properties (force development and resistance to stretch) of mdx and transgenic mdx skeletal and diaphragm muscle.  The utrophin levels required in muscle are significantly less than the normal endogenous in utrophin levels seen in lung and kidney, and the authors provide evidence that the pathol. depends on the amt. of utrophin expression.  These results also have important implications for DMD therapies in which utrophin replacement is achieved by delivery using exogenous vectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkZwAIp6gKKrVg90H21EOLACvtfcHk0liKmhAOBlzBjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvVOhur0%253D&md5=3bc3ecaf7e29380b3289796b9f444ab1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F4033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F4033%26sid%3Dliteratum%253Aachs%26aulast%3DTinsley%26aufirst%3DJ.%26aulast%3DDeconinck%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DR.%26aulast%3DKahn%26aufirst%3DD.%26aulast%3DPhelps%26aufirst%3DS.%26aulast%3DGillis%26aufirst%3DJ.-M.%26aulast%3DDavies%26aufirst%3DK.%26atitle%3DExpression%2520of%2520full-length%2520utrophin%2520prevents%2520muscular%2520dystrophy%2520in%2520mdx%2520mice%26jtitle%3DNat.%2520Med.%26date%3D1998%26volume%3D4%26spage%3D1441%26epage%3D1444%26doi%3D10.1038%2F4033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">707</span>, <span class="refDoi"> DOI: 10.1002/jcph.468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1002%2Fjcph.468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=25651188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVeltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=698-707&author=J.+Tinsleyauthor=N.+Robinsonauthor=K.+E.+Davies&title=Safety%2C+tolerability%2C+and+pharmacokinetics+of+SMT+C1100%2C+a+2-arylbenzoxazole+utrophin+modulator%2C+following+single-+and+multiple-dose+administration+to+healthy+male+adult+volunteers&doi=10.1002%2Fjcph.468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers</span></div><div class="casAuthors">Tinsley, Jon; Robinson, Neil; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">698-707</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">SMT C1100 is a small mol. utrophin modulator in development to treat Duchenne muscular dystrophy.  This study evaluated the safety, tolerability, and pharmacokinetics of SMT C1100 in healthy volunteers.  This double-blind, placebo-controlled Phase 1 study comprised: Part 1, an escalating, single-dose with/without fasting involving 50 mg/kg, 100 mg/kg, 200 mg/kg, and 400 mg/kg doses; and Part 2, a multiple 10 day dose evaluation involving 100 mg/kg bid and 200 mg/kg bid doses.  Adverse events were recorded.  SMT C1100 was absorbed rapidly following single and multiple oral doses, with median tmax attained within 2-3.5 h across all doses.  Considerable variability of pharmacokinetic parameters was noted among subjects.  Following single doses, systemic exposure increased in a sub-proportional manner, with the 8.0-fold dose increment resulting in 2.7- and 2.4-fold increases in AUC0-∞ and Cmax, resp.  AUC0-∞ and Cmax were estd. as 4.2- and 4.8-fold greater, resp., following food.  Systemic exposure reduced upon repeat dosing with steady-state concns. achieved within 3-5 days of multiple bid dosing.  No serious or severe adverse events were reported.  SMT C1100 was safe and well tolerated with plasma concns. achieved sufficient to cause a 50% increase in concns. of utrophin in cells in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS-otCqjm06rVg90H21EOLACvtfcHk0liKmhAOBlzBjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVeltL0%253D&md5=be9902e46e42d7921a17657a263ff552</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fjcph.468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcph.468%26sid%3Dliteratum%253Aachs%26aulast%3DTinsley%26aufirst%3DJ.%26aulast%3DRobinson%26aufirst%3DN.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520pharmacokinetics%2520of%2520SMT%2520C1100%252C%2520a%25202-arylbenzoxazole%2520utrophin%2520modulator%252C%2520following%2520single-%2520and%2520multiple-dose%2520administration%2520to%2520healthy%2520male%2520adult%2520volunteers%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2015%26volume%3D55%26spage%3D698%26epage%3D707%26doi%3D10.1002%2Fjcph.468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ricotti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roper, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejura, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muntoni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to pediatric patients with Duchenne muscular dystrophy</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0152840</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0152840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1371%2Fjournal.pone.0152840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=27055247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1OqsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&author=V.+Ricottiauthor=S.+Spintyauthor=H.+Roperauthor=I.+Hughesauthor=B.+Tejuraauthor=N.+Robinsonauthor=G.+Laytonauthor=K.+Daviesauthor=F.+Muntoniauthor=J.+Tinsley&title=Safety%2C+tolerability%2C+and+pharmacokinetics+of+SMT+C1100%2C+a+2-arylbenzoxazole+utrophin+modulator%2C+following+single-+and+multiple-dose+administration+to+pediatric+patients+with+Duchenne+muscular+dystrophy&doi=10.1371%2Fjournal.pone.0152840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to pediatric patients with duchenne muscular dystrophy</span></div><div class="casAuthors">Ricotti, Valeria; Spinty, Stefan; Roper, Helen; Hughes, Imelda; Tejura, Bina; Robinson, Neil; Layton, Gary; Davies, Kay; Muntoni, Francesco; Tinsley, Jonathon</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0152840/1-e0152840/16</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Purpose SMT C1100 is a utrophin modulator being evaluated as a treatment for Duchenne muscular dystrophy (DMD).  This study, the first in pediatric DMD patients, reports the safety, tolerability and PK parameters of single and multiple doses of SMT C1100, as well as analyze potential biomarkers of muscle damage.  Methods This multicenter, Phase 1 study enrolled 12 patients, divided equally into three groups (A- C).  Group A were given 50 mg/kg on Days 1 and 11, and 50 mg/kg bid on Days 2 to 10.  Group B and C received 100 mg/kg on Days 1 and 11; Group B and Group C were given 100 mg/kg bid and 100 mg/kg tid, resp., on Days 2 to 10.  A safety review was performed on all patients following the single dose and there was at least 2 wk between each dose escalation, for safety and PK review.  Adverse events (AEs) were monitored throughout the study.  Results Most patients experienced mild AEs and there were no serious AEs.  Two patients required analgesia for pain (headache, ear pain and toothache).  One patient experienced moderate psychiatric AEs (abnormal behavior and mood swings).  Plasma concns. of SMT C1100 at Days 1 and 11 indicated a high degree of patient variability regardless of dose.  Unexpectedly the SMT C1100 levels were significantly lower than similar doses administered to healthy volunteers in an earlier clin. study.  In general, individual baseline changes of creatine phosphokinase, alanine aminotransferase, aspartate aminotransferase levels fell with SMT C1100 dosing.  Conclusions SMT C1100 was well tolerated in pediatric DMD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt0w7VChgcJbVg90H21EOLACvtfcHk0lgPUMcPK9u1Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1OqsLzM&md5=7e3080644fb23bed4b3b4bbfab8263de</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0152840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0152840%26sid%3Dliteratum%253Aachs%26aulast%3DRicotti%26aufirst%3DV.%26aulast%3DSpinty%26aufirst%3DS.%26aulast%3DRoper%26aufirst%3DH.%26aulast%3DHughes%26aufirst%3DI.%26aulast%3DTejura%26aufirst%3DB.%26aulast%3DRobinson%26aufirst%3DN.%26aulast%3DLayton%26aufirst%3DG.%26aulast%3DDavies%26aufirst%3DK.%26aulast%3DMuntoni%26aufirst%3DF.%26aulast%3DTinsley%26aufirst%3DJ.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520pharmacokinetics%2520of%2520SMT%2520C1100%252C%2520a%25202-arylbenzoxazole%2520utrophin%2520modulator%252C%2520following%2520single-%2520and%2520multiple-dose%2520administration%2520to%2520pediatric%2520patients%2520with%2520Duchenne%2520muscular%2520dystrophy%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26doi%3D10.1371%2Fjournal.pone.0152840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><a href="https://musculardystrophynews.com/2018/06/29/summit-therapeutics-ends-ezutromid-development-trail-failure/" class="extLink">https://musculardystrophynews.com/2018/06/29/summit-therapeutics-ends-ezutromid-development-trail-failure/</a> (accessed June 1, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fmusculardystrophynews.com%2F2018%2F06%2F29%2Fsummit-therapeutics-ends-ezutromid-development-trail-failure%2F+%28accessed+June+1%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatzopoulou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsey, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harriman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, I. V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span></span> <span> </span><span class="NLM_article-title">Isolation, structural identification, synthesis, and pharmacological profiling of 1,2-trans-dihydro-1,2-diol metabolites of the utrophin modulator ezutromid</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2547</span>– <span class="NLM_lpage">2556</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01547</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01547" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCgtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2547-2556&author=M.+Chatzopoulouauthor=T.+D.+W.+Claridgeauthor=K.+E.+Daviesauthor=S.+G.+Daviesauthor=D.+J.+Elseyauthor=E.+Emerauthor=A.+M.+Fletcherauthor=S.+Harrimanauthor=N.+Robinsonauthor=J.+A.+Rowleyauthor=A.+J.+Russellauthor=J.+M.+Tinsleyauthor=R.+Weaverauthor=I.+V.+L.+Wilkinsonauthor=N.+J.+Willisauthor=F.+X.+Wilsonauthor=G.+M.+Wynne&title=Isolation%2C+structural+identification%2C+synthesis%2C+and+pharmacological+profiling+of+1%2C2-trans-dihydro-1%2C2-diol+metabolites+of+the+utrophin+modulator+ezutromid&doi=10.1021%2Facs.jmedchem.9b01547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-trans-Dihydro-1,2-diol Metabolites of the Utrophin Modulator Ezutromid</span></div><div class="casAuthors">Chatzopoulou, Maria; Claridge, Tim D. W.; Davies, Kay E.; Davies, Stephen G.; Elsey, David J.; Emer, Enrico; Fletcher, Ai M.; Harriman, Shawn; Robinson, Neil; Rowley, Jessica A.; Russell, Angela J.; Tinsley, Jonathon M.; Weaver, Richard; Wilkinson, Isabel V. L.; Willis, Nicky J.; Wilson, Francis X.; Wynne, Graham M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2547-2556</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">5-(Ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole (ezutromid, 1) is a first-in-class utrophin modulator that has been evaluated in a phase 2 clin. study for the treatment of Duchenne muscular dystrophy (DMD).  Ezutromid was found to undergo hepatic oxidn. of its 2-naphthyl substituent to produce two regioisomeric 1,2-dihydronaphthalene-1,2-diols, DHD1 and DHD3, as the major metabolites after oral administration in humans and rodents.  In many patients, plasma levels of the DHD metabolites were found to exceed those of ezutromid.  Herein, we describe the structural elucidation of the main metabolites of ezutromid, the regio- and relative stereochem. assignments of DHD1 and DHD3, their de novo chem. synthesis, and their prodn. in systems in vitro.  We further elucidate the likely metabolic pathway and CYP isoforms responsible for DHD1 and DHD3 prodn. and characterize their physicochem., ADME, and pharmacol. properties and their preliminary toxicol. profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAF3273Wda9rVg90H21EOLACvtfcHk0li03UEx6Qp2bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCgtL7E&md5=7b96559aeb7aa13eb81417bd556ff1fb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01547%26sid%3Dliteratum%253Aachs%26aulast%3DChatzopoulou%26aufirst%3DM.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%2BW.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26aulast%3DDavies%26aufirst%3DS.%2BG.%26aulast%3DElsey%26aufirst%3DD.%2BJ.%26aulast%3DEmer%26aufirst%3DE.%26aulast%3DFletcher%26aufirst%3DA.%2BM.%26aulast%3DHarriman%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DN.%26aulast%3DRowley%26aufirst%3DJ.%2BA.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DTinsley%26aufirst%3DJ.%2BM.%26aulast%3DWeaver%26aufirst%3DR.%26aulast%3DWilkinson%26aufirst%3DI.%2BV.%2BL.%26aulast%3DWillis%26aufirst%3DN.%2BJ.%26aulast%3DWilson%26aufirst%3DF.%2BX.%26aulast%3DWynne%26aufirst%3DG.%2BM.%26atitle%3DIsolation%252C%2520structural%2520identification%252C%2520synthesis%252C%2520and%2520pharmacological%2520profiling%2520of%25201%252C2-trans-dihydro-1%252C2-diol%2520metabolites%2520of%2520the%2520utrophin%2520modulator%2520ezutromid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D2547%26epage%3D2556%26doi%3D10.1021%2Facs.jmedchem.9b01547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chancellor, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Moor, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorgan, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maillol, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugent, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poignant, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pye, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Well, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vile, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkes, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wren, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">3241</span>– <span class="NLM_lpage">3250</span>, <span class="refDoi"> DOI: 10.1021/jm200135z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200135z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVSgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3241-3250&author=D.+R.+Chancellorauthor=K.+E.+Daviesauthor=O.+De+Moorauthor=C.+R.+Dorganauthor=P.+D.+Johnsonauthor=A.+G.+Lambertauthor=D.+Lawrenceauthor=C.+Lecciauthor=C.+Maillolauthor=P.+J.+Middletonauthor=G.+Nugentauthor=S.+D.+Poignantauthor=A.+C.+Potterauthor=P.+D.+Priceauthor=R.+J.+Pyeauthor=R.+Storerauthor=J.+M.+Tinsleyauthor=R.+van+Wellauthor=R.+Vickersauthor=J.+Vileauthor=F.+J.+Wilkesauthor=F.+X.+Wilsonauthor=S.+P.+Wrenauthor=G.+M.+Wynne&title=Discovery+of+2-arylbenzoxazoles+as+upregulators+of+utrophin+production+for+the+treatment+of+Duchenne+muscular+dystrophy&doi=10.1021%2Fjm200135z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-Arylbenzoxazoles as Upregulators of Utrophin Production for the Treatment of Duchenne Muscular Dystrophy</span></div><div class="casAuthors">Chancellor, Daniel R.; Davies, Kay E.; De Moor, Olivier; Dorgan, Colin R.; Johnson, Peter D.; Lambert, Adam G.; Lawrence, Daniel; Lecci, Cristina; Maillol, Carole; Middleton, Penny J.; Nugent, Gary; Poignant, Severine D.; Potter, Allyson C.; Price, Paul D.; Pye, Richard J.; Storer, Richard; Tinsley, Jonathon M.; van Well, Renate; Vickers, Richard; Vile, Julia; Wilkes, Fraser J.; Wilson, Francis X.; Wren, Stephen P.; Wynne, Graham M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3241-3250</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel 2-arylbenzoxazoles that upregulate the prodn. of utrophin in murine H2K cells, as assessed using a luciferase reporter linked assay, have been identified.  This compd. class appears to hold considerable promise as a potential treatment for Duchenne muscular dystrophy.  Following the delineation of structure-activity relationships in the series, a no. of potent upregulators were identified, and preliminary ADME evaluation is described.  These studies have resulted in the identification 5-(ethylsulfonyl)-2-(2-naphthyl)benzo[d]oxazole, a compd. that has been progressed to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5YotrFzaHAbVg90H21EOLACvtfcHk0li03UEx6Qp2bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVSgu74%253D&md5=3e4add2ecaebc8c4517cf113b5399371</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm200135z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200135z%26sid%3Dliteratum%253Aachs%26aulast%3DChancellor%26aufirst%3DD.%2BR.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26aulast%3DDe%2BMoor%26aufirst%3DO.%26aulast%3DDorgan%26aufirst%3DC.%2BR.%26aulast%3DJohnson%26aufirst%3DP.%2BD.%26aulast%3DLambert%26aufirst%3DA.%2BG.%26aulast%3DLawrence%26aufirst%3DD.%26aulast%3DLecci%26aufirst%3DC.%26aulast%3DMaillol%26aufirst%3DC.%26aulast%3DMiddleton%26aufirst%3DP.%2BJ.%26aulast%3DNugent%26aufirst%3DG.%26aulast%3DPoignant%26aufirst%3DS.%2BD.%26aulast%3DPotter%26aufirst%3DA.%2BC.%26aulast%3DPrice%26aufirst%3DP.%2BD.%26aulast%3DPye%26aufirst%3DR.%2BJ.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DTinsley%26aufirst%3DJ.%2BM.%26aulast%3Dvan%2BWell%26aufirst%3DR.%26aulast%3DVickers%26aufirst%3DR.%26aulast%3DVile%26aufirst%3DJ.%26aulast%3DWilkes%26aufirst%3DF.%2BJ.%26aulast%3DWilson%26aufirst%3DF.%2BX.%26aulast%3DWren%26aufirst%3DS.%2BP.%26aulast%3DWynne%26aufirst%3DG.%2BM.%26atitle%3DDiscovery%2520of%25202-arylbenzoxazoles%2520as%2520upregulators%2520of%2520utrophin%2520production%2520for%2520the%2520treatment%2520of%2520Duchenne%2520muscular%2520dystrophy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3241%26epage%3D3250%26doi%3D10.1021%2Fjm200135z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Babbs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatzopoulou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsey, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figuccia, A. L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guiraud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harriman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moir, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squire, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of SMT022357 enantiomers and in vivo evaluation in a Duchenne muscular dystrophy mouse model</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">130819</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2019.130819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1016%2Fj.tet.2019.130819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVajsr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2020&pages=130819&author=A.+Babbsauthor=A.+Bergauthor=M.+Chatzopoulouauthor=K.+E.+Daviesauthor=S.+G.+Daviesauthor=B.+Edwardsauthor=D.+J.+Elseyauthor=E.+Emerauthor=A.+L.+A.+Figucciaauthor=A.+M.+Fletcherauthor=S.+Guiraudauthor=S.+Harrimanauthor=L.+Moirauthor=N.+Robinsonauthor=J.+A.+Rowleyauthor=A.+J.+Russellauthor=S.+E.+Squireauthor=J.+E.+Thomsonauthor=J.+M.+Tinsleyauthor=F.+X.+Wilsonauthor=G.+M.+Wynne&title=Synthesis+of+SMT022357+enantiomers+and+in+vivo+evaluation+in+a+Duchenne+muscular+dystrophy+mouse+model&doi=10.1016%2Fj.tet.2019.130819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of SMT022357 enantiomers and in vivo evaluation in a Duchenne muscular dystrophy mouse model</span></div><div class="casAuthors">Babbs, Arran; Berg, Adam; Chatzopoulou, Maria; Davies, Kay E.; Davies, Stephen G.; Edwards, Benjamin; Elsey, David J.; Emer, Enrico; Figuccia, Aude L. A.; Fletcher, Ai M.; Guiraud, Simon; Harriman, Shawn; Moir, Lee; Robinson, Neil; Rowley, Jessica A.; Russell, Angela J.; Squire, Sarah E.; Thomson, James E.; Tinsley, Jonathon M.; Wilson, Francis X.; Wynne, Graham M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">130819</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Following on from ezutromid, the first-in-class benzoxazole utrophin modulator that progressed to Phase 2 clin. trials for the treatment of Duchenne muscular dystrophy, a new chemotype was designed to optimize its physicochem. and ADME profile.  Herein, we report the synthesis of SMT022357 (I), a second generation utrophin modulator preclin. candidate, and an asym. synthesis of its constituent enantiomers.  The pharmacol. properties of both enantiomers were evaluated in vitro and in vivo.  No significant difference in the activity or efficacy was obsd. between the two enantiomers; activity was found to be comparable to the racemic mixt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbXKqmEeQNcbVg90H21EOLACvtfcHk0liHExyHMF9X1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVajsr7F&md5=428938ac686524943c7a3a550b2bd2a2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2019.130819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2019.130819%26sid%3Dliteratum%253Aachs%26aulast%3DBabbs%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DA.%26aulast%3DChatzopoulou%26aufirst%3DM.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26aulast%3DDavies%26aufirst%3DS.%2BG.%26aulast%3DEdwards%26aufirst%3DB.%26aulast%3DElsey%26aufirst%3DD.%2BJ.%26aulast%3DEmer%26aufirst%3DE.%26aulast%3DFiguccia%26aufirst%3DA.%2BL.%2BA.%26aulast%3DFletcher%26aufirst%3DA.%2BM.%26aulast%3DGuiraud%26aufirst%3DS.%26aulast%3DHarriman%26aufirst%3DS.%26aulast%3DMoir%26aufirst%3DL.%26aulast%3DRobinson%26aufirst%3DN.%26aulast%3DRowley%26aufirst%3DJ.%2BA.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DSquire%26aufirst%3DS.%2BE.%26aulast%3DThomson%26aufirst%3DJ.%2BE.%26aulast%3DTinsley%26aufirst%3DJ.%2BM.%26aulast%3DWilson%26aufirst%3DF.%2BX.%26aulast%3DWynne%26aufirst%3DG.%2BM.%26atitle%3DSynthesis%2520of%2520SMT022357%2520enantiomers%2520and%2520in%2520vivo%2520evaluation%2520in%2520a%2520Duchenne%2520muscular%2520dystrophy%2520mouse%2520model%26jtitle%3DTetrahedron%26date%3D2020%26volume%3D76%26spage%3D130819%26doi%3D10.1016%2Fj.tet.2019.130819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, I. V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugdale, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moir, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuorinen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatzopoulou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squire, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monecke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charles, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastinejad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, A. J.</span></span> <span> </span><span class="NLM_article-title">Chemical proteomics and phenotypic profiling identifies the aryl hydrocarbon receptor as a molecular target of the utrophin modulator ezutromid</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2420</span>– <span class="NLM_lpage">2428</span>, <span class="refDoi"> DOI: 10.1002/anie.201912392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1002%2Fanie.201912392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjt1OisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2020&pages=2420-2428&author=I.+V.+L.+Wilkinsonauthor=K.+J.+Perkinsauthor=H.+Dugdaleauthor=L.+Moirauthor=A.+Vuorinenauthor=M.+Chatzopoulouauthor=S.+E.+Squireauthor=S.+Moneckeauthor=A.+Lomowauthor=M.+Geeseauthor=P.+D.+Charlesauthor=P.+Burchauthor=J.+M.+Tinsleyauthor=G.+M.+Wynneauthor=S.+G.+Daviesauthor=F.+X.+Wilsonauthor=F.+Rastinejadauthor=S.+Mohammedauthor=K.+E.+Daviesauthor=A.+J.+Russell&title=Chemical+proteomics+and+phenotypic+profiling+identifies+the+aryl+hydrocarbon+receptor+as+a+molecular+target+of+the+utrophin+modulator+ezutromid&doi=10.1002%2Fanie.201912392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Proteomics and Phenotypic Profiling Identifies the Aryl Hydrocarbon Receptor as a Molecular Target of the Utrophin Modulator Ezutromid</span></div><div class="casAuthors">Wilkinson, Isabel V. L.; Perkins, Kelly J.; Dugdale, Hannah; Moir, Lee; Vuorinen, Aini; Chatzopoulou, Maria; Squire, Sarah E.; Monecke, Sebastian; Lomow, Alexander; Geese, Marcus; Charles, Philip D.; Burch, Peter; Tinsley, Jonathan M.; Wynne, Graham M.; Davies, Stephen G.; Wilson, Francis X.; Rastinejad, Fraydoon; Mohammed, Shabaz; Davies, Kay E.; Russell, Angela J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2420-2428</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Duchenne muscular dystrophy (DMD) is a fatal muscle-wasting disease arising from mutations in the dystrophin gene.  Upregulation of utrophin to compensate for the missing dystrophin offers a potential therapy independent of patient genotype.  The first-in-class utrophin modulator ezutromid/SMT C1100 was developed from a phenotypic screen through to a Phase 2 clin. trial.  Promising efficacy and evidence of target engagement was obsd. in DMD patients after 24 wk of treatment, however trial endpoints were not met after 48 wk.  The objective of this study was to understand the mechanism of action of ezutromid which could explain the lack of sustained efficacy and help development of new generations of utrophin modulators.  Using chem. proteomics and phenotypic profiling we show that the aryl hydrocarbon receptor (AhR) is a target of ezutromid.  Several lines of evidence demonstrate that ezutromid binds AhR with an apparent KD of 50 nM and behaves as an AhR antagonist.  Furthermore, other reported AhR antagonists also upregulate utrophin, showing that this pathway, which is currently being explored in other clin. applications including oncol. and rheumatoid arthritis, could also be exploited in future DMD therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8uhmyItj_pLVg90H21EOLACvtfcHk0liKLPL2NwNwvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjt1OisA%253D%253D&md5=1860fc7c7884d932be4938d6627c692c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fanie.201912392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201912392%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DI.%2BV.%2BL.%26aulast%3DPerkins%26aufirst%3DK.%2BJ.%26aulast%3DDugdale%26aufirst%3DH.%26aulast%3DMoir%26aufirst%3DL.%26aulast%3DVuorinen%26aufirst%3DA.%26aulast%3DChatzopoulou%26aufirst%3DM.%26aulast%3DSquire%26aufirst%3DS.%2BE.%26aulast%3DMonecke%26aufirst%3DS.%26aulast%3DLomow%26aufirst%3DA.%26aulast%3DGeese%26aufirst%3DM.%26aulast%3DCharles%26aufirst%3DP.%2BD.%26aulast%3DBurch%26aufirst%3DP.%26aulast%3DTinsley%26aufirst%3DJ.%2BM.%26aulast%3DWynne%26aufirst%3DG.%2BM.%26aulast%3DDavies%26aufirst%3DS.%2BG.%26aulast%3DWilson%26aufirst%3DF.%2BX.%26aulast%3DRastinejad%26aufirst%3DF.%26aulast%3DMohammed%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26atitle%3DChemical%2520proteomics%2520and%2520phenotypic%2520profiling%2520identifies%2520the%2520aryl%2520hydrocarbon%2520receptor%2520as%2520a%2520molecular%2520target%2520of%2520the%2520utrophin%2520modulator%2520ezutromid%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2020%26volume%3D59%26spage%3D2420%26epage%3D2428%26doi%3D10.1002%2Fanie.201912392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span>; <span class="NLM_string-name">Wren, S. P.</span>; <span class="NLM_string-name">Johnson, P. D.</span>; <span class="NLM_string-name">Price, D.</span>; <span class="NLM_string-name">De Moor, O.</span>; <span class="NLM_string-name">Nugent, G.</span>; <span class="NLM_string-name">Tinsley, J. M.</span>; <span class="NLM_string-name">Storer, R.</span>; <span class="NLM_string-name">Mulvaney, A.</span>; <span class="NLM_string-name">Pye, R. J.</span>; <span class="NLM_string-name">Dorgan, C. R.</span></span> <span> </span><span class="NLM_article-title">Treatment of duchenne muscular dystrophy</span>. <span class="NLM_patent">WO2007091106A2</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=G.+M.+Wynne&author=S.+P.+Wren&author=P.+D.+Johnson&author=D.+Price&author=O.+De+Moor&author=G.+Nugent&author=J.+M.+Tinsley&author=R.+Storer&author=A.+Mulvaney&author=R.+J.+Pye&author=C.+R.+Dorgan&title=Treatment+of+duchenne+muscular+dystrophy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWynne%26aufirst%3DG.%2BM.%26atitle%3DTreatment%2520of%2520duchenne%2520muscular%2520dystrophy%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birch, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brocklehurst, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butlin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidsson, Ö.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ertan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groombridge, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macfaul, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrecher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickup, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sörme, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, J.</span></span> <span> </span><span class="NLM_article-title">Use of small-molecule crystal structures to address solubility in a novel series of G protein coupled receptor 119 agonists: optimization of a lead and in vivo evaluation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5361</span>– <span class="NLM_lpage">5379</span>, <span class="refDoi"> DOI: 10.1021/jm300310c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300310c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Oqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5361-5379&author=J.+S.+Scottauthor=A.+M.+Birchauthor=K.+J.+Brocklehurstauthor=A.+Brooauthor=H.+S.+Brownauthor=R.+J.+Butlinauthor=D.+S.+Clarkeauthor=%C3%96.+Davidssonauthor=A.+Ertanauthor=K.+Goldbergauthor=S.+D.+Groombridgeauthor=J.+A.+Hudsonauthor=D.+Laberauthor=A.+G.+Leachauthor=P.+A.+Macfaulauthor=D.+McKerrecherauthor=A.+Pickupauthor=P.+Schofieldauthor=P.+H.+Svenssonauthor=P.+S%C3%B6rmeauthor=J.+Teague&title=Use+of+small-molecule+crystal+structures+to+address+solubility+in+a+novel+series+of+G+protein+coupled+receptor+119+agonists%3A+optimization+of+a+lead+and+in+vivo+evaluation&doi=10.1021%2Fjm300310c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Small-Molecule Crystal Structures To Address Solubility in a Novel Series of G Protein Coupled Receptor 119 Agonists: Optimization of a Lead and in Vivo Evaluation</span></div><div class="casAuthors">Scott, James S.; Birch, Alan M.; Brocklehurst, Katy J.; Broo, Anders; Brown, Hayley S.; Butlin, Roger J.; Clarke, David S.; Davidsson, Ojvind; Ertan, Anne; Goldberg, Kristin; Groombridge, Sam D.; Hudson, Julian A.; Laber, David; Leach, Andrew G.; MacFaul, Philip A.; McKerrecher, Darren; Pickup, Adrian; Schofield, Paul; Svensson, Per H.; Sorme, Pernilla; Teague, Joanne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5361-5379</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">G protein coupled receptor 119 (GPR119) is viewed as an attractive target for the treatment of type 2 diabetes and other elements of the metabolic syndrome.  During a program toward discovering agonists of GPR119, we herein describe optimization of an initial lead compd., 2, into a development candidate, 42.  A key challenge in this program of work was the insoly. of the lead compd.  Small-mol. crystallog. was utilized to understand the intermol. interactions in the solid state and resulted in a switch from an aryl sulfone to a 3-cyanopyridyl motif.  The compd. was shown to be effective in wild-type but not knockout animals, confirming that the biol. effects were due to GPR119 agonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXZ_DoHJ0cfrVg90H21EOLACvtfcHk0liKLPL2NwNwvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Oqt78%253D&md5=3cd34d57e05864ddcc87c51f034f9188</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm300310c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300310c%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DBirch%26aufirst%3DA.%2BM.%26aulast%3DBrocklehurst%26aufirst%3DK.%2BJ.%26aulast%3DBroo%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DH.%2BS.%26aulast%3DButlin%26aufirst%3DR.%2BJ.%26aulast%3DClarke%26aufirst%3DD.%2BS.%26aulast%3DDavidsson%26aufirst%3D%25C3%2596.%26aulast%3DErtan%26aufirst%3DA.%26aulast%3DGoldberg%26aufirst%3DK.%26aulast%3DGroombridge%26aufirst%3DS.%2BD.%26aulast%3DHudson%26aufirst%3DJ.%2BA.%26aulast%3DLaber%26aufirst%3DD.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DMacfaul%26aufirst%3DP.%2BA.%26aulast%3DMcKerrecher%26aufirst%3DD.%26aulast%3DPickup%26aufirst%3DA.%26aulast%3DSchofield%26aufirst%3DP.%26aulast%3DSvensson%26aufirst%3DP.%2BH.%26aulast%3DS%25C3%25B6rme%26aufirst%3DP.%26aulast%3DTeague%26aufirst%3DJ.%26atitle%3DUse%2520of%2520small-molecule%2520crystal%2520structures%2520to%2520address%2520solubility%2520in%2520a%2520novel%2520series%2520of%2520G%2520protein%2520coupled%2520receptor%2520119%2520agonists%253A%2520optimization%2520of%2520a%2520lead%2520and%2520in%2520vivo%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5361%26epage%3D5379%26doi%3D10.1021%2Fjm300310c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krise, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stella, V. J.</span></span> <span> </span><span class="NLM_article-title">Prodrugs of phosphates, phosphonates, and phosphinates</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1016/0169-409X(95)00111-J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1016%2F0169-409X%2895%2900111-J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADyaK28XjtFaktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1996&pages=287-310&author=J.+P.+Kriseauthor=V.+J.+Stella&title=Prodrugs+of+phosphates%2C+phosphonates%2C+and+phosphinates&doi=10.1016%2F0169-409X%2895%2900111-J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs of phosphates, phosphonates, and phosphinates</span></div><div class="casAuthors">Krise, Jeffrey P.; Stella, Valentino J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">287-310</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 140 refs.  The literature on the use of prodrugs to overcome the drug delivery obstacles assocd. with phosphate, phosphonate and phosphinate functional group-contg. drugs is discussed..  This is an important area of research because, although we have been successful at identifying numerous phosphate and phosphonate functional group-contg. drugs as antiviral and anticancer agents, as well as for other uses, our ability to orally deliver these drugs and to target them to desired sites has led to limited success.  Various acyloxymethyl- and aryl-ester prodrugs have shown promise.  Alternative and imaginative approaches may be necessary before complete success is realized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYd9eXJQQYTbVg90H21EOLACvtfcHk0lhhsaldQMzk1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtFaktrk%253D&md5=a713ce634f888106c16e67052da37b2e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0169-409X%2895%2900111-J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0169-409X%252895%252900111-J%26sid%3Dliteratum%253Aachs%26aulast%3DKrise%26aufirst%3DJ.%2BP.%26aulast%3DStella%26aufirst%3DV.%2BJ.%26atitle%3DProdrugs%2520of%2520phosphates%252C%2520phosphonates%252C%2520and%2520phosphinates%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1996%26volume%3D19%26spage%3D287%26epage%3D310%26doi%3D10.1016%2F0169-409X%2895%2900111-J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, G.-X.</span>; <span class="NLM_string-name">Krise, J. P.</span>; <span class="NLM_string-name">Oliyai, R.</span></span> <span> </span><span class="NLM_article-title">Prodrugs of Phosphonates, Phosphinates, and Phosphates</span>. In  <i>Prodrugs: Challenges and Rewards Part 1</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stella, V. J.</span>, <span class="NLM_string-name">Borchardt, R. T.</span>, <span class="NLM_string-name">Hageman, M. J.</span>, <span class="NLM_string-name">Oliyai, R.</span>, <span class="NLM_string-name">Maag, H.</span>, <span class="NLM_string-name">Tilley, J. W.</span></span>, Eds.; <span class="NLM_publisher-name">Springer New York</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">964</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1007%2F978-0-387-49785-3_25" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=923-964&author=G.-X.+He&author=J.+P.+Krise&author=R.+Oliyaiauthor=V.+J.+Stella&author=R.+T.+Borchardt&author=M.+J.+Hageman&author=R.+Oliyai&author=H.+Maag&author=J.+W.+Tilley&title=Prodrugs%3A+Challenges+and+Rewards+Part+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-49785-3_25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-0-387-49785-3_25%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DG.-X.%26atitle%3DProdrugs%2520of%2520Phosphonates%252C%2520Phosphinates%252C%2520and%2520Phosphates%26btitle%3DProdrugs%253A%2520Challenges%2520and%2520Rewards%2520Part%25201%26aulast%3DStella%26aufirst%3DV.%2BJ.%26pub%3DSpringer%2520New%2520York%26date%3D2007%26spage%3D923%26epage%3D964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njardarson, J. T.</span></span> <span> </span><span class="NLM_article-title">Beyond C, H, O, and N! Analysis of the elemental composition of U.S. FDA approved drug architectures</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9764</span>– <span class="NLM_lpage">9773</span>, <span class="refDoi"> DOI: 10.1021/jm501105n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501105n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1WlurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9764-9773&author=B.+R.+Smithauthor=C.+M.+Eastmanauthor=J.+T.+Njardarson&title=Beyond+C%2C+H%2C+O%2C+and+N%21+Analysis+of+the+elemental+composition+of+U.S.+FDA+approved+drug+architectures&doi=10.1021%2Fjm501105n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond C, H, O, and N! Analysis of the Elemental Composition of U.S. FDA Approved Drug Architectures</span></div><div class="casAuthors">Smith, Brandon R.; Eastman, Candice M.; Njardarson, Jon T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9764-9773</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The diversity of elements among U.S.  Food and Drug Administration (FDA) approved pharmaceuticals is analyzed and reported, with a focus on atoms other than carbon, hydrogen, oxygen, and nitrogen.  Our anal. reveals that sulfur, chlorine, fluorine, and phosphorous represent about 90% of elemental substitutions, with sulfur being the fifth most used element followed closely by chlorine, then fluorine and finally phosphorous in the eighth place.  The remaining 10% of substitutions are represented by 16 other elements of which bromine, iodine, and iron occur most frequently.  The most detailed parts of our anal. are focused on chlorinated drugs as a function of approval date, disease condition, chlorine attachment, and structure.  To better aid our chlorine drug analyses, a new poster showcasing the structures of chlorinated pharmaceuticals was created specifically for this study.  Phosphorus, bromine, and iodine contg. drugs are analyzed closely as well, followed by a discussion about other elements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqLwTieDN1HbVg90H21EOLACvtfcHk0lhhsaldQMzk1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1WlurbL&md5=95e1ab686ba41c63070059ad0987ff6c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm501105n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501105n%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DEastman%26aufirst%3DC.%2BM.%26aulast%3DNjardarson%26aufirst%3DJ.%2BT.%26atitle%3DBeyond%2520C%252C%2520H%252C%2520O%252C%2520and%2520N%2521%2520Analysis%2520of%2520the%2520elemental%2520composition%2520of%2520U.S.%2520FDA%2520approved%2520drug%2520architectures%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9764%26epage%3D9773%26doi%3D10.1021%2Fjm501105n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lea, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auld, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglese, J.</span></span> <span> </span><span class="NLM_article-title">Firefly luciferase in chemical biology: a compendium of Inhibitors, mechanistic evaluation of chemotypes, and suggested use as a reporter</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1072</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2012.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1016%2Fj.chembiol.2012.07.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=22921073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KkurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1060-1072&author=N.+Thorneauthor=M.+Shenauthor=W.+A.+Leaauthor=A.+Simeonovauthor=S.+Lovellauthor=D.+S.+Auldauthor=J.+Inglese&title=Firefly+luciferase+in+chemical+biology%3A+a+compendium+of+Inhibitors%2C+mechanistic+evaluation+of+chemotypes%2C+and+suggested+use+as+a+reporter&doi=10.1016%2Fj.chembiol.2012.07.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Firefly Luciferase in Chemical Biology: A Compendium of Inhibitors, Mechanistic Evaluation of Chemotypes, and Suggested Use As a Reporter</span></div><div class="casAuthors">Thorne, Natasha; Shen, Min; Lea, Wendy A.; Simeonov, Anton; Lovell, Scott; Auld, Douglas S.; Inglese, James</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1060-1072</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Firefly luciferase (FLuc) is frequently used as a reporter in high-throughput screening assays, owing to the exceptional sensitivity, dynamic range, and rapid measurement that bioluminescence affords.  However, interaction of small mols. with FLuc has, to some extent, confounded its use in chem. biol. and drug discovery.  To identify and characterize chemotypes interacting with FLuc, we detd. potency values for 360,864 compds. found in the NIH Mol. Libraries Small Mol. Repository, available in PubChem.  FLuc inhibitory activity was obsd. for 12% of this library with discernible SAR.  Characterization of 151 inhibitors demonstrated a variety of inhibition modes, including FLuc-catalyzed formation of multisubstrate adduct enzyme inhibitor complexes.  As in some cell-based FLuc reporter assays, compds. acting as FLuc inhibitors yield paradoxical luminescence increases, thus data on compds. acquired from FLuc-dependent assays require careful anal. as described here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWw4FbLlFcILVg90H21EOLACvtfcHk0lhmv6O3m0q4Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KkurjM&md5=5ab0f756ab0a3ece1ea28ffac52bbd5f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DThorne%26aufirst%3DN.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DLea%26aufirst%3DW.%2BA.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DLovell%26aufirst%3DS.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DInglese%26aufirst%3DJ.%26atitle%3DFirefly%2520luciferase%2520in%2520chemical%2520biology%253A%2520a%2520compendium%2520of%2520Inhibitors%252C%2520mechanistic%2520evaluation%2520of%2520chemotypes%252C%2520and%2520suggested%2520use%2520as%2520a%2520reporter%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D1060%26epage%3D1072%26doi%3D10.1016%2Fj.chembiol.2012.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, I. V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, S. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuorinen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sills, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pires, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, A. J.</span></span> <span> </span><span class="NLM_article-title">Characterisation of utrophin modulator SMT C1100 as a non-competitive inhibitor of firefly luciferase</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">103395</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2019.103395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1016%2Fj.bioorg.2019.103395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=31733898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFOmurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2020&pages=103395&author=I.+V.+L.+Wilkinsonauthor=J.+K.+Reynoldsauthor=S.+R.+G.+Galanauthor=A.+Vuorinenauthor=A.+J.+Sillsauthor=E.+Piresauthor=G.+M.+Wynneauthor=F.+X.+Wilsonauthor=A.+J.+Russell&title=Characterisation+of+utrophin+modulator+SMT+C1100+as+a+non-competitive+inhibitor+of+firefly+luciferase&doi=10.1016%2Fj.bioorg.2019.103395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of utrophin modulator SMT C1100 as a non-competitive inhibitor of firefly luciferase</span></div><div class="casAuthors">Wilkinson, Isabel V. L.; Reynolds, Jessica K.; Galan, Sebastien R. G.; Vuorinen, Aini; Sills, Adam J.; Pires, Elisabete; Wynne, Graham M.; Wilson, Francis X.; Russell, Angela J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103395</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Firefly luciferase (FLuc) is a powerful tool for mol. and cellular biol., and popular in high-throughput screening and drug discovery.  However, FLuc assays have been plagued with pos. and neg. artifacts due to stabilization and inhibition by small mols. from a range of chem. classes.  Here we disclose Phase II clin. compd. SMT C1100 for the treatment of Duchenne muscular dystrophy as an FLuc inhibitor (KD of 0.40 ± 0.15 μM).  Enzyme kinetic studies using SMT C1100 and other non-competitive inhibitors including resveratrol and NFκBAI4 identified previously undescribed modes of inhibition with respect to FLuc's luciferyl adenylate intermediate.  Employing a photoaffinity strategy to identify SMT C1100's binding site, a photolabeled SMT C1100 probe instead underwent FLuc-dependent photooxidn.  Our findings support novel binding sites on FLuc for non-competitive inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvU89dI6LwBLVg90H21EOLACvtfcHk0lhmv6O3m0q4Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFOmurnN&md5=b0bdb5b5c075340ce01ca103acfe82ba</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2019.103395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2019.103395%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DI.%2BV.%2BL.%26aulast%3DReynolds%26aufirst%3DJ.%2BK.%26aulast%3DGalan%26aufirst%3DS.%2BR.%2BG.%26aulast%3DVuorinen%26aufirst%3DA.%26aulast%3DSills%26aufirst%3DA.%2BJ.%26aulast%3DPires%26aufirst%3DE.%26aulast%3DWynne%26aufirst%3DG.%2BM.%26aulast%3DWilson%26aufirst%3DF.%2BX.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26atitle%3DCharacterisation%2520of%2520utrophin%2520modulator%2520SMT%2520C1100%2520as%2520a%2520non-competitive%2520inhibitor%2520of%2520firefly%2520luciferase%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D94%26spage%3D103395%26doi%3D10.1016%2Fj.bioorg.2019.103395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baatsen, P. H. W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maréchal, G.</span></span> <span> </span><span class="NLM_article-title">Increased susceptibility of EDL muscles from <i>mdx</i> mice to damage induced by contractions with stretch</span>. <i>J. Muscle Res. Cell Motil.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1007/BF00121296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1007%2FBF00121296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=7693747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A280%3ADyaK2c%252FktlKrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1993&pages=446-451&author=P.+Moensauthor=P.+H.+W.+W.+Baatsenauthor=G.+Mar%C3%A9chal&title=Increased+susceptibility+of+EDL+muscles+from+mdx+mice+to+damage+induced+by+contractions+with+stretch&doi=10.1007%2FBF00121296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch</span></div><div class="casAuthors">Moens P; Baatsen P H; Marechal G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of muscle research and cell motility</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">446-51</span>
        ISSN:<span class="NLM_cas:issn">0142-4319</span>.
    </div><div class="casAbstract">Absence of dystrophin in mdx muscles may render the muscle more susceptible to damage when submitted to high stress levels.  To test this, typically slow (soleus) and fast (EDL) limb muscles of dystrophic (mdx) and normal (C57BL/10) mice were submitted (in vitro) to a series of isometric contractions, followed by a series of contractions with stretches.  Muscle injury was assessed by monitoring the force signal.  Membrane damage was evaluated by bathing the muscle in Procion Red, a dye that does not penetrate intact fibres, and subsequent analysis by light microscopy.  After isometric contractions, only a very small force drop (< 3% of maximal isometric force) was observed which indicated that no injury had occurred in soleus and EDL muscles in either mdx or C57 strains.  After contractions with a stretch, a force drop of 10% was observed in soleus muscles from both strains and in EDL muscles from C57 mice.  However, in mdx mice EDL muscles displayed an irreversible force drop of 40-60%.  Histological analysis of the muscles indicates that force drop is associated with membrane damage.  These results show that EDL muscles from mdx mice are more vulnerable than their controls, supporting the structural role hypothesis for dystrophin.  Furthermore, they suggest that contractions with stretches may contribute to the muscle damage and degeneration observed in DMD-patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3iRAPWYXqWEwlCcfExbvbfW6udTcc2eZh7k_LJzpiq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252FktlKrtA%253D%253D&md5=16f5bd383e2f84ffea33c1caaf7d3903</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2FBF00121296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00121296%26sid%3Dliteratum%253Aachs%26aulast%3DMoens%26aufirst%3DP.%26aulast%3DBaatsen%26aufirst%3DP.%2BH.%2BW.%2BW.%26aulast%3DMar%25C3%25A9chal%26aufirst%3DG.%26atitle%3DIncreased%2520susceptibility%2520of%2520EDL%2520muscles%2520from%2520mdx%2520mice%2520to%2520damage%2520induced%2520by%2520contractions%2520with%2520stretch%26jtitle%3DJ.%2520Muscle%2520Res.%2520Cell%2520Motil.%26date%3D1993%26volume%3D14%26spage%3D446%26epage%3D451%26doi%3D10.1007%2FBF00121296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrof, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrager, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stedman, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, H. L.</span></span> <span> </span><span class="NLM_article-title">Dystrophin protects the sarcolemma from stresses developed during muscle contraction</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">3710</span>– <span class="NLM_lpage">3714</span>, <span class="refDoi"> DOI: 10.1073/pnas.90.8.3710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1073%2Fpnas.90.8.3710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=8475120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADyaK3sXktVKnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=3710-3714&author=B.+J.+Petrofauthor=J.+B.+Shragerauthor=H.+H.+Stedmanauthor=A.+M.+Kellyauthor=H.+L.+Sweeney&title=Dystrophin+protects+the+sarcolemma+from+stresses+developed+during+muscle+contraction&doi=10.1073%2Fpnas.90.8.3710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Dystrophin protects the sarcolemma from stresses developed during muscle contraction</span></div><div class="casAuthors">Petrof, Basil J.; Shrager, Joseph B.; Stedman, Hansell H.; Kelly, Alan M.; Sweeney, H. Lee</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3710-14</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The protein dystrophin, normally found on the cytoplasmic surface of skeletal muscle cell membranes, is absent in patients with Duchenne muscular dystrophy as well as mdx (X-linked muscular dystrophy) mice.  Although its primary structure has been detd., the precise functional role of dystrophin remains the subject of speculation.  In the present study, it is demonstrated that dystrophin-deficient muscle fibers of the mdx mouse exhibit an increased susceptibility to contraction-induced sarcolemmal rupture.  The level of sarcolemmal damage is directly correlated with the magnitude of mech. stress placed upon the membrane during contraction rather than the no. of activations of the muscle.  These findings strongly support the proposition that the primary function of dystrophin is to provide mech. reinforcement to the sarcolemma and thereby protect it from the membrane stresses developed during muscle contraction.  Furthermore, the methodol. used in this study should prove useful in assessing the efficacy of dystrophin gene therapy in the mdx mouse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS5UsqDsTMTrVg90H21EOLACvtfcHk0lii7Rk9xy0a4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXktVKnsb4%253D&md5=f4b0bd67110ebef785f6a9ce4b33339d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.8.3710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.8.3710%26sid%3Dliteratum%253Aachs%26aulast%3DPetrof%26aufirst%3DB.%2BJ.%26aulast%3DShrager%26aufirst%3DJ.%2BB.%26aulast%3DStedman%26aufirst%3DH.%2BH.%26aulast%3DKelly%26aufirst%3DA.%2BM.%26aulast%3DSweeney%26aufirst%3DH.%2BL.%26atitle%3DDystrophin%2520protects%2520the%2520sarcolemma%2520from%2520stresses%2520developed%2520during%2520muscle%2520contraction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1993%26volume%3D90%26spage%3D3710%26epage%3D3714%26doi%3D10.1073%2Fpnas.90.8.3710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Maria Chatzopoulou, Enrico Emer, Cristina Lecci, Jessica A. Rowley, Anne-Sophie Casagrande, Lee Moir, Sarah E. Squire, Stephen G. Davies, Shawn Harriman, Graham M. Wynne, Francis X. Wilson, Kay E. Davies, <span class="NLM_string-name hlFld-ContribAuthor">Angela J. Russell</span>. </span><span class="cited-content_cbyCitation_article-title">Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (12)
                                     , 2421-2427. <a href="https://doi.org/10.1021/acsmedchemlett.0c00405" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00405</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00405%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDecreasing%252BHepG2%252BCytotoxicity%252Bby%252BLowering%252Bthe%252BLipophilicity%252Bof%252BBenzo%25255Bd%25255Doxazolephosphinate%252BEster%252BUtrophin%252BModulators%26aulast%3DChatzopoulou%26aufirst%3DMaria%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20072020%26date%3D26102020%26date%3D04112020%26volume%3D11%26issue%3D12%26spage%3D2421%26epage%3D2427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth M  Gibbs</span>, <span class="hlFld-ContribAuthor ">Jackie L  McCourt</span>, <span class="hlFld-ContribAuthor ">Kara M  Shin</span>, <span class="hlFld-ContribAuthor ">Katherine G  Hammond</span>, <span class="hlFld-ContribAuthor ">Jamie L  Marshall</span>, <span class="hlFld-ContribAuthor ">Rachelle H  Crosbie</span>. </span><span class="cited-content_cbyCitation_article-title">Loss of sarcospan exacerbates pathology in
              mdx
              mice, but does not affect utrophin amelioration of disease. </span><span class="cited-content_cbyCitation_journal-name">Human Molecular Genetics</span><span> <strong>2021,</strong> <em>30 </em>
                                    (3-4)
                                     , 149-159. <a href="https://doi.org/10.1093/hmg/ddaa264" title="DOI URL">https://doi.org/10.1093/hmg/ddaa264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/hmg/ddaa264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fhmg%2Fddaa264%26sid%3Dliteratum%253Aachs%26jtitle%3DHuman%2520Molecular%2520Genetics%26atitle%3DLoss%252Bof%252Bsarcospan%252Bexacerbates%252Bpathology%252Bin%252Bmdx%252Bmice%25252C%252Bbut%252Bdoes%252Bnot%252Baffect%252Butrophin%252Bamelioration%252Bof%252Bdisease%26aulast%3DGibbs%26aufirst%3DElizabeth%2BM%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D3-4%26spage%3D149%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00807&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Clinical candidate ezutromid (<b>1</b>, SMT C1100). Regions A and B denote sites of modifications to improve solubility (A) and metabolic stability (B) whilst maintaining a good efficacy and safety profile.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00807&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Amide and Sulphonamide Derivatives <b>2</b>−<b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00807&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) naphthoic acid, PPA, 180 °C, 3 h, 63%; (ii) acyl chloride, pyridine, rt, 24 h, 67–83% (<b>2–3</b>); (iii) 1.3-chloropropanesulfonyl chloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, reflux, 1 h 2. NaH, DMF, rt to 90 °C, 16 h, 22% over two steps; (iv) 1. ArCHO, MeOH, 50 °C, 45 min, 2. DDQ, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Route to Phosphinate Esters<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00807&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Method A: Step 1. ArCOCl, dioxane, 210 °C, 3 h, MW, or Method B: ArCHO, MeOH, 50 °C, 45 min, Step 2. DDQ, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h, 38% (7–83% and 19–82% for Methods A and B, respectively), or Method C: Step 1. ArCHO, EtOH, 80 °C, 90 min, Step 2. PhI(OAc)<sub>2</sub>, MeOH, 60 °C, 30 min, (44–57%) or Method D: Step 1. ArCOCl, xylenes, 155 °C, 1 h, Step 2. MsOH, 155 °C, 2–3 h, (12–81%); (ii) Method F: HP(O)OR<sub>1</sub>R<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Et<sub>3</sub>N, toluene, 110 °C, 3 h, (5–81%) or Method G: HP(O)OMeEt, Pd<sub>2</sub>(dba)<sub>3</sub>, Cs<sub>2</sub>CO<sub>3</sub>, THF, 140 °C, 30 min, MW, (6–58%); (iii) Method E: EtPH(O)OH, Pd(OAc)<sub>2</sub>, Xantphos, DIPEA, DME/toluene, 90 °C, 2 h, (46–98%); (iv) Method H: (1) SOCl<sub>2</sub>, DMF, 70 °C, 1 h, (2) DIPEA, MeOH, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 30 min, (36–85%).</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Treatment with <b>27</b>, <b>30</b>, and <b>41</b> increases utrophin protein in dystrophin-deficient mouse muscle cells. Relative utrophin expression was determined by western blot, standardized for α-actinin loading and is shown as the mean of fold increase relative to DMSO ± SD (two biological replicates, 3 technical replicates each) *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00807&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Major <b>30</b> metabolites identified by MetID in samples from the MTD rat study (representative fragment ions are given).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00807&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/medium/jm0c00807_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>In vivo</i> efficacy study of <b>27</b> and enantiomers dosed once per day at 30 mg/kg p.o. in 2 week-old <i>mdx</i> mice for 5 weeks. (A) Racemic <b>27</b> and its enantiomers increase the utrophin protein expression in EDL muscles. 2.1-fold increase for <b>(−)-27</b> (non-significant) and 1.9-fold increase with <b>(+)-27</b> was observed. Values are mean ± SEM of <i>n</i> = 6 per group; *<i>p</i> < 0.05 (B) EDL force drop (%). The resistance of muscle to stress-induced damage appears improved in mice treated with <b>27</b> (29% improvement) and <b>(+)-27</b> (35% improvement). Values are mean ± SEM of <i>n</i> = 9 or higher per group; **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00807/20200716/images/large/jm0c00807_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00807&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00574" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00574" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 24 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guiraud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squire, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babbs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">Second-generation compound for the modulation of utrophin in the therapy of DMD</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4212</span>– <span class="NLM_lpage">4224</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddv154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1093%2Fhmg%2Fddv154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=25935002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2rt7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=4212-4224&author=S.+Guiraudauthor=S.+E.+Squireauthor=B.+Edwardsauthor=H.+Chenauthor=D.+T.+Burnsauthor=N.+Shahauthor=A.+Babbsauthor=S.+G.+Daviesauthor=G.+M.+Wynneauthor=A.+J.+Russellauthor=D.+Elseyauthor=F.+X.+Wilsonauthor=J.+M.+Tinsleyauthor=K.+E.+Davies&title=Second-generation+compound+for+the+modulation+of+utrophin+in+the+therapy+of+DMD&doi=10.1093%2Fhmg%2Fddv154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Second-generation compound for the modulation of utrophin in the therapy of DMD</span></div><div class="casAuthors">Guiraud, Simon; Squire, Sarah E.; Edwards, Benjamin; Chen, Huijia; Burns, David T.; Shah, Nandini; Babbs, Arran; Davies, Stephen G.; Wynne, Graham M.; Russell, Angela J.; Elsey, David; Wilson, Francis X.; Tinsley, Jon M.; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4212-4224</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Duchenne muscular dystrophy (DMD) is a lethal, X-linked muscle-wasting disease caused by lack of the cytoskeletal protein dystrophin.  There is currently no cure for DMD although various promising approaches are progressing through human clin. trials.  By pharmacol. modulating the expression of the dystrophin-related protein utrophin, we have previously demonstrated in dystrophin-deficient mdx studies, daily SMT C1100 treatment significantly reduced muscle degeneration leading to improved muscle function.  This manuscript describes the significant disease modifying benefits assocd. with daily dosing of SMT022357, a second-generation compd. in this drug series with improved physicochem. properties and a more robust metab. profile.  These studies in the mdx mouse demonstrate that oral administration of SMT022357 leads to increased utrophin expression in skeletal, respiratory and cardiac muscles.  Significantly, utrophin expression is localized along the length of the muscle fiber, not just at the synapse, and is fiber-type independent, suggesting that drug treatment is modulating utrophin transcription in extra-synaptic myonuclei.  This results in improved sarcolemmal stability and prevents dystrophic pathol. through a significant redn. of regeneration, necrosis and fibrosis.  All these improvements combine to protect the mdx muscle from contraction induced damage and enhance physiol. function.  This detailed evaluation of the SMT C1100 drug series strongly endorses the therapeutic potential of utrophin modulation as a disease modifying therapeutic strategy for all DMD patients irresp. of their dystrophin mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAcUx0IEEY0rVg90H21EOLACvtfcHk0lgfLV0AVqMMOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2rt7jJ&md5=7a422c65b1b4fbeecb3e440630d5a173</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddv154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddv154%26sid%3Dliteratum%253Aachs%26aulast%3DGuiraud%26aufirst%3DS.%26aulast%3DSquire%26aufirst%3DS.%2BE.%26aulast%3DEdwards%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DBurns%26aufirst%3DD.%2BT.%26aulast%3DShah%26aufirst%3DN.%26aulast%3DBabbs%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DS.%2BG.%26aulast%3DWynne%26aufirst%3DG.%2BM.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DElsey%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DF.%2BX.%26aulast%3DTinsley%26aufirst%3DJ.%2BM.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DSecond-generation%2520compound%2520for%2520the%2520modulation%2520of%2520utrophin%2520in%2520the%2520therapy%2520of%2520DMD%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2015%26volume%3D24%26spage%3D4212%26epage%3D4224%26doi%3D10.1093%2Fhmg%2Fddv154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guiraud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">Pharmacological advances for treatment in Duchenne muscular dystrophy</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2017.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1016%2Fj.coph.2017.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=28486179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVGqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2017&pages=36-48&author=S.+Guiraudauthor=K.+E.+Davies&title=Pharmacological+advances+for+treatment+in+Duchenne+muscular+dystrophy&doi=10.1016%2Fj.coph.2017.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological advances for treatment in Duchenne muscular dystrophy</span></div><div class="casAuthors">Guiraud, Simon; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36-48</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Duchenne muscular dystrophy (DMD) is a lethal, X-linked muscle-wasting disease caused by lack of dystrophin, essential for muscle fiber integrity.  Despite extensive pre-clin. studies, development of an effective treatment has proved challenging.  More recently, significant progress has been made with the first drug approval using a genetic approach and the application of pharmacol. agents which slow the progression of the disease.  Drug development for DMD has mainly used two strategies: (1) the restoration of dystrophin expression or the expression of the compensatory utrophin protein as an efficient surrogate, and (2) the mitigation of secondary downstream pathol. mechanisms.  This review details current most promising pharmacol. approaches and clin. trials aiming to tackle the pathogenesis of this multifaceted disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4bL76CfzS1rVg90H21EOLACvtfcHk0libgsrq8ghKkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVGqurw%253D&md5=ed36a5afd8e07f41f8c3ae14195f304e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2017.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2017.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DGuiraud%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DPharmacological%2520advances%2520for%2520treatment%2520in%2520Duchenne%2520muscular%2520dystrophy%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2017%26volume%3D34%26spage%3D36%26epage%3D48%26doi%3D10.1016%2Fj.coph.2017.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guiraud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roblin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kay, D. E.</span></span> <span> </span><span class="NLM_article-title">The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy</span>. <i>Expert Opin. Orphan Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1080/21678707.2018.1438261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1080%2F21678707.2018.1438261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFSmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=179-192&author=S.+Guiraudauthor=D.+Roblinauthor=D.+E.+Kay&title=The+potential+of+utrophin+modulators+for+the+treatment+of+Duchenne+muscular+dystrophy&doi=10.1080%2F21678707.2018.1438261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy</span></div><div class="casAuthors">Guiraud, Simon; Roblin, David; Kay, Davies. E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Orphan Drugs</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">179-192</span>CODEN:
                <span class="NLM_cas:coden">EOODAJ</span>;
        ISSN:<span class="NLM_cas:issn">2167-8707</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Duchenne muscular dystrophy (DMD) is a lethal, X-linked muscle-wasting disease caused by the lack of dystrophin.  A few years after the identification of the dystrophin gene, a ubiquitously expressed transcript with high homol. to dystrophin was identified leading to the postulate that utrophin might be an effective surrogate to compensate for the lack of dystrophin in dystrophic muscles.: We review the utrophin gene, its regulation, the organization of the corresponding protein and its dynamic expression pattern in comparison with dystrophin.  In view of the evidence that utrophin acts as an efficient substitute to dystrophin to prevent the pathol., we describe the therapeutic approaches to modulate utrophin expression.  We review the current status in the development of ezutromid, the first small utrophin modulator drug currently tested in DMD patients.: A utrophin based strategy is a highly promising approach applicable to all DMD patients irresp. of their genetic defect.  Whereas accurate utrophin and regeneration quantification tools are urgently needed, the foundation of utrophin based therapies, defined 20 years ago, recently delivered first promising results in DMD patients with ezutromid.  The field is at an exciting stage on the road of a universal treatment for all DMD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcS_zSFMYHPrVg90H21EOLACvtfcHk0libgsrq8ghKkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFSmtL0%253D&md5=7c785199bc688ebe4b0f143da09fa70d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1080%2F21678707.2018.1438261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21678707.2018.1438261%26sid%3Dliteratum%253Aachs%26aulast%3DGuiraud%26aufirst%3DS.%26aulast%3DRoblin%26aufirst%3DD.%26aulast%3DKay%26aufirst%3DD.%2BE.%26atitle%3DThe%2520potential%2520of%2520utrophin%2520modulators%2520for%2520the%2520treatment%2520of%2520Duchenne%2520muscular%2520dystrophy%26jtitle%3DExpert%2520Opin.%2520Orphan%2520Drugs%26date%3D2018%26volume%3D6%26spage%3D179%26epage%3D192%26doi%3D10.1080%2F21678707.2018.1438261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leadley, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleijnen, J.</span></span> <span> </span><span class="NLM_article-title">The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review</span>. <i>Orphanet J. Rare Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">79</span>, <span class="refDoi"> DOI: 10.1186/s13023-017-0631-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1186%2Fs13023-017-0631-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=28446219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A280%3ADC%252BC1crhsVyktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=79&author=S.+Ryderauthor=R.+M.+Leadleyauthor=N.+Armstrongauthor=M.+Westwoodauthor=S.+de+Kockauthor=T.+Buttauthor=M.+Jainauthor=J.+Kleijnen&title=The+burden%2C+epidemiology%2C+costs+and+treatment+for+Duchenne+muscular+dystrophy%3A+an+evidence+review&doi=10.1186%2Fs13023-017-0631-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review</span></div><div class="casAuthors">Ryder S; Leadley R M; Armstrong N; Westwood M; de Kock S; Butt T; Jain M; Kleijnen J</div><div class="citationInfo"><span class="NLM_cas:title">Orphanet journal of rare diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Duchenne Muscular Dystrophy (DMD) is a rapidly progressive, lethal neuromuscular disorder, present from birth, which occurs almost exclusively in males.  We have reviewed contemporary evidence of burden, epidemiology, illness costs and treatment patterns of DMD.  This systematic review adhered to published methods with information also sought from the web and contacting registries.  Searches were carried out from 2005 to June 2015.  The population of interest was individuals with clearly defined DMD or their carers.  RESULTS:  Nine thousand eight hundred fifty titles were retrieved from searches.  Fifty-eight studies were reviewed with three assessed as high, 33 as medium and 22 as low quality.  We found two studies reporting birth and four reporting point prevalence, three reporting mortality, 41 reporting severity and/or progression, 18 reporting treatment patterns, 12 reporting quality of life, two reporting utility measures, three reporting costs of illness and three treatment guidelines.  Birth prevalence ranged from 15.9 to 19.5 per 100,000 live births.  Point prevalence per 100,000 males was for France, USA, UK and Canada, 10.9, 1.9, 2.2 and 6.1 respectively.  A study of adult DMD patients at a centre in France found median survival for those born between 1970 and 1994 was 40.95 years compared to 25.77 years for those born between 1955 and 1969.  Loss of ambulation occurred at a median age of 12 and ventilation starts at about 20 years.  There was international variation in use of corticosteroids, scoliosis surgery, ventilation and physiotherapy.  The economic cost of DMD climbs dramatically with disease progression - rising as much as 5.7 fold from the early ambulatory phase to the non-ambulatory phase in Germany.  CONCLUSIONS:  This is the first systematic review of treatment, progression, severity and quality of life in DMD.  It also provides the most recent description of the burden, epidemiology, illness costs and treatment patterns in DMD.  There are evidence gaps, particularly in prevalence and mortality.  People with DMD seem to be living longer, possibly due to corticosteroid use, cardiac medical management and ventilation.  Future research should incorporate registry data to improve comparability across time and between countries and to investigate the quality of life impact as the condition progresses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRKgZz0hzs5qBfKb6ELK8t0fW6udTcc2eb1F96emQ81Hbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crhsVyktw%253D%253D&md5=52e354eec8932fd87e0a489786449551</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1186%2Fs13023-017-0631-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13023-017-0631-3%26sid%3Dliteratum%253Aachs%26aulast%3DRyder%26aufirst%3DS.%26aulast%3DLeadley%26aufirst%3DR.%2BM.%26aulast%3DArmstrong%26aufirst%3DN.%26aulast%3DWestwood%26aufirst%3DM.%26aulast%3Dde%2BKock%26aufirst%3DS.%26aulast%3DButt%26aufirst%3DT.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DKleijnen%26aufirst%3DJ.%26atitle%3DThe%2520burden%252C%2520epidemiology%252C%2520costs%2520and%2520treatment%2520for%2520Duchenne%2520muscular%2520dystrophy%253A%2520an%2520evidence%2520review%26jtitle%3DOrphanet%2520J.%2520Rare%2520Dis.%26date%3D2017%26volume%3D12%26spage%3D79%26doi%3D10.1186%2Fs13023-017-0631-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, A.</span></span> <span> </span><span class="NLM_article-title">Mutation-Based Therapeutic Strategies for Duchenne Muscular Dystrophy: From Genetic Diagnosis to Therapy</span>. <i>J. Pers. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">16</span>, <span class="refDoi"> DOI: 10.3390/jpm9010016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.3390%2Fjpm9010016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=16&author=A.+Nakamura&title=Mutation-Based+Therapeutic+Strategies+for+Duchenne+Muscular+Dystrophy%3A+From+Genetic+Diagnosis+to+Therapy&doi=10.3390%2Fjpm9010016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3390%2Fjpm9010016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjpm9010016%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DA.%26atitle%3DMutation-Based%2520Therapeutic%2520Strategies%2520for%2520Duchenne%2520Muscular%2520Dystrophy%253A%2520From%2520Genetic%2520Diagnosis%2520to%2520Therapy%26jtitle%3DJ.%2520Pers.%2520Med.%26date%3D2019%26volume%3D9%26spage%3D16%26doi%3D10.3390%2Fjpm9010016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Love, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurr, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byth, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsden, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">An autosomal transcript in skeletal muscle with homology to dystrophin</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1038/339055a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1038%2F339055a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=2541343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADyaL1MXktVWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1989&pages=55-58&author=D.+R.+Loveauthor=D.+F.+Hillauthor=G.+Dicksonauthor=N.+K.+Spurrauthor=B.+C.+Bythauthor=R.+F.+Marsdenauthor=F.+S.+Walshauthor=Y.+H.+Edwardsauthor=K.+E.+Davies&title=An+autosomal+transcript+in+skeletal+muscle+with+homology+to+dystrophin&doi=10.1038%2F339055a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An autosomal transcript in skeletal muscle with homology to dystrophin</span></div><div class="casAuthors">Love, Donald R.; Hill, Diane F.; Dickson, George; Spurr, Nigel K.; Byth, Barbara C.; Marsden, Rosalind F.; Walsh, Frank S.; Edwards, Yvonne H.; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6219</span>),
    <span class="NLM_cas:pages">55-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The Duchenne muscular dystrophy (DMD) gene has been localized to chromosome Xp21 and codes for a 14-kilobase (kb) transcript and a protein called dystrophin, of relative mol. mass 427,000.  Dystrophin is assocd. with the cytoplasmic face of muscle fiber membranes, and its C-terminal domain is thought to mediate membrane attachment.  Although N-terminal and central domain structures share common features with other cytoskeletal components, no significant sequence similarity between the C-terminal region of dystrophin and other previously characterized proteins has been described.  Fragments from the C-terminal domain of the DMD cDNA detect a closely related sequence which exhibits nucleic acid and predicted amino acid identities with dystrophin of approx. 65 and 80%, resp.  The dystrophin-related sequence identifies a 13-kb transcript in human fetal muscle and maps to chromosome 6.  Thus, dystrophin may be a member of a family of functionally related large structural proteins in muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruW-WbVv6WP7Vg90H21EOLACvtfcHk0ljzoAM8Wzk6KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktVWqtbk%253D&md5=39b72b03aa694a6c5cecb70110bc244a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F339055a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F339055a0%26sid%3Dliteratum%253Aachs%26aulast%3DLove%26aufirst%3DD.%2BR.%26aulast%3DHill%26aufirst%3DD.%2BF.%26aulast%3DDickson%26aufirst%3DG.%26aulast%3DSpurr%26aufirst%3DN.%2BK.%26aulast%3DByth%26aufirst%3DB.%2BC.%26aulast%3DMarsden%26aufirst%3DR.%2BF.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DEdwards%26aufirst%3DY.%2BH.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DAn%2520autosomal%2520transcript%2520in%2520skeletal%2520muscle%2520with%2520homology%2520to%2520dystrophin%26jtitle%3DNature%26date%3D1989%26volume%3D339%26spage%3D55%26epage%3D58%26doi%3D10.1038%2F339055a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deconinck, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backer, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phelps, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, J.-M.</span></span> <span> </span><span class="NLM_article-title">Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1216</span>– <span class="NLM_lpage">1221</span>, <span class="refDoi"> DOI: 10.1038/nm1197-1216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1038%2Fnm1197-1216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=9359695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADyaK2sXntFansb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=1216-1221&author=N.+Deconinckauthor=J.+Tinsleyauthor=F.+D.+Backerauthor=R.+Fisherauthor=D.+Kahnauthor=S.+Phelpsauthor=K.+Daviesauthor=J.-M.+Gillis&title=Expression+of+truncated+utrophin+leads+to+major+functional+improvements+in+dystrophin-deficient+muscles+of+mice&doi=10.1038%2Fnm1197-1216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice</span></div><div class="casAuthors">Deconinck, Nicolas; Tinsley, Jonathon; De Backer, Fabienne; Fisher, Rosie; Kahn, David; Phelps, Steve; Davies, Kay; Gillis, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1216-1221</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Dystrophin-deficient mice (mdx) expressing a truncated (trc) utrophin transgene show amelioration of the dystrophic phenotype.  Here, we report a multifunctional study demonstrating that trc-utrophin expression leads to major improvements of the mech. performance of muscle (i.e., force development, mech. resistance to forced lengthenings, and maximal spontaneous activity) and of the maintenance of the intracellular calcium homeostasis.  These are two essential functions of muscle fibers, known to be impaired in mdx mouse muscles and Duchenne muscular dystrophy (DMD) patients.  Our results bring strong support to the hypothesis that muscle wasting in dystrophin-deficient DMD patients could be prevented by upregulation of utrophin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4gcI8wE3cErVg90H21EOLACvtfcHk0ljH05pq4G2mbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXntFansb8%253D&md5=e1680364e0b9b2d703caf8fc2e5a5113</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnm1197-1216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1197-1216%26sid%3Dliteratum%253Aachs%26aulast%3DDeconinck%26aufirst%3DN.%26aulast%3DTinsley%26aufirst%3DJ.%26aulast%3DBacker%26aufirst%3DF.%2BD.%26aulast%3DFisher%26aufirst%3DR.%26aulast%3DKahn%26aufirst%3DD.%26aulast%3DPhelps%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DK.%26aulast%3DGillis%26aufirst%3DJ.-M.%26atitle%3DExpression%2520of%2520truncated%2520utrophin%2520leads%2520to%2520major%2520functional%2520improvements%2520in%2520dystrophin-deficient%2520muscles%2520of%2520mice%26jtitle%3DNat.%2520Med.%26date%3D1997%26volume%3D3%26spage%3D1216%26epage%3D1221%26doi%3D10.1038%2Fnm1197-1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deconinck, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phelps, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K.</span></span> <span> </span><span class="NLM_article-title">Expression of full-length utrophin prevents muscular dystrophy in <i>mdx</i> mice</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1441</span>– <span class="NLM_lpage">1444</span>, <span class="refDoi"> DOI: 10.1038/4033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1038%2F4033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=9846586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADyaK1cXnvVOhur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=1441-1444&author=J.+Tinsleyauthor=N.+Deconinckauthor=R.+Fisherauthor=D.+Kahnauthor=S.+Phelpsauthor=J.-M.+Gillisauthor=K.+Davies&title=Expression+of+full-length+utrophin+prevents+muscular+dystrophy+in+mdx+mice&doi=10.1038%2F4033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of full-length utrophin prevents muscular dystrophy in mdx mice</span></div><div class="casAuthors">Tinsley, Jonathon; Deconinck, Nicolas; Fisher, Rosie; Kahn, David; Phelps, Steve; Gillis, Jean-Marie; Davies, Kay</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1441-1444</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the muscle fiber leading to the gradual depletion of skeletal muscle.  The mol. structure of dystrophin is very similar to that of the related protein utrophin2.  Utrophin is found in all tissues and is confined to the neuromuscular and myotendinous junctions in mature muscle.  Sarcolemmal localization of a truncated utrophin transgene in the dystrophin-deficient mdx mouse significantly improves the dystrophic muscle phenotype.  Therefore, up-regulation of utrophin by drug therapy is a plausible therapeutic approach in the treatment of DMD.  Here, the authors demonstrate that expression of full-length utrophin in mdx mice prevents the development of muscular dystrophy.  The authors assessed muscle morphol., fiber regeneration and mech. properties (force development and resistance to stretch) of mdx and transgenic mdx skeletal and diaphragm muscle.  The utrophin levels required in muscle are significantly less than the normal endogenous in utrophin levels seen in lung and kidney, and the authors provide evidence that the pathol. depends on the amt. of utrophin expression.  These results also have important implications for DMD therapies in which utrophin replacement is achieved by delivery using exogenous vectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkZwAIp6gKKrVg90H21EOLACvtfcHk0ljH05pq4G2mbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvVOhur0%253D&md5=3bc3ecaf7e29380b3289796b9f444ab1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F4033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F4033%26sid%3Dliteratum%253Aachs%26aulast%3DTinsley%26aufirst%3DJ.%26aulast%3DDeconinck%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DR.%26aulast%3DKahn%26aufirst%3DD.%26aulast%3DPhelps%26aufirst%3DS.%26aulast%3DGillis%26aufirst%3DJ.-M.%26aulast%3DDavies%26aufirst%3DK.%26atitle%3DExpression%2520of%2520full-length%2520utrophin%2520prevents%2520muscular%2520dystrophy%2520in%2520mdx%2520mice%26jtitle%3DNat.%2520Med.%26date%3D1998%26volume%3D4%26spage%3D1441%26epage%3D1444%26doi%3D10.1038%2F4033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">707</span>, <span class="refDoi"> DOI: 10.1002/jcph.468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1002%2Fjcph.468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=25651188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVeltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=698-707&author=J.+Tinsleyauthor=N.+Robinsonauthor=K.+E.+Davies&title=Safety%2C+tolerability%2C+and+pharmacokinetics+of+SMT+C1100%2C+a+2-arylbenzoxazole+utrophin+modulator%2C+following+single-+and+multiple-dose+administration+to+healthy+male+adult+volunteers&doi=10.1002%2Fjcph.468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers</span></div><div class="casAuthors">Tinsley, Jon; Robinson, Neil; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">698-707</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">SMT C1100 is a small mol. utrophin modulator in development to treat Duchenne muscular dystrophy.  This study evaluated the safety, tolerability, and pharmacokinetics of SMT C1100 in healthy volunteers.  This double-blind, placebo-controlled Phase 1 study comprised: Part 1, an escalating, single-dose with/without fasting involving 50 mg/kg, 100 mg/kg, 200 mg/kg, and 400 mg/kg doses; and Part 2, a multiple 10 day dose evaluation involving 100 mg/kg bid and 200 mg/kg bid doses.  Adverse events were recorded.  SMT C1100 was absorbed rapidly following single and multiple oral doses, with median tmax attained within 2-3.5 h across all doses.  Considerable variability of pharmacokinetic parameters was noted among subjects.  Following single doses, systemic exposure increased in a sub-proportional manner, with the 8.0-fold dose increment resulting in 2.7- and 2.4-fold increases in AUC0-∞ and Cmax, resp.  AUC0-∞ and Cmax were estd. as 4.2- and 4.8-fold greater, resp., following food.  Systemic exposure reduced upon repeat dosing with steady-state concns. achieved within 3-5 days of multiple bid dosing.  No serious or severe adverse events were reported.  SMT C1100 was safe and well tolerated with plasma concns. achieved sufficient to cause a 50% increase in concns. of utrophin in cells in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS-otCqjm06rVg90H21EOLACvtfcHk0lgyC2w5IsF4vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVeltL0%253D&md5=be9902e46e42d7921a17657a263ff552</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fjcph.468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcph.468%26sid%3Dliteratum%253Aachs%26aulast%3DTinsley%26aufirst%3DJ.%26aulast%3DRobinson%26aufirst%3DN.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520pharmacokinetics%2520of%2520SMT%2520C1100%252C%2520a%25202-arylbenzoxazole%2520utrophin%2520modulator%252C%2520following%2520single-%2520and%2520multiple-dose%2520administration%2520to%2520healthy%2520male%2520adult%2520volunteers%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2015%26volume%3D55%26spage%3D698%26epage%3D707%26doi%3D10.1002%2Fjcph.468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ricotti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roper, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejura, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muntoni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to pediatric patients with Duchenne muscular dystrophy</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0152840</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0152840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1371%2Fjournal.pone.0152840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=27055247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1OqsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&author=V.+Ricottiauthor=S.+Spintyauthor=H.+Roperauthor=I.+Hughesauthor=B.+Tejuraauthor=N.+Robinsonauthor=G.+Laytonauthor=K.+Daviesauthor=F.+Muntoniauthor=J.+Tinsley&title=Safety%2C+tolerability%2C+and+pharmacokinetics+of+SMT+C1100%2C+a+2-arylbenzoxazole+utrophin+modulator%2C+following+single-+and+multiple-dose+administration+to+pediatric+patients+with+Duchenne+muscular+dystrophy&doi=10.1371%2Fjournal.pone.0152840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to pediatric patients with duchenne muscular dystrophy</span></div><div class="casAuthors">Ricotti, Valeria; Spinty, Stefan; Roper, Helen; Hughes, Imelda; Tejura, Bina; Robinson, Neil; Layton, Gary; Davies, Kay; Muntoni, Francesco; Tinsley, Jonathon</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0152840/1-e0152840/16</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Purpose SMT C1100 is a utrophin modulator being evaluated as a treatment for Duchenne muscular dystrophy (DMD).  This study, the first in pediatric DMD patients, reports the safety, tolerability and PK parameters of single and multiple doses of SMT C1100, as well as analyze potential biomarkers of muscle damage.  Methods This multicenter, Phase 1 study enrolled 12 patients, divided equally into three groups (A- C).  Group A were given 50 mg/kg on Days 1 and 11, and 50 mg/kg bid on Days 2 to 10.  Group B and C received 100 mg/kg on Days 1 and 11; Group B and Group C were given 100 mg/kg bid and 100 mg/kg tid, resp., on Days 2 to 10.  A safety review was performed on all patients following the single dose and there was at least 2 wk between each dose escalation, for safety and PK review.  Adverse events (AEs) were monitored throughout the study.  Results Most patients experienced mild AEs and there were no serious AEs.  Two patients required analgesia for pain (headache, ear pain and toothache).  One patient experienced moderate psychiatric AEs (abnormal behavior and mood swings).  Plasma concns. of SMT C1100 at Days 1 and 11 indicated a high degree of patient variability regardless of dose.  Unexpectedly the SMT C1100 levels were significantly lower than similar doses administered to healthy volunteers in an earlier clin. study.  In general, individual baseline changes of creatine phosphokinase, alanine aminotransferase, aspartate aminotransferase levels fell with SMT C1100 dosing.  Conclusions SMT C1100 was well tolerated in pediatric DMD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt0w7VChgcJbVg90H21EOLACvtfcHk0lgyC2w5IsF4vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1OqsLzM&md5=7e3080644fb23bed4b3b4bbfab8263de</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0152840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0152840%26sid%3Dliteratum%253Aachs%26aulast%3DRicotti%26aufirst%3DV.%26aulast%3DSpinty%26aufirst%3DS.%26aulast%3DRoper%26aufirst%3DH.%26aulast%3DHughes%26aufirst%3DI.%26aulast%3DTejura%26aufirst%3DB.%26aulast%3DRobinson%26aufirst%3DN.%26aulast%3DLayton%26aufirst%3DG.%26aulast%3DDavies%26aufirst%3DK.%26aulast%3DMuntoni%26aufirst%3DF.%26aulast%3DTinsley%26aufirst%3DJ.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520pharmacokinetics%2520of%2520SMT%2520C1100%252C%2520a%25202-arylbenzoxazole%2520utrophin%2520modulator%252C%2520following%2520single-%2520and%2520multiple-dose%2520administration%2520to%2520pediatric%2520patients%2520with%2520Duchenne%2520muscular%2520dystrophy%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26doi%3D10.1371%2Fjournal.pone.0152840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><a href="https://musculardystrophynews.com/2018/06/29/summit-therapeutics-ends-ezutromid-development-trail-failure/" class="extLink">https://musculardystrophynews.com/2018/06/29/summit-therapeutics-ends-ezutromid-development-trail-failure/</a> (accessed June 1, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fmusculardystrophynews.com%2F2018%2F06%2F29%2Fsummit-therapeutics-ends-ezutromid-development-trail-failure%2F+%28accessed+June+1%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatzopoulou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsey, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harriman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, I. V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span></span> <span> </span><span class="NLM_article-title">Isolation, structural identification, synthesis, and pharmacological profiling of 1,2-trans-dihydro-1,2-diol metabolites of the utrophin modulator ezutromid</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2547</span>– <span class="NLM_lpage">2556</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01547</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01547" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCgtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2547-2556&author=M.+Chatzopoulouauthor=T.+D.+W.+Claridgeauthor=K.+E.+Daviesauthor=S.+G.+Daviesauthor=D.+J.+Elseyauthor=E.+Emerauthor=A.+M.+Fletcherauthor=S.+Harrimanauthor=N.+Robinsonauthor=J.+A.+Rowleyauthor=A.+J.+Russellauthor=J.+M.+Tinsleyauthor=R.+Weaverauthor=I.+V.+L.+Wilkinsonauthor=N.+J.+Willisauthor=F.+X.+Wilsonauthor=G.+M.+Wynne&title=Isolation%2C+structural+identification%2C+synthesis%2C+and+pharmacological+profiling+of+1%2C2-trans-dihydro-1%2C2-diol+metabolites+of+the+utrophin+modulator+ezutromid&doi=10.1021%2Facs.jmedchem.9b01547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-trans-Dihydro-1,2-diol Metabolites of the Utrophin Modulator Ezutromid</span></div><div class="casAuthors">Chatzopoulou, Maria; Claridge, Tim D. W.; Davies, Kay E.; Davies, Stephen G.; Elsey, David J.; Emer, Enrico; Fletcher, Ai M.; Harriman, Shawn; Robinson, Neil; Rowley, Jessica A.; Russell, Angela J.; Tinsley, Jonathon M.; Weaver, Richard; Wilkinson, Isabel V. L.; Willis, Nicky J.; Wilson, Francis X.; Wynne, Graham M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2547-2556</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">5-(Ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole (ezutromid, 1) is a first-in-class utrophin modulator that has been evaluated in a phase 2 clin. study for the treatment of Duchenne muscular dystrophy (DMD).  Ezutromid was found to undergo hepatic oxidn. of its 2-naphthyl substituent to produce two regioisomeric 1,2-dihydronaphthalene-1,2-diols, DHD1 and DHD3, as the major metabolites after oral administration in humans and rodents.  In many patients, plasma levels of the DHD metabolites were found to exceed those of ezutromid.  Herein, we describe the structural elucidation of the main metabolites of ezutromid, the regio- and relative stereochem. assignments of DHD1 and DHD3, their de novo chem. synthesis, and their prodn. in systems in vitro.  We further elucidate the likely metabolic pathway and CYP isoforms responsible for DHD1 and DHD3 prodn. and characterize their physicochem., ADME, and pharmacol. properties and their preliminary toxicol. profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAF3273Wda9rVg90H21EOLACvtfcHk0lhIecS8vkJyjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCgtL7E&md5=7b96559aeb7aa13eb81417bd556ff1fb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01547%26sid%3Dliteratum%253Aachs%26aulast%3DChatzopoulou%26aufirst%3DM.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%2BW.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26aulast%3DDavies%26aufirst%3DS.%2BG.%26aulast%3DElsey%26aufirst%3DD.%2BJ.%26aulast%3DEmer%26aufirst%3DE.%26aulast%3DFletcher%26aufirst%3DA.%2BM.%26aulast%3DHarriman%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DN.%26aulast%3DRowley%26aufirst%3DJ.%2BA.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DTinsley%26aufirst%3DJ.%2BM.%26aulast%3DWeaver%26aufirst%3DR.%26aulast%3DWilkinson%26aufirst%3DI.%2BV.%2BL.%26aulast%3DWillis%26aufirst%3DN.%2BJ.%26aulast%3DWilson%26aufirst%3DF.%2BX.%26aulast%3DWynne%26aufirst%3DG.%2BM.%26atitle%3DIsolation%252C%2520structural%2520identification%252C%2520synthesis%252C%2520and%2520pharmacological%2520profiling%2520of%25201%252C2-trans-dihydro-1%252C2-diol%2520metabolites%2520of%2520the%2520utrophin%2520modulator%2520ezutromid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D2547%26epage%3D2556%26doi%3D10.1021%2Facs.jmedchem.9b01547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chancellor, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Moor, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorgan, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maillol, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugent, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poignant, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pye, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Well, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vile, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkes, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wren, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">3241</span>– <span class="NLM_lpage">3250</span>, <span class="refDoi"> DOI: 10.1021/jm200135z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200135z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVSgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3241-3250&author=D.+R.+Chancellorauthor=K.+E.+Daviesauthor=O.+De+Moorauthor=C.+R.+Dorganauthor=P.+D.+Johnsonauthor=A.+G.+Lambertauthor=D.+Lawrenceauthor=C.+Lecciauthor=C.+Maillolauthor=P.+J.+Middletonauthor=G.+Nugentauthor=S.+D.+Poignantauthor=A.+C.+Potterauthor=P.+D.+Priceauthor=R.+J.+Pyeauthor=R.+Storerauthor=J.+M.+Tinsleyauthor=R.+van+Wellauthor=R.+Vickersauthor=J.+Vileauthor=F.+J.+Wilkesauthor=F.+X.+Wilsonauthor=S.+P.+Wrenauthor=G.+M.+Wynne&title=Discovery+of+2-arylbenzoxazoles+as+upregulators+of+utrophin+production+for+the+treatment+of+Duchenne+muscular+dystrophy&doi=10.1021%2Fjm200135z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-Arylbenzoxazoles as Upregulators of Utrophin Production for the Treatment of Duchenne Muscular Dystrophy</span></div><div class="casAuthors">Chancellor, Daniel R.; Davies, Kay E.; De Moor, Olivier; Dorgan, Colin R.; Johnson, Peter D.; Lambert, Adam G.; Lawrence, Daniel; Lecci, Cristina; Maillol, Carole; Middleton, Penny J.; Nugent, Gary; Poignant, Severine D.; Potter, Allyson C.; Price, Paul D.; Pye, Richard J.; Storer, Richard; Tinsley, Jonathon M.; van Well, Renate; Vickers, Richard; Vile, Julia; Wilkes, Fraser J.; Wilson, Francis X.; Wren, Stephen P.; Wynne, Graham M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3241-3250</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel 2-arylbenzoxazoles that upregulate the prodn. of utrophin in murine H2K cells, as assessed using a luciferase reporter linked assay, have been identified.  This compd. class appears to hold considerable promise as a potential treatment for Duchenne muscular dystrophy.  Following the delineation of structure-activity relationships in the series, a no. of potent upregulators were identified, and preliminary ADME evaluation is described.  These studies have resulted in the identification 5-(ethylsulfonyl)-2-(2-naphthyl)benzo[d]oxazole, a compd. that has been progressed to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5YotrFzaHAbVg90H21EOLACvtfcHk0ljwDCFKAdp8hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVSgu74%253D&md5=3e4add2ecaebc8c4517cf113b5399371</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm200135z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200135z%26sid%3Dliteratum%253Aachs%26aulast%3DChancellor%26aufirst%3DD.%2BR.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26aulast%3DDe%2BMoor%26aufirst%3DO.%26aulast%3DDorgan%26aufirst%3DC.%2BR.%26aulast%3DJohnson%26aufirst%3DP.%2BD.%26aulast%3DLambert%26aufirst%3DA.%2BG.%26aulast%3DLawrence%26aufirst%3DD.%26aulast%3DLecci%26aufirst%3DC.%26aulast%3DMaillol%26aufirst%3DC.%26aulast%3DMiddleton%26aufirst%3DP.%2BJ.%26aulast%3DNugent%26aufirst%3DG.%26aulast%3DPoignant%26aufirst%3DS.%2BD.%26aulast%3DPotter%26aufirst%3DA.%2BC.%26aulast%3DPrice%26aufirst%3DP.%2BD.%26aulast%3DPye%26aufirst%3DR.%2BJ.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DTinsley%26aufirst%3DJ.%2BM.%26aulast%3Dvan%2BWell%26aufirst%3DR.%26aulast%3DVickers%26aufirst%3DR.%26aulast%3DVile%26aufirst%3DJ.%26aulast%3DWilkes%26aufirst%3DF.%2BJ.%26aulast%3DWilson%26aufirst%3DF.%2BX.%26aulast%3DWren%26aufirst%3DS.%2BP.%26aulast%3DWynne%26aufirst%3DG.%2BM.%26atitle%3DDiscovery%2520of%25202-arylbenzoxazoles%2520as%2520upregulators%2520of%2520utrophin%2520production%2520for%2520the%2520treatment%2520of%2520Duchenne%2520muscular%2520dystrophy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3241%26epage%3D3250%26doi%3D10.1021%2Fjm200135z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Babbs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatzopoulou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsey, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figuccia, A. L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guiraud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harriman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moir, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squire, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of SMT022357 enantiomers and in vivo evaluation in a Duchenne muscular dystrophy mouse model</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">130819</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2019.130819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1016%2Fj.tet.2019.130819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVajsr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2020&pages=130819&author=A.+Babbsauthor=A.+Bergauthor=M.+Chatzopoulouauthor=K.+E.+Daviesauthor=S.+G.+Daviesauthor=B.+Edwardsauthor=D.+J.+Elseyauthor=E.+Emerauthor=A.+L.+A.+Figucciaauthor=A.+M.+Fletcherauthor=S.+Guiraudauthor=S.+Harrimanauthor=L.+Moirauthor=N.+Robinsonauthor=J.+A.+Rowleyauthor=A.+J.+Russellauthor=S.+E.+Squireauthor=J.+E.+Thomsonauthor=J.+M.+Tinsleyauthor=F.+X.+Wilsonauthor=G.+M.+Wynne&title=Synthesis+of+SMT022357+enantiomers+and+in+vivo+evaluation+in+a+Duchenne+muscular+dystrophy+mouse+model&doi=10.1016%2Fj.tet.2019.130819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of SMT022357 enantiomers and in vivo evaluation in a Duchenne muscular dystrophy mouse model</span></div><div class="casAuthors">Babbs, Arran; Berg, Adam; Chatzopoulou, Maria; Davies, Kay E.; Davies, Stephen G.; Edwards, Benjamin; Elsey, David J.; Emer, Enrico; Figuccia, Aude L. A.; Fletcher, Ai M.; Guiraud, Simon; Harriman, Shawn; Moir, Lee; Robinson, Neil; Rowley, Jessica A.; Russell, Angela J.; Squire, Sarah E.; Thomson, James E.; Tinsley, Jonathon M.; Wilson, Francis X.; Wynne, Graham M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">130819</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Following on from ezutromid, the first-in-class benzoxazole utrophin modulator that progressed to Phase 2 clin. trials for the treatment of Duchenne muscular dystrophy, a new chemotype was designed to optimize its physicochem. and ADME profile.  Herein, we report the synthesis of SMT022357 (I), a second generation utrophin modulator preclin. candidate, and an asym. synthesis of its constituent enantiomers.  The pharmacol. properties of both enantiomers were evaluated in vitro and in vivo.  No significant difference in the activity or efficacy was obsd. between the two enantiomers; activity was found to be comparable to the racemic mixt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbXKqmEeQNcbVg90H21EOLACvtfcHk0ljwDCFKAdp8hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVajsr7F&md5=428938ac686524943c7a3a550b2bd2a2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2019.130819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2019.130819%26sid%3Dliteratum%253Aachs%26aulast%3DBabbs%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DA.%26aulast%3DChatzopoulou%26aufirst%3DM.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26aulast%3DDavies%26aufirst%3DS.%2BG.%26aulast%3DEdwards%26aufirst%3DB.%26aulast%3DElsey%26aufirst%3DD.%2BJ.%26aulast%3DEmer%26aufirst%3DE.%26aulast%3DFiguccia%26aufirst%3DA.%2BL.%2BA.%26aulast%3DFletcher%26aufirst%3DA.%2BM.%26aulast%3DGuiraud%26aufirst%3DS.%26aulast%3DHarriman%26aufirst%3DS.%26aulast%3DMoir%26aufirst%3DL.%26aulast%3DRobinson%26aufirst%3DN.%26aulast%3DRowley%26aufirst%3DJ.%2BA.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DSquire%26aufirst%3DS.%2BE.%26aulast%3DThomson%26aufirst%3DJ.%2BE.%26aulast%3DTinsley%26aufirst%3DJ.%2BM.%26aulast%3DWilson%26aufirst%3DF.%2BX.%26aulast%3DWynne%26aufirst%3DG.%2BM.%26atitle%3DSynthesis%2520of%2520SMT022357%2520enantiomers%2520and%2520in%2520vivo%2520evaluation%2520in%2520a%2520Duchenne%2520muscular%2520dystrophy%2520mouse%2520model%26jtitle%3DTetrahedron%26date%3D2020%26volume%3D76%26spage%3D130819%26doi%3D10.1016%2Fj.tet.2019.130819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, I. V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugdale, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moir, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuorinen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatzopoulou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squire, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monecke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charles, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastinejad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, A. J.</span></span> <span> </span><span class="NLM_article-title">Chemical proteomics and phenotypic profiling identifies the aryl hydrocarbon receptor as a molecular target of the utrophin modulator ezutromid</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2420</span>– <span class="NLM_lpage">2428</span>, <span class="refDoi"> DOI: 10.1002/anie.201912392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1002%2Fanie.201912392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjt1OisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2020&pages=2420-2428&author=I.+V.+L.+Wilkinsonauthor=K.+J.+Perkinsauthor=H.+Dugdaleauthor=L.+Moirauthor=A.+Vuorinenauthor=M.+Chatzopoulouauthor=S.+E.+Squireauthor=S.+Moneckeauthor=A.+Lomowauthor=M.+Geeseauthor=P.+D.+Charlesauthor=P.+Burchauthor=J.+M.+Tinsleyauthor=G.+M.+Wynneauthor=S.+G.+Daviesauthor=F.+X.+Wilsonauthor=F.+Rastinejadauthor=S.+Mohammedauthor=K.+E.+Daviesauthor=A.+J.+Russell&title=Chemical+proteomics+and+phenotypic+profiling+identifies+the+aryl+hydrocarbon+receptor+as+a+molecular+target+of+the+utrophin+modulator+ezutromid&doi=10.1002%2Fanie.201912392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Proteomics and Phenotypic Profiling Identifies the Aryl Hydrocarbon Receptor as a Molecular Target of the Utrophin Modulator Ezutromid</span></div><div class="casAuthors">Wilkinson, Isabel V. L.; Perkins, Kelly J.; Dugdale, Hannah; Moir, Lee; Vuorinen, Aini; Chatzopoulou, Maria; Squire, Sarah E.; Monecke, Sebastian; Lomow, Alexander; Geese, Marcus; Charles, Philip D.; Burch, Peter; Tinsley, Jonathan M.; Wynne, Graham M.; Davies, Stephen G.; Wilson, Francis X.; Rastinejad, Fraydoon; Mohammed, Shabaz; Davies, Kay E.; Russell, Angela J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2420-2428</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Duchenne muscular dystrophy (DMD) is a fatal muscle-wasting disease arising from mutations in the dystrophin gene.  Upregulation of utrophin to compensate for the missing dystrophin offers a potential therapy independent of patient genotype.  The first-in-class utrophin modulator ezutromid/SMT C1100 was developed from a phenotypic screen through to a Phase 2 clin. trial.  Promising efficacy and evidence of target engagement was obsd. in DMD patients after 24 wk of treatment, however trial endpoints were not met after 48 wk.  The objective of this study was to understand the mechanism of action of ezutromid which could explain the lack of sustained efficacy and help development of new generations of utrophin modulators.  Using chem. proteomics and phenotypic profiling we show that the aryl hydrocarbon receptor (AhR) is a target of ezutromid.  Several lines of evidence demonstrate that ezutromid binds AhR with an apparent KD of 50 nM and behaves as an AhR antagonist.  Furthermore, other reported AhR antagonists also upregulate utrophin, showing that this pathway, which is currently being explored in other clin. applications including oncol. and rheumatoid arthritis, could also be exploited in future DMD therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8uhmyItj_pLVg90H21EOLACvtfcHk0lhlfm5kQwitUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjt1OisA%253D%253D&md5=1860fc7c7884d932be4938d6627c692c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fanie.201912392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201912392%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DI.%2BV.%2BL.%26aulast%3DPerkins%26aufirst%3DK.%2BJ.%26aulast%3DDugdale%26aufirst%3DH.%26aulast%3DMoir%26aufirst%3DL.%26aulast%3DVuorinen%26aufirst%3DA.%26aulast%3DChatzopoulou%26aufirst%3DM.%26aulast%3DSquire%26aufirst%3DS.%2BE.%26aulast%3DMonecke%26aufirst%3DS.%26aulast%3DLomow%26aufirst%3DA.%26aulast%3DGeese%26aufirst%3DM.%26aulast%3DCharles%26aufirst%3DP.%2BD.%26aulast%3DBurch%26aufirst%3DP.%26aulast%3DTinsley%26aufirst%3DJ.%2BM.%26aulast%3DWynne%26aufirst%3DG.%2BM.%26aulast%3DDavies%26aufirst%3DS.%2BG.%26aulast%3DWilson%26aufirst%3DF.%2BX.%26aulast%3DRastinejad%26aufirst%3DF.%26aulast%3DMohammed%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26atitle%3DChemical%2520proteomics%2520and%2520phenotypic%2520profiling%2520identifies%2520the%2520aryl%2520hydrocarbon%2520receptor%2520as%2520a%2520molecular%2520target%2520of%2520the%2520utrophin%2520modulator%2520ezutromid%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2020%26volume%3D59%26spage%3D2420%26epage%3D2428%26doi%3D10.1002%2Fanie.201912392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span>; <span class="NLM_string-name">Wren, S. P.</span>; <span class="NLM_string-name">Johnson, P. D.</span>; <span class="NLM_string-name">Price, D.</span>; <span class="NLM_string-name">De Moor, O.</span>; <span class="NLM_string-name">Nugent, G.</span>; <span class="NLM_string-name">Tinsley, J. M.</span>; <span class="NLM_string-name">Storer, R.</span>; <span class="NLM_string-name">Mulvaney, A.</span>; <span class="NLM_string-name">Pye, R. J.</span>; <span class="NLM_string-name">Dorgan, C. R.</span></span> <span> </span><span class="NLM_article-title">Treatment of duchenne muscular dystrophy</span>. <span class="NLM_patent">WO2007091106A2</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=G.+M.+Wynne&author=S.+P.+Wren&author=P.+D.+Johnson&author=D.+Price&author=O.+De+Moor&author=G.+Nugent&author=J.+M.+Tinsley&author=R.+Storer&author=A.+Mulvaney&author=R.+J.+Pye&author=C.+R.+Dorgan&title=Treatment+of+duchenne+muscular+dystrophy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWynne%26aufirst%3DG.%2BM.%26atitle%3DTreatment%2520of%2520duchenne%2520muscular%2520dystrophy%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birch, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brocklehurst, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butlin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidsson, Ö.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ertan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groombridge, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macfaul, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrecher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickup, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sörme, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, J.</span></span> <span> </span><span class="NLM_article-title">Use of small-molecule crystal structures to address solubility in a novel series of G protein coupled receptor 119 agonists: optimization of a lead and in vivo evaluation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5361</span>– <span class="NLM_lpage">5379</span>, <span class="refDoi"> DOI: 10.1021/jm300310c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300310c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Oqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5361-5379&author=J.+S.+Scottauthor=A.+M.+Birchauthor=K.+J.+Brocklehurstauthor=A.+Brooauthor=H.+S.+Brownauthor=R.+J.+Butlinauthor=D.+S.+Clarkeauthor=%C3%96.+Davidssonauthor=A.+Ertanauthor=K.+Goldbergauthor=S.+D.+Groombridgeauthor=J.+A.+Hudsonauthor=D.+Laberauthor=A.+G.+Leachauthor=P.+A.+Macfaulauthor=D.+McKerrecherauthor=A.+Pickupauthor=P.+Schofieldauthor=P.+H.+Svenssonauthor=P.+S%C3%B6rmeauthor=J.+Teague&title=Use+of+small-molecule+crystal+structures+to+address+solubility+in+a+novel+series+of+G+protein+coupled+receptor+119+agonists%3A+optimization+of+a+lead+and+in+vivo+evaluation&doi=10.1021%2Fjm300310c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Small-Molecule Crystal Structures To Address Solubility in a Novel Series of G Protein Coupled Receptor 119 Agonists: Optimization of a Lead and in Vivo Evaluation</span></div><div class="casAuthors">Scott, James S.; Birch, Alan M.; Brocklehurst, Katy J.; Broo, Anders; Brown, Hayley S.; Butlin, Roger J.; Clarke, David S.; Davidsson, Ojvind; Ertan, Anne; Goldberg, Kristin; Groombridge, Sam D.; Hudson, Julian A.; Laber, David; Leach, Andrew G.; MacFaul, Philip A.; McKerrecher, Darren; Pickup, Adrian; Schofield, Paul; Svensson, Per H.; Sorme, Pernilla; Teague, Joanne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5361-5379</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">G protein coupled receptor 119 (GPR119) is viewed as an attractive target for the treatment of type 2 diabetes and other elements of the metabolic syndrome.  During a program toward discovering agonists of GPR119, we herein describe optimization of an initial lead compd., 2, into a development candidate, 42.  A key challenge in this program of work was the insoly. of the lead compd.  Small-mol. crystallog. was utilized to understand the intermol. interactions in the solid state and resulted in a switch from an aryl sulfone to a 3-cyanopyridyl motif.  The compd. was shown to be effective in wild-type but not knockout animals, confirming that the biol. effects were due to GPR119 agonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXZ_DoHJ0cfrVg90H21EOLACvtfcHk0lgN6vbS-F_i5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Oqt78%253D&md5=3cd34d57e05864ddcc87c51f034f9188</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm300310c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300310c%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DBirch%26aufirst%3DA.%2BM.%26aulast%3DBrocklehurst%26aufirst%3DK.%2BJ.%26aulast%3DBroo%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DH.%2BS.%26aulast%3DButlin%26aufirst%3DR.%2BJ.%26aulast%3DClarke%26aufirst%3DD.%2BS.%26aulast%3DDavidsson%26aufirst%3D%25C3%2596.%26aulast%3DErtan%26aufirst%3DA.%26aulast%3DGoldberg%26aufirst%3DK.%26aulast%3DGroombridge%26aufirst%3DS.%2BD.%26aulast%3DHudson%26aufirst%3DJ.%2BA.%26aulast%3DLaber%26aufirst%3DD.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DMacfaul%26aufirst%3DP.%2BA.%26aulast%3DMcKerrecher%26aufirst%3DD.%26aulast%3DPickup%26aufirst%3DA.%26aulast%3DSchofield%26aufirst%3DP.%26aulast%3DSvensson%26aufirst%3DP.%2BH.%26aulast%3DS%25C3%25B6rme%26aufirst%3DP.%26aulast%3DTeague%26aufirst%3DJ.%26atitle%3DUse%2520of%2520small-molecule%2520crystal%2520structures%2520to%2520address%2520solubility%2520in%2520a%2520novel%2520series%2520of%2520G%2520protein%2520coupled%2520receptor%2520119%2520agonists%253A%2520optimization%2520of%2520a%2520lead%2520and%2520in%2520vivo%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5361%26epage%3D5379%26doi%3D10.1021%2Fjm300310c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krise, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stella, V. J.</span></span> <span> </span><span class="NLM_article-title">Prodrugs of phosphates, phosphonates, and phosphinates</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1016/0169-409X(95)00111-J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1016%2F0169-409X%2895%2900111-J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADyaK28XjtFaktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1996&pages=287-310&author=J.+P.+Kriseauthor=V.+J.+Stella&title=Prodrugs+of+phosphates%2C+phosphonates%2C+and+phosphinates&doi=10.1016%2F0169-409X%2895%2900111-J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs of phosphates, phosphonates, and phosphinates</span></div><div class="casAuthors">Krise, Jeffrey P.; Stella, Valentino J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">287-310</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 140 refs.  The literature on the use of prodrugs to overcome the drug delivery obstacles assocd. with phosphate, phosphonate and phosphinate functional group-contg. drugs is discussed..  This is an important area of research because, although we have been successful at identifying numerous phosphate and phosphonate functional group-contg. drugs as antiviral and anticancer agents, as well as for other uses, our ability to orally deliver these drugs and to target them to desired sites has led to limited success.  Various acyloxymethyl- and aryl-ester prodrugs have shown promise.  Alternative and imaginative approaches may be necessary before complete success is realized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYd9eXJQQYTbVg90H21EOLACvtfcHk0lgN6vbS-F_i5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtFaktrk%253D&md5=a713ce634f888106c16e67052da37b2e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0169-409X%2895%2900111-J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0169-409X%252895%252900111-J%26sid%3Dliteratum%253Aachs%26aulast%3DKrise%26aufirst%3DJ.%2BP.%26aulast%3DStella%26aufirst%3DV.%2BJ.%26atitle%3DProdrugs%2520of%2520phosphates%252C%2520phosphonates%252C%2520and%2520phosphinates%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1996%26volume%3D19%26spage%3D287%26epage%3D310%26doi%3D10.1016%2F0169-409X%2895%2900111-J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, G.-X.</span>; <span class="NLM_string-name">Krise, J. P.</span>; <span class="NLM_string-name">Oliyai, R.</span></span> <span> </span><span class="NLM_article-title">Prodrugs of Phosphonates, Phosphinates, and Phosphates</span>. In  <i>Prodrugs: Challenges and Rewards Part 1</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stella, V. J.</span>, <span class="NLM_string-name">Borchardt, R. T.</span>, <span class="NLM_string-name">Hageman, M. J.</span>, <span class="NLM_string-name">Oliyai, R.</span>, <span class="NLM_string-name">Maag, H.</span>, <span class="NLM_string-name">Tilley, J. W.</span></span>, Eds.; <span class="NLM_publisher-name">Springer New York</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">964</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1007%2F978-0-387-49785-3_25" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=923-964&author=G.-X.+He&author=J.+P.+Krise&author=R.+Oliyaiauthor=V.+J.+Stella&author=R.+T.+Borchardt&author=M.+J.+Hageman&author=R.+Oliyai&author=H.+Maag&author=J.+W.+Tilley&title=Prodrugs%3A+Challenges+and+Rewards+Part+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-49785-3_25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-0-387-49785-3_25%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DG.-X.%26atitle%3DProdrugs%2520of%2520Phosphonates%252C%2520Phosphinates%252C%2520and%2520Phosphates%26btitle%3DProdrugs%253A%2520Challenges%2520and%2520Rewards%2520Part%25201%26aulast%3DStella%26aufirst%3DV.%2BJ.%26pub%3DSpringer%2520New%2520York%26date%3D2007%26spage%3D923%26epage%3D964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njardarson, J. T.</span></span> <span> </span><span class="NLM_article-title">Beyond C, H, O, and N! Analysis of the elemental composition of U.S. FDA approved drug architectures</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9764</span>– <span class="NLM_lpage">9773</span>, <span class="refDoi"> DOI: 10.1021/jm501105n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501105n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1WlurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9764-9773&author=B.+R.+Smithauthor=C.+M.+Eastmanauthor=J.+T.+Njardarson&title=Beyond+C%2C+H%2C+O%2C+and+N%21+Analysis+of+the+elemental+composition+of+U.S.+FDA+approved+drug+architectures&doi=10.1021%2Fjm501105n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond C, H, O, and N! Analysis of the Elemental Composition of U.S. FDA Approved Drug Architectures</span></div><div class="casAuthors">Smith, Brandon R.; Eastman, Candice M.; Njardarson, Jon T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9764-9773</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The diversity of elements among U.S.  Food and Drug Administration (FDA) approved pharmaceuticals is analyzed and reported, with a focus on atoms other than carbon, hydrogen, oxygen, and nitrogen.  Our anal. reveals that sulfur, chlorine, fluorine, and phosphorous represent about 90% of elemental substitutions, with sulfur being the fifth most used element followed closely by chlorine, then fluorine and finally phosphorous in the eighth place.  The remaining 10% of substitutions are represented by 16 other elements of which bromine, iodine, and iron occur most frequently.  The most detailed parts of our anal. are focused on chlorinated drugs as a function of approval date, disease condition, chlorine attachment, and structure.  To better aid our chlorine drug analyses, a new poster showcasing the structures of chlorinated pharmaceuticals was created specifically for this study.  Phosphorus, bromine, and iodine contg. drugs are analyzed closely as well, followed by a discussion about other elements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqLwTieDN1HbVg90H21EOLACvtfcHk0lhoL8B49mFRCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1WlurbL&md5=95e1ab686ba41c63070059ad0987ff6c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm501105n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501105n%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DEastman%26aufirst%3DC.%2BM.%26aulast%3DNjardarson%26aufirst%3DJ.%2BT.%26atitle%3DBeyond%2520C%252C%2520H%252C%2520O%252C%2520and%2520N%2521%2520Analysis%2520of%2520the%2520elemental%2520composition%2520of%2520U.S.%2520FDA%2520approved%2520drug%2520architectures%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9764%26epage%3D9773%26doi%3D10.1021%2Fjm501105n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lea, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auld, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglese, J.</span></span> <span> </span><span class="NLM_article-title">Firefly luciferase in chemical biology: a compendium of Inhibitors, mechanistic evaluation of chemotypes, and suggested use as a reporter</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1072</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2012.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1016%2Fj.chembiol.2012.07.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=22921073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KkurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1060-1072&author=N.+Thorneauthor=M.+Shenauthor=W.+A.+Leaauthor=A.+Simeonovauthor=S.+Lovellauthor=D.+S.+Auldauthor=J.+Inglese&title=Firefly+luciferase+in+chemical+biology%3A+a+compendium+of+Inhibitors%2C+mechanistic+evaluation+of+chemotypes%2C+and+suggested+use+as+a+reporter&doi=10.1016%2Fj.chembiol.2012.07.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Firefly Luciferase in Chemical Biology: A Compendium of Inhibitors, Mechanistic Evaluation of Chemotypes, and Suggested Use As a Reporter</span></div><div class="casAuthors">Thorne, Natasha; Shen, Min; Lea, Wendy A.; Simeonov, Anton; Lovell, Scott; Auld, Douglas S.; Inglese, James</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1060-1072</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Firefly luciferase (FLuc) is frequently used as a reporter in high-throughput screening assays, owing to the exceptional sensitivity, dynamic range, and rapid measurement that bioluminescence affords.  However, interaction of small mols. with FLuc has, to some extent, confounded its use in chem. biol. and drug discovery.  To identify and characterize chemotypes interacting with FLuc, we detd. potency values for 360,864 compds. found in the NIH Mol. Libraries Small Mol. Repository, available in PubChem.  FLuc inhibitory activity was obsd. for 12% of this library with discernible SAR.  Characterization of 151 inhibitors demonstrated a variety of inhibition modes, including FLuc-catalyzed formation of multisubstrate adduct enzyme inhibitor complexes.  As in some cell-based FLuc reporter assays, compds. acting as FLuc inhibitors yield paradoxical luminescence increases, thus data on compds. acquired from FLuc-dependent assays require careful anal. as described here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWw4FbLlFcILVg90H21EOLACvtfcHk0lhoL8B49mFRCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KkurjM&md5=5ab0f756ab0a3ece1ea28ffac52bbd5f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DThorne%26aufirst%3DN.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DLea%26aufirst%3DW.%2BA.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DLovell%26aufirst%3DS.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DInglese%26aufirst%3DJ.%26atitle%3DFirefly%2520luciferase%2520in%2520chemical%2520biology%253A%2520a%2520compendium%2520of%2520Inhibitors%252C%2520mechanistic%2520evaluation%2520of%2520chemotypes%252C%2520and%2520suggested%2520use%2520as%2520a%2520reporter%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D1060%26epage%3D1072%26doi%3D10.1016%2Fj.chembiol.2012.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, I. V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, S. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuorinen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sills, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pires, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, A. J.</span></span> <span> </span><span class="NLM_article-title">Characterisation of utrophin modulator SMT C1100 as a non-competitive inhibitor of firefly luciferase</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">103395</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2019.103395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1016%2Fj.bioorg.2019.103395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=31733898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFOmurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2020&pages=103395&author=I.+V.+L.+Wilkinsonauthor=J.+K.+Reynoldsauthor=S.+R.+G.+Galanauthor=A.+Vuorinenauthor=A.+J.+Sillsauthor=E.+Piresauthor=G.+M.+Wynneauthor=F.+X.+Wilsonauthor=A.+J.+Russell&title=Characterisation+of+utrophin+modulator+SMT+C1100+as+a+non-competitive+inhibitor+of+firefly+luciferase&doi=10.1016%2Fj.bioorg.2019.103395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of utrophin modulator SMT C1100 as a non-competitive inhibitor of firefly luciferase</span></div><div class="casAuthors">Wilkinson, Isabel V. L.; Reynolds, Jessica K.; Galan, Sebastien R. G.; Vuorinen, Aini; Sills, Adam J.; Pires, Elisabete; Wynne, Graham M.; Wilson, Francis X.; Russell, Angela J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103395</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Firefly luciferase (FLuc) is a powerful tool for mol. and cellular biol., and popular in high-throughput screening and drug discovery.  However, FLuc assays have been plagued with pos. and neg. artifacts due to stabilization and inhibition by small mols. from a range of chem. classes.  Here we disclose Phase II clin. compd. SMT C1100 for the treatment of Duchenne muscular dystrophy as an FLuc inhibitor (KD of 0.40 ± 0.15 μM).  Enzyme kinetic studies using SMT C1100 and other non-competitive inhibitors including resveratrol and NFκBAI4 identified previously undescribed modes of inhibition with respect to FLuc's luciferyl adenylate intermediate.  Employing a photoaffinity strategy to identify SMT C1100's binding site, a photolabeled SMT C1100 probe instead underwent FLuc-dependent photooxidn.  Our findings support novel binding sites on FLuc for non-competitive inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvU89dI6LwBLVg90H21EOLACvtfcHk0lhoL8B49mFRCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFOmurnN&md5=b0bdb5b5c075340ce01ca103acfe82ba</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2019.103395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2019.103395%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DI.%2BV.%2BL.%26aulast%3DReynolds%26aufirst%3DJ.%2BK.%26aulast%3DGalan%26aufirst%3DS.%2BR.%2BG.%26aulast%3DVuorinen%26aufirst%3DA.%26aulast%3DSills%26aufirst%3DA.%2BJ.%26aulast%3DPires%26aufirst%3DE.%26aulast%3DWynne%26aufirst%3DG.%2BM.%26aulast%3DWilson%26aufirst%3DF.%2BX.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26atitle%3DCharacterisation%2520of%2520utrophin%2520modulator%2520SMT%2520C1100%2520as%2520a%2520non-competitive%2520inhibitor%2520of%2520firefly%2520luciferase%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D94%26spage%3D103395%26doi%3D10.1016%2Fj.bioorg.2019.103395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baatsen, P. H. W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maréchal, G.</span></span> <span> </span><span class="NLM_article-title">Increased susceptibility of EDL muscles from <i>mdx</i> mice to damage induced by contractions with stretch</span>. <i>J. Muscle Res. Cell Motil.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1007/BF00121296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1007%2FBF00121296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=7693747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A280%3ADyaK2c%252FktlKrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1993&pages=446-451&author=P.+Moensauthor=P.+H.+W.+W.+Baatsenauthor=G.+Mar%C3%A9chal&title=Increased+susceptibility+of+EDL+muscles+from+mdx+mice+to+damage+induced+by+contractions+with+stretch&doi=10.1007%2FBF00121296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch</span></div><div class="casAuthors">Moens P; Baatsen P H; Marechal G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of muscle research and cell motility</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">446-51</span>
        ISSN:<span class="NLM_cas:issn">0142-4319</span>.
    </div><div class="casAbstract">Absence of dystrophin in mdx muscles may render the muscle more susceptible to damage when submitted to high stress levels.  To test this, typically slow (soleus) and fast (EDL) limb muscles of dystrophic (mdx) and normal (C57BL/10) mice were submitted (in vitro) to a series of isometric contractions, followed by a series of contractions with stretches.  Muscle injury was assessed by monitoring the force signal.  Membrane damage was evaluated by bathing the muscle in Procion Red, a dye that does not penetrate intact fibres, and subsequent analysis by light microscopy.  After isometric contractions, only a very small force drop (< 3% of maximal isometric force) was observed which indicated that no injury had occurred in soleus and EDL muscles in either mdx or C57 strains.  After contractions with a stretch, a force drop of 10% was observed in soleus muscles from both strains and in EDL muscles from C57 mice.  However, in mdx mice EDL muscles displayed an irreversible force drop of 40-60%.  Histological analysis of the muscles indicates that force drop is associated with membrane damage.  These results show that EDL muscles from mdx mice are more vulnerable than their controls, supporting the structural role hypothesis for dystrophin.  Furthermore, they suggest that contractions with stretches may contribute to the muscle damage and degeneration observed in DMD-patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3iRAPWYXqWEwlCcfExbvbfW6udTcc2ebdsCVvEYdfjLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252FktlKrtA%253D%253D&md5=16f5bd383e2f84ffea33c1caaf7d3903</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2FBF00121296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00121296%26sid%3Dliteratum%253Aachs%26aulast%3DMoens%26aufirst%3DP.%26aulast%3DBaatsen%26aufirst%3DP.%2BH.%2BW.%2BW.%26aulast%3DMar%25C3%25A9chal%26aufirst%3DG.%26atitle%3DIncreased%2520susceptibility%2520of%2520EDL%2520muscles%2520from%2520mdx%2520mice%2520to%2520damage%2520induced%2520by%2520contractions%2520with%2520stretch%26jtitle%3DJ.%2520Muscle%2520Res.%2520Cell%2520Motil.%26date%3D1993%26volume%3D14%26spage%3D446%26epage%3D451%26doi%3D10.1007%2FBF00121296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrof, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrager, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stedman, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, H. L.</span></span> <span> </span><span class="NLM_article-title">Dystrophin protects the sarcolemma from stresses developed during muscle contraction</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">3710</span>– <span class="NLM_lpage">3714</span>, <span class="refDoi"> DOI: 10.1073/pnas.90.8.3710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=10.1073%2Fpnas.90.8.3710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=8475120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;key=1%3ACAS%3A528%3ADyaK3sXktVKnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=3710-3714&author=B.+J.+Petrofauthor=J.+B.+Shragerauthor=H.+H.+Stedmanauthor=A.+M.+Kellyauthor=H.+L.+Sweeney&title=Dystrophin+protects+the+sarcolemma+from+stresses+developed+during+muscle+contraction&doi=10.1073%2Fpnas.90.8.3710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Dystrophin protects the sarcolemma from stresses developed during muscle contraction</span></div><div class="casAuthors">Petrof, Basil J.; Shrager, Joseph B.; Stedman, Hansell H.; Kelly, Alan M.; Sweeney, H. Lee</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3710-14</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The protein dystrophin, normally found on the cytoplasmic surface of skeletal muscle cell membranes, is absent in patients with Duchenne muscular dystrophy as well as mdx (X-linked muscular dystrophy) mice.  Although its primary structure has been detd., the precise functional role of dystrophin remains the subject of speculation.  In the present study, it is demonstrated that dystrophin-deficient muscle fibers of the mdx mouse exhibit an increased susceptibility to contraction-induced sarcolemmal rupture.  The level of sarcolemmal damage is directly correlated with the magnitude of mech. stress placed upon the membrane during contraction rather than the no. of activations of the muscle.  These findings strongly support the proposition that the primary function of dystrophin is to provide mech. reinforcement to the sarcolemma and thereby protect it from the membrane stresses developed during muscle contraction.  Furthermore, the methodol. used in this study should prove useful in assessing the efficacy of dystrophin gene therapy in the mdx mouse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS5UsqDsTMTrVg90H21EOLACvtfcHk0lgK45CUFnYitA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXktVKnsb4%253D&md5=f4b0bd67110ebef785f6a9ce4b33339d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.8.3710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.8.3710%26sid%3Dliteratum%253Aachs%26aulast%3DPetrof%26aufirst%3DB.%2BJ.%26aulast%3DShrager%26aufirst%3DJ.%2BB.%26aulast%3DStedman%26aufirst%3DH.%2BH.%26aulast%3DKelly%26aufirst%3DA.%2BM.%26aulast%3DSweeney%26aufirst%3DH.%2BL.%26atitle%3DDystrophin%2520protects%2520the%2520sarcolemma%2520from%2520stresses%2520developed%2520during%2520muscle%2520contraction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1993%26volume%3D90%26spage%3D3710%26epage%3D3714%26doi%3D10.1073%2Fpnas.90.8.3710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i32"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00807">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_83122"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00807?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00807</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional tables, figures, schemes, graphs, experimental procedures, and copies of NMR spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_001.pdf">PDF</a>)</p></li><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C spectra of all the compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Molecular Formula Strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_001.pdf">jm0c00807_si_001.pdf (620.11 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_002.pdf">jm0c00807_si_002.pdf (13.54 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00807/suppl_file/jm0c00807_si_003.csv">jm0c00807_si_003.csv (6.41 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00807&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00807%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-14%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00807" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999d728853d942","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
